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Though mass spectrometry has earned a central role in the field of proteomics due 
to its versatility in a wide range of experiments, challenges and complications are still 
encountered when using mass spectrometry to characterize protein structures, post-
translational modifications (PTMs), and abundances.  In this dissertation, analytical 
methods utilizing mass spectrometry have been developed to address challenges 
associated with both qualitative and quantitative protein characterization.  The 
effectiveness of using multiple pepsin-like proteases, both separately and in mixtures, 
combined with online proteolysis using a special triaxial probe has been demonstrated on 
an amyloid beta peptide related to the onset of Alzheimer’s disease.  These findings have 
broad implications in protein structural characterization studies using hydrogen-
deuterium exchange mass spectrometry.  A wider range of proteases (Lys-C, Glu-C, and 
trypsin) and multiple fragmentation methods (collisionally activated dissociation, 
electron transfer dissociation, and decision tree) have been utilized in the discovery-based 
PTM characterization of extracellular cellulosome proteins of the bioenergy-relevent 
organism Clostridium thermocellum, resulting in the identification of 85 previously 
unknown modification sites in 28 cellulosome proteins.  These modifications may 
contribute to the structure and/or function of the cellulosome protein complex.  By using 
peptide internal standards and a triple quadrupole mass spectrometer operating in selected 
reaction monitoring mode, a method has been developed for the absolute quantitation of 
the Clostridium thermocellum cellulosome protein machine in samples ranging in 
complexity from purified cellulosome samples to whole cell lysates as an alternative to a 
previously-developed enzyme-linked immunosorbent assay method of cellulosome 
quantitation.  The precision of the cellulosome mass concentration in technical replicates 
is better than 5% relative standard deviation for all samples, indicating high precision of 
cellulosome mass concentration for this method.  Though methods and results presented 
in this dissertation have implications in the study of Alzheimer’s disease and bioenergy 
research, more broadly this dissertation focuses on development of methods to contend 
with some of the more complex challenges associated with protein characterization 
currently presented to the field of proteomics. 
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THE ROLE OF PROTEOMICS IN BIOANALYTICAL CHEMISTRY 
 
 
1.1 Mass Spectrometry in Bioanalytical Chemistry 
Understanding the fundamental interactions in biological systems is crucial to 
characterizing and thereby addressing complex problems ranging from human health (i.e. 
the origin, treatment and perhaps even prevention of disease) to environmental issues 
(how to address the ever-developing shortage of oil and environmental damage that has 
been caused through pollution of various types).  Key to understanding these biological 
interactions is determining what molecules play critical roles in biological systems, be 
they proteins, nucleic acids, lipids, or carbohydrates, among others.  Because so many 
cellular processes are dependent upon and governed by interactions at the molecular 
level, technologies based in analytical chemistry have gained widespread application, 
particularly in the “omics” fields of study, which include but are not limited to genomics, 
transcriptomics, proteomics, lipidomics, and glycomics.  As such, attacking multi-faceted 
complex biological problems requires the understanding and integration of both biology 
and analytical chemistry; an emerging field of study that merges these two extremely 
broad fields of study is referred to as bioanalytical chemistry.  Mass spectrometry is a 
very powerful tool for measurement of an analyte’s molecular mass, an intrinsic physical 
property that can be used to deduce a wide range of biological information relative to the 
analyte and biological conditions it experiences.   Mass spectrometry is particularly well 
suited for bioanalytical studies due to several key performance features (i.e. figures of 
merit), such as dynamic range, limit of detection, duty cycle, resolution, selectivity, and 
sensitivity.  These are critical factors that permit high performance characterization of 
biological samples ranging in complexity from single proteins to whole cell lysates and 
even tissues.  Although the field of mass spectrometry is certainly far from its infancy, 
the complexity of both samples and biological problems makes mass spectrometry ripe 
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for development and extension into these research fields.  As such, mass spectrometry is 
ideal for bioanalytical studies, particularly those based in protein science. 
1.2 Introduction to Proteomics 
The central dogma of molecular biology dictates that the three general transfers of 
biological information between the information-carrying biopolymers proceed as follows: 
deoxyribonucleic acid (DNA) can copy itself through DNA replication, genetic 
information from DNA can be copied to ribonucleic acid (RNA) through transcription, 
and genetic information from RNA can be decoded into proteins through translation1, 2.  
Related to these three classes of biopolymers are the studies of genomics, 
transcriptomics, and proteomics, respectively.   
Genomics is concerned with the study of an organism’s genome, which consists 
of the totality of an organism’s genetic information, both genes and non-coding DNA 
sequences.  Techniques for determining the DNA sequences were developed in the 
1970s3, 4.  The first virus genome was completed in 19775, and in 1995, whole-genome 
shotgun sequencing was used to sequence the genome of a free-living organism in its 
entirety6.  By 2001, draft sequences of the human genome were announced by two 
independent research groups7, 8.  As of early 2011, 918 species have had their genomes 
completely sequenced, including 799 species of bacteria and 39 eukaryotic species9.  
Next-generation sequencing10 methods such as pyrosequencing11, 12 and massively 
parallel signature sequencing13 ensure an ever-growing number of sequenced genomes.  
Though major efforts in genomics are still focused on sequencing genomes of different 
organisms, the availability of a massive amount of genomic data made possible through 
different genome projects has given rise to functional genomics, which strives to 
comprehend the function of genes and interactions between genes with the goal of 
understanding mechanisms of cellular functions14. 
While the genome is primarily a static library of genetic information, the 
transcriptome, which contains all RNA transcripts expressed by an organism’s genome at 
a particular point in time, is dynamic and extremely dependent upon the environmental 
conditions experienced by an organism15.  The genome contains all of an organism’s 
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genes that can be used in biological response to any condition the organism may 
experience, but in order for the organism to respond to a particular condition, genes must 
be expressed through RNA transcription to react to the stimulus.  Transcriptomics, also 
referred to as gene expression profiling, typically utilizes DNA microarrays, which 
exploit the ability of messenger RNA (mRNA) to bind specifically to the DNA sequence 
from which it originated.  The mRNA expressed in the sample is hybridized with 
complementary DNA (cDNA) that is fluorescently tagged.  By exposing the cDNA to 
microarray chips with up to thousands of spots, each containing DNA sequences 
corresponding to particular genes, the amount of gene expression under certain conditions 
can be determined by measuring the amount of fluorescence corresponding to each spot 
on the array.  The amount of cDNA detected should be equivalent to amount of mRNA in 
the sample, thus indicating the level of gene expression16.  Fluorescence measurements 
obtained with microarrays are usually compared against different conditions17, at 
different time points in a growth curve18, or more complex multiconditional 
experiments19 to determine which genes are differentially expressed relative to the 
particular conditions.  Being able to determine whether a particular gene is turned on or 
off has obvious biological significance, as the functions of many of genes in sequenced 
genomes are not entirely known.  In addition, transcriptomics has also gained popularity 
in clinical studies as a means of analyzing genes that may be upregulated or 
downregulated as the result of disease states such as cancer20. 
Analysis of the human genome draft reveals 20,000-25,000 protein-coding 
genes21.  However, it has been suggested that these genes code for up to an estimated 
1,000,000 distinct proteins22.  The large discrepancy between genes and proteins (gene: 
protein ratio of ~1:40) is likely due to factors such as alternative splicing and post-
translational modification of proteins.  The disconnect between gene expression and the 
actual form of biologically active protein is one of the main drawbacks of 
transcriptomics.  DNA microarrays have been used in studies to determine gene 
expression profiles, but oftentimes these profiles do not agree23-25 with quantitative 
protein measurements as described below in Section 1.3.  While transcriptomics certainly 
has a very important place in biological studies, one could argue that studying proteins in 
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particular organisms yields more significant biological information with respect to gene 
expression because proteins are the active participants involved in metabolic pathways 
and cellular processes as opposed to RNA, which serves more as an intermediate between 
genetic information and the active proteins.  
 Analogous to the genome, an organism’s proteome consists of all proteins 
expressed by the organism as well as all modifications made to these proteins by either 
the organism itself or environmental factors26.  As such, proteomics27 is the study and 
characterization of proteins expressed by the genome.  This involves the large-scale study 
of protein expression, function, structure, and interaction with other biomolecules28, 29.  
Proteomics is an extremely complex undertaking because proteins differ in expression 
depending upon the type of cell in an organism that is being examined and conditions to 
which that particular cell is exposed.  Because so many different aspects of proteins are 
of interest, a number of analytical and biochemical techniques have been used in 
proteomics studies, including but not limited to gel electrophoresis30, immunoblotting31, 
32, various forms of liquid chromatography (LC)33, circular dichroism34, immunoassays35, 
x-ray crystallography36, nuclear magnetic resonance (NMR) spectroscopy37, electron 
microscopy38, and mass spectrometry (MS)39.  In addition, many of these techniques have 
been combined, such as liquid chromatography and mass spectrometry (LC-MS), in 
proteomics studies to achieve characterization of proteins by analyzing multiple physical 
characteristics of the protein in a single experiment. 
1.3 Mass Spectrometry in Proteomics 
 Mass spectrometry in particular has earned a central role in proteomics40-45.  The 
analytical technology requires the ionization of proteins or peptides, typically through 
electrospray ionization (ESI)46 or matrix-assisted laser desorption ionization (MALDI)46-
49 followed by detailed measurements of their mass-to-charge ratios (m/z), generally 
using a time-of-flight mass analyzer (TOF)50, a quadrupole mass analyzer51, an ion trap 
mass analyzer52, 53, an Orbitrap mass analyzer54, or a Fourier transform ion cyclotron 
resonance (FTICR) mass analyzer55 in proteomics experiments.  Intact peptides or 
proteins, referred to as precursor ions, can be fragmented to yield product ions; this 
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process is termed tandem mass spectrometry (MS/MS or MS2)56. After analysis in the 
mass analyzer, signals from the ions are detected, typically with electron multipliers that 
measure secondary electrons emitted after collisions of ions with a plate made of an 
emissive material or detection plates that measure current induced by ions57.  Mass 
spectra are constructed by plotting ion intensity as a function of m/z.   
Typical proteomics studies are performed as either “top-down” experiments58 or 
“bottom-up” experiments59.  In top-down proteomics, intact proteins are introduced into 
the mass spectrometer, where they are fragmented.  Resulting fragment m/z values and 
intact protein m/z values are then interpreted to determine the amino acid sequence of the 
entire protein.  Bottom-up proteomics, also referred to as shotgun proteomics, requires 
the enzymatic digestion of proteins of interest followed by fragmentation of peptide 
precursor ions.  The combination of the peptide precursor ion m/z and m/z values for 
resulting product ions is matched to potential peptides determined by hypothetical (in 
silico) digestion of the protein database.  Peptide sequences are then matched to a protein 
database, which is, in turn, determined from the gene-annotated genome sequence.  
Though the sample complexity in bottom-up proteomics is increased by at least an order 
of magnitude compared to top-down proteomics due to the larger number of peptides 
resulting from enzymatic digestion of proteins, bottom-up proteomics is more widely 
used than top-down proteomics partially because chromatographic separation, ionization, 
and fragmentation of extremely complex mixtures of peptides can typically be performed 
with higher efficiency compared to analysis of complex mixtures of intact proteins.  
However, recent advances in mass spectrometry technology and informatics platforms 
have contributed to an increased utilization of top-down proteomics60. 
Mass spectrometry is well-suited for proteomics experiments based on several 
figures of merit.  Analysis of complex peptide mixtures is challenging for many 
analytical instruments because of the difficulties associated with completely separating 
components of the mixture.  Because peptides or proteins often coelute in LC-MS 
experiments, both high resolution and high mass accuracy are needed to distinguish the 
different components of biological samples.  Resolution for instruments used in proteome 
analysis ranges from ~2000 in quadrupole instruments to over 1,000,000 for FTICR 
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instruments.  Likewise, mass accuracy ranges from the ~100 mDa range for quadrupole 
instruments up to the ~100 µDa range for FTICR instruments61.  However, higher 
resolution and mass accuracy instruments come with higher prices.  A mass range from 
400 to 2,000 m/z is often utilized in discovery based proteomics experiments.   The wide 
range of resolution and mass accuracy specifications allow for a large variety of 
experiments, each with unique resolution and mass accuracy demands.   
Dynamic range is of critical concern in proteomics studies due to the wide 
difference of concentrations of proteins under biological conditions (in situ).  Studies 
with yeast have revealed proteins ranging from as few as 50 copies per cell up to 106 
copies per cell62 while estimates place the dynamic range of proteins in human plasma as 
high as 7 orders of magnitude63.  Currently, dynamic ranges as high as 5 orders of 
magnitude have been reported using mass spectrometry in unfractionated yeast samples64.  
Related to dynamic range is sensitivity; limits of detection have been reported as low as 
the zeptomolar range65 with attomole limits of quantitation in complex samples66.  High 
selectivity, also crucial to proteomics experiments given the sample complexity, can be 
achieved using repetitive tandem mass spectrometry (MSn)67  as well as targeted 
experiments68.  Likewise, the complexity of samples analyzed in proteomics requires a 
large duty cycle in order for meaningful data to be collected in reasonable time frames.  
Scans speeds as high as 16 Da/ms have been reported69 in discovery-based proteomics 
experiments whereas scan speeds of 0.1 Da/ms are typically utilized in targeted 
experiments70 described in Section 1.3.2.  These high scan rates can be combined with 
multiple dimensions of chromatography, either online or offline with an autosampler, to 
acquire data unattended for anywhere from under an hour to over 24 hours, resulting in 
enormous amounts of data with limited amount of operator input.  The combination of 
these figures of merit make mass spectrometry ideal for analysis of proteomes, and mass 
spectrometry allows for the greatest amount of high quality data and biological 
information in the least amount of time compared to other previously mentioned 
techniques commonly used in proteomics. 
Discovery-based, also referred to as global, proteomics experiments have been 
used to deduce the identities of large numbers of proteins expressed by organisms from a 
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variety of environments, including human plasma71 and tissue72, bacteria found in soil73, 
bacteria that grow under extremophile conditions74, and plants75.  Discovery-based 
experiments strive to determine the full gamut of proteins expressed by the organism 
under a particular condition using shotgun proteins.  These studies have proved useful in 
the elucidation of baseline genome expression, but the range of experiments performed 
with mass spectrometry-based proteomics extends beyond genome expression and 
profiling.  For example, by incubating proteins in deuterated buffers, their tertiary 
structure can be deduced by monitoring rates of hydrogen-deuterium exchange between 
protonated amide hydrogens along the protein backbone in a process known as hydrogen-
deuterium exchange mass spectrometery76.  This information can then be used to 
elucidate protein folding77 and determine protein dynamics78.  Moving beyond individual 
proteins, mass spectrometry has been used in the large-scale mapping of protein-protein 
interactions in humans79.  Mass spectrometry has also made strides in the acquisition of 
qualitative information for systems biology studies, and this general approach has more 
recently been extended to more fine level aspects, such as quantitation and 
characterization of post-translational modifications.  However, since complications and 
challenges still exist in these latter two aspects, a significant portion of this dissertation 
will be devoted to advancement of each of these two areas. 
1.4 Quantitation in Mass Spectrometry  
1.4.1 Challenges with Mass-Spectrometry-Based Quantitation 
Differences in abundances of specific proteins in situ may provide important clues 
about cellular function, thus moving beyond simply identifying the proteins present in a 
sample.  The ability to determine abundances of particular proteins as a function of 
different conditions is necessary for the development of proteomics and the 
comprehensive characterization of biologically relevant proteins and biological systems. 
In addition, quantitative proteomics holds vast potential for the study of biomarkers, 
molecules (including but not limited to proteins) that act as indicators of normal versus 
stressed states or healthy versus diseased states, i.e. expression of certain proteins may 
ultimately be utilized as assays in clinical studies80.  Expression of particular proteins 
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may be indicative of environmental stresses that an organism may encounter such as the 
upregulation of heat shock proteins in the presence of increased temperatures81 or the 
downregulation of insulin receptors in the presence of increased insulin, which in turn is 
upregulated in the presence of increased glucose in the blood82.  Differential protein 
expression may also be indicative of the onset of disease such as the upregulation of the 
myocardial protein Annexin A5 in individuals with hypertension83 or downregulation of 
protein kinase C in brains of individuals with Alzheimer’s disease84. 
Mass spectrometry-based quantitation seems intuitive because each peak in a 
mass spectrum has an associated intensity; reason suggests that the higher the intensity of 
the peak, the more abundant the corresponding peptide and thus protein is in the sample.  
However, the combination of both ion suppression85 as well as different ionization 
efficiencies for different peptides greatly complicates quantitation.  Ion suppression and 
ionization efficiency affect ions differently depending on whether analytes are ionized 
through ESI or MALDI, though only limitations relative to ESI will be examined here. 
The matrix effect in LC-MS occurs when solvent and sample components coelute86.  This 
coelution induces ion suppression, which results in variable signal intensity and 
reproducibility.  Further complications in quantitative peptide analysis result from the 
varying amino acid composition of peptides.  Peptides have different chemical properties 
based upon their composition, and some peptides, particularly hydrophobic peptides, 
ionize more efficiently than other peptides, particularly hydrophilic peptides87.  This 
makes comparing intensities of peptide peaks resulting from the same protein difficult 
because they likely have very different intensities.  Though effects are primarily 
limitations of sampling rather than mass spectrometry, if signal is not constant from 
sample to sample due to ion suppression or from peptide to peptide because of varying 
ionization efficiencies, then intensity alone cannot be used as a reliable characteristic 
upon which quantitation is based. 
1.4.2 Current Approaches to Quantitative Proteomics 
In response to these problems, a number of approaches to quantitative proteomics 
have been pioneered.  Approaches to quantitation that rely on either signal intensity or 
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number of fragment spectra corresponding to a particular protein are referred to as label-
free quantitation.  Rather than comparing simple ion intensities, more reliable means of 
quantitating in LC-MS experiments involve extracting ion intensity from a particular 
peptide over the course of an entire experiment (ion chromatogram) and integrating the 
peak(s).  Extracted ion chromatograms for the peptide in different samples can then be 
compared to derive relative quantitative data about the corresponding protein88-93.  
Spectral counting-based approaches to label-free relative quantitation are based on the 
idea that the more abundant a peptide is in a sample, the more spectra corresponding to 
that peptide should be detected by the mass spectrometer94-96.  Whereas the extracted ion 
chromatogram intensity-based approach relies on precursor ion intensity, spectral 
counting depends more on the number of MS/MS spectra acquired over the duration of an 
experiment.  Because changes in intensity can be the result of background interference 
and contamination from coeluting species, a fragment spectra-based approach provides 
more reliable results with higher specificity than quantitation based in precursor extracted 
ion chromatograms.  Normalized Spectral Abundances Factors (NSAFs) were developed 
to correct for the fact that larger proteins will produce more peptides in enzymatic 
digestion and thus higher spectral counts regardless of whether they are more abundant in 
the sample.  NSAFs are calculated with the following equation96: 
   Equation 1.1 
where SpC is the spectral counts (total number of MS/MS spectra corresponding to a 
particular protein) and L is the number of amino acids that comprise protein k.  
Additional means of deriving more accurate label-free quatitation data such as Protein 
Abundance Index (PAI)97 and Exponentially Modified Protein Abundance Index 
(emPAI) have been proposed98.  These methods both derive quantitative data based on 
the number of peptides per protein normalized to the number of theoretical peptides for a 
particular protein.  There is currently great interest in developing the field of label-free 
quantitation primarily because it utilizes data that is being acquired for global proteomics 
experiments without the need for isotopic labels or additional quantitative experiments. 
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 The use of chemical labels has also been demonstrated in relative quantitative 
proteomics.  Mass differences resulting from labels or tracers utilizing stable isotope 
versions of analytes of interest have long been exploited in chemistry and biochemistry 
with studies dating as early as the 1930’s99.  Stable isotopes such as 13C and 15N have 
been shown to have minimal biological effect or associated health risks when 
incorporated into organisms of interest, including mammals100, 101.  For example, 15N-
based food sources have been used to completely incorporate 15N into entire organisms 
such as yeast102, 103, Caenorhabditis elegans104, Drosophila melanogaster104, and complex 
microbial communities105.  Partial106 and complete107 15N labeling of rats have also been 
achieved in quantitative proteomics experiments.  Likewise, Stable Isotope Labeling by 
Amino acids in Cell culture (SILAC)108, 109 utilizes a food source in which one amino 
acid, arginine for example, is composed of 2H, 13C, or 15N.  After five generations of 
stable isotope incorporation, every protein in the organism consists only of the 
isotopically-labeled version of the amino acid, and this method of labeling has been 
successfully utilized to label an entire mouse110.  Mass shifts are much smaller if only a 
single amino acid is labeled compared to entire proteins in which 15N is labeled, thus 
simplifying informatics challenges associated with searching for mass shifts111, 112.  The 
utility of the isotopic label becomes evident when the proteome of an organism grown 
using a “light-isotope” food source is compared to the proteome of an organism grown 
using a “heavy-isotope” food source.  As previously described, either the intensities of 
extracted ion chromatograms or spectra counts can be compared between the light and 
heavy versions of a protein to determine whether a protein is upregulated, downregulated, 
or unchanged as a function of environmental stimulus or disease.  Labeling has also been 
demonstrated using Isotope-Coded Affinity Tags (ICAT) in which proteins are labeled 
with a chemical probe consisting of a reactive group that binds to a specific amino acid 
side chain, a linker region, and an affinity tag that allows for the isolation of the labeled 
peptide or protein113.  Affinity chromatography is used to isolate proteins of interest, 
proteins are digested, and ion intensities from mass spectra are then compared to 
relatively quantitate proteins of interest.  Peptides can also be labeled for quantitative 
experiments without isotopic labels using Isobaric Tag for Relative and Absolute 
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Quantitation (iTRAQ)114 or Tandem Mass Tag (TMT)115 methods.  With both iTRAQ 
and TMT, proteins are enzymatically digested, and resulting peptides are covalently 
labeled with tags that consist of linker regions and reporter regions.  iTRAQ and TMT 
differ only in the composition of the tags and in the number of tags that can be used.  
Peptides resulting from digests corresponding to 4 or 8 (iTRAQ) or 2 or 6 (TMT) 
different conditions are then mixed together and analyzed with a mass spectrometer.  The 
covalent tags used are isobaric for all the conditions, so the precursor mass of all peptides 
from all conditions is identical.  However, upon fragmentation, the linker region and 
reporter region of the tag are fragmented, and reporter ions observed in the low mass 
range (~100 m/z) all have different m/z values.  One reporter ion corresponds to an 
individual experimental condition, and by measuring intensities of the reporter ions 
relative to each other in a single spectrum, the peptide and thus protein can be relatively 
quantitated.  This allows for multiplexing up to eight samples, and proteins from multiple 
conditions to be analyzed and quantitated in the same amount of time typically required 
to analyze a single sample without quantitation.  The use of isotopic or isobaric labels has 
yielded an abundance of biological information pertaining to systems of interest, and the 
development of iTRAQ, TMT, and SILAC in particular hold great potential for the field 
of relative quantitation in proteomics. 
 The previously described methods are all used for relative quantitation; these 
methods only allow for the determination of whether a particular protein is upregulated, 
downregulated, or unchanged given a stimulus or condition.  In order to determine how 
much of a particular protein is present in a sample using mass spectrometry, internal 
standards must be used.  Absolute quantitation (AQUA) utilizes commercially available 
isotopically-labeled peptides that are provided in very precisely and accurately known 
amounts116.  AQUA peptides are spiked into a sample, and the ratio of chromatographic 
peak areas corresponding to unlabeled and labeled samples obtained using selected 
reaction monitoring on a triple quadrupole mass spectrometer is determined.  Because the 
amount of labeled peptide spiked into the sample prior to digest is known, the amount of 
unlabeled peptide, and thus protein, can then be determined.  This method extends 
quantitative capabilities beyond relative comparisons to the determination of 
 
 12 
concentrations of specific proteins in mixtures and stoichiometries of proteins that 
function together as complexes.  The use of AQUA peptides is gaining widespread use in 
both protein biomarker validation and systems biology117 as this is the most accurate 
means of quantitation in mass spectrometry; however, it is usually applied in a more 
targeted context, rather than proteome-wide.  Thus, it is a more limited quantitation 
approach as compared to the approaches described above. 
1.5 Analysis of Post-Translational Modifications with Mass 
Spectrometry 
1.5.1 Challenges with Analyzing Post-Translational Modifications 
Post-translational modifications (PTMs) to a protein occur after RNA is translated 
into a protein and are thus removed from the genomic database or transcriptomic 
expression.  Some of the more common types include formation of cysteine disulfide 
bridges, in situ proteolytic cleavage, glycosylation, oxidation, acetylation, oxidation, 
alkylation, phosphorylation, and ubiquitization.  PTMs allow for an organism to express a 
drastically larger number of functional proteins than would otherwise be allowed based 
on the number of genes coded in the organism’s genome, thus making a more efficient 
use of genetic information118.  As such, PTMs can be a cell’s natural means of turning on 
or off certain cellular processes.  For example, chemotaxis, the process by which bacteria 
move in response to chemical stimuli, is often directed by methyl-accepting chemotaxis 
proteins.  These proteins become post-translationally methylated as a response to their 
chemical environment; in the presence of nutrients or toxins, they are methylated, 
inducing bacterial movement toward the nutrients or away from the toxins119.  While 
PTMs may add functionality to a protein, they may also be indicative of disease such as 
cancer120, neurodegenerative disease121, and heart disease122.  However, PTMs may also 
be the benign result of conditions related to sample preparation prior to mass 
spectrometric analysis123.  Despite the vital role PTMs play in systems biology, reliable 
detection of modifications with mass spectrometry remains elusive.  Most proteomics 
experiments make use of database search algorithms that match the combination of 
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peptide precursor and fragment ion m/z values to a protein database derived from an 
organism’s genome.  Because of PTMs, the m/z value of a detected peptide can be 
significantly different than that of the form of the peptide that appears in the protein 
database.  In addition, proteins and even peptides can have multiple modifications, thus 
increasing difficulties with PTM searches.  As such, proteomics studies are left with few 
options for PTM analysis in global experiments, though current approaches are presented 
in the following section. 
 In the course of performing a global proteomics experiment, many spectra remain 
unassigned after a database search of the data.  Many unassigned spectra correspond to 
modified peptides not identified due to limitations of the search algorithm.  As previously 
mentioned, database search algorithms typically attempt to match the combination of 
precursor ion and fragment ion m/z values to theoretically determined fragmentation 
spectra for a given peptide that is derived through an in silico digest of a protein database.  
A nonsense database of similar size and amino acid composition is concatenated to the 
protein database, usually by reversing the amino acid sequence of all proteins in the 
database.  The rate of discovery of false positives, also known as the false discovery rate 
(FDR), is calculated by the equation124: 
FDR = (2 * Number of Reversed Database IDs) / (Total IDs). (Equation 1.2) 
The false discovery rate can be controlled by filtering identifications by confidence 
scores unique to the algorithm used (such as E values for OMSSA or Xcorr values for 
SEQUESt) until the numbers of reversed database identifications and total identifications 
correspond to the desired FDR.  Though adding multiple modifications, both static and 
variable, to database search parameters is possible, search space, or the set of all possible 
solutions utilized by the search algorithm, is drastically increased, which increases search 
time and ultimately results in either a high FDR or filtering out of real peptides in the 
process of adjusting the FDR.  This makes database searching of PTMs difficult on a 
global scale.   
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1.5.2 Current Approaches to Detecting Post-Translational Modifications 
 The current approach most often employed toward the detection of PTMs in 
global proteomics studies is to ignore them, since they are often deemed unnecessary for 
protein identification.  Discovery-based studies rarely report PTMs identified in the 
course of the experiments related to the study because modifications are often not entered 
into search parameters.  PTMs most often incorporated into database searches include 
those associated with sample preparation such as alkylation resulting from treatment with 
iodoacetamide123 and urea-induced carbamylation125.  Most PTM analysis is done on 
modifications previously identified through more traditional biochemical methods such 
affinity separations or immunoblotting126.  Once identified, modified proteins are often 
enriched127 or isolated using affinity purification128, 129 prior to analysis with mass 
spectrometry. 
Attempts to elucidate PTMs have also been made with bioinformatics.  With de 
novo sequencing, which is the determination of a peptide sequence without use of a 
protein database, spacings between peaks in fragmentation spectra are used to deduce the 
amino acid sequence of the precursor ion.  This form of searching MS/MS data allows for 
greater tolerance toward sequence modifications and mutations compared to database 
search algorithms130.  Sequence tag algorithms, which determine short amino acid 
sequences (sequence tags) from fragmentation spectra and match the sequence tags to a 
protein database, are a sort of hybrid between database search algorithms and de novo 
algorithms.  These algorithms are also more tolerant to PTMs while preserving the higher 
identification accuracy found in database search algorithms.  Sequence tag algorithms 
also show promise in the detection of PTMs in global proteomics experiments130.  The 
most obvious approaches to detecting PTMs are based on informatics because chemical 
information about modified peptides is acquired in most global proteomics experiments, 
and progress is gradually being made in mining PTM information from mass spectra. 
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1.6 Bioenergy-Related Proteomics  
1.6.1 Introduction to Bioenergy 
Bioenergy is energy (electrical or fuel) extracted from renewable material derived 
from biological sources (biomass).  Lignocellulosic biomass, illustrated in Figure 1.1, 
typically consists of ~45% crystalline cellulose, ~30% hemicellulose, and ~25% lignin 
(dry weight percentages)131.   Cellulose makes up the majority of solid waste generated in 
the United States132, and as lignocellulose comprises an estimated 50% of all biomass 
world-wide133, cellulose is the most abundant natural biopolymer on earth.  However, 
extracting cellulose and hemicellulose (an amorphous mixture consisting of xylans, 
xyloglucans, mannoses) from lignocellulosic material is quite recalcitrant due to the 
extreme difficulty of converting the highly stable lignocellulosic material into the sugars 
needed for fermentation.  Manufacturing renewable fuels by conversion of lignocellulosic 
biomass is currently a three-step process including substrate pretreatment by either 
thermal or chemical methods to release cellulose and hemicellulose from lignin, 
enzymatic deconstruction of cellulose polymers into monosaccharide components, and 
the fermentation of the resulting sugars into ethanol (Figure 1.2).  However, costs 
involved in ethanol production by these means currently exceed those of oil134; current 
costs of commercial scale cellulosic ethanol are estimated at $2.43/gallon135 versus the 
wholesale gasoline cost of $1.90/gallon136.  To make ethanol production more 
commercially viable, an integrated process was proposed134 to increase yield and biomass 
utilization.  Consolidated bioprocessing (CBP) would integrate cellulolytic enzyme 
production, cellulose hydrolysis, hexose fermentation, and pentose fermentation in one 
step by exploiting a cellulolytic, hemicellulolytic and ethanologenic microbe or a 
microbial community. Current projections estimate CBP could reduce the cost of large-
scale ethanol production from lignocellulosic biomass by up to 41%, which, when 
combined with other technologies under development137, will reduce the cost of cellulosic 
ethanol product well below the goal of $1.33/gallon135.  Among the candidates for this 
process are genetically engineered mesophilic yeasts, fungi or thermophilic bacteria138.  





Figure 1.1.  Illustration of lignocellulosic biomass, ranging from the feedstock on the 
macroscale to the structure of cellulose on the microscale (courtesy of U.S. Department 








Figure 1.2.  Illustration of both the current methods used for producing ethanol from lignocellulose and consolidated 
bioprocessing (courtesy of U.S. Department of Energy Genome Programs, http://genomics.energy.gov). 
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and economic and environmental importance of deriving ethanol from renewable 
biomass, bioenergy research provides ample opportunity for developments in 
bioanalytical chemistry with respect to both quantitative proteomics, such as quantitating 
specific components involved in cellulose degradation, and analysis of PTMs that may be 
involved in structural of functional aspects of cellulose utilization. 
1.6.2 Clostridium thermocellum 
 Clostridium thermocellum is a bacterium of particular interest to bioenergy 
research due to its ability to break down cellulose into carbohydrates that can be more 
effectively used in the production of ethanol.  First isolated from horse manure in 
1926139, C. thermocellum thrives on decomposing organic material, and strains have been 
identified in a wide variety of environments including cotton bales140, sewage digestion 
sludge132, river mud141, soil142, and hot springs143.  The organism has rod-shaped 
morphology with tapered ends and is characterized as an anaerobic, thermophilic, and 
Gram-positive bacterium144.  Optimal grown temperature is 58-61° C, and optimal pH 
range on cellulose is 6.7-7.0145.  The microbe extracts energy from cellulose first by 
degrading cellulose primarily to cellobiose, a β-1,4 linked glucose dimer that serves as 
the primary repeating unit of the biopolymer.  Cellobiose is digested to glucose, which in 
turn is metabolized to pyruvate, a key component in several vital metabolic pathways146.  
Primary products of cellulolytic degradation of cellulose by C. thermocellum include 
lactate, ethanol, acetate, H2, and CO2145.  The organism’s genome sequence was 
completed in 2007 by the United States Department of Energy Joint Genome Institute 
and consists of 3,843,301 base pairs, which correspond to 3,305 proteins147.   
C. thermocellum has one of the fastest observed growth rates on cellulose148, a 
characteristic primarily due to the cellulosome, an extracellular multi-component protein 
complex first described in 1983149, 150 and illustrated in a transmission electron 
micrograph in Figure 1.3A.  The fundamental component of the C. thermocellum 
cellulosome is the scaffoldin protein, referred to as cellulase-integrating protein A 
(CipA), illustrated in Figure 1.3B.  The protein consists of a cellulose-specific 






Figure 1.3. C. thermocellum cellulosome presented as (A) a transmission electon 
micrograph and (B) illustration showing the interaction cellulases with the CipA as well 
as CipA with anchoring proteins151.
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cohesin modules that bind with a high affinity to Type I dockerin domains of catalytic 
subunits, and a C-terminal Type II dockerin domain that binds with high affinity to Type 
II cohesin domains of anchoring proteins152.  The three most prominent anchoring 
proteins, scaffoldin-dockerin binding component A (SbdA), open reading frame 2p 
(Orf2p), and outer layer protein B (OlpB), each have three repeated surface-layer 
homology (SLH) domains that anchor the proteins into the extracellular surface of the 
cell membrane.  These three anchoring proteins have 1 (SbdA), 2 (Orf2p), or 7 (OlpB) 
Type II cohesin domains; when these anchoring proteins accommodate the maximum 
number of CipA proteins, anywhere from 9 (SbdA) to 63 (OlpB) cellulolytic enzymes 
can be tethered to the cell surface through the cellulosome complex.  In addition to this, 
anchoring proteins such as OlpA and OlpC have Type I cohesin domains, which can bind 
directly to Type I dockerins in individual cellulolytic enzymes, and proteins such as 
Cthe_0736 can accommodate up to 63 cellulolytic enzymes through 7 Type II cohesin 
domains but are not tethered to the cell surface, suggesting the protein forms extracellular 
cell-free celluloloytic complexes151.  Type I cohesin-dockerin interactions are universal in 
the C. thermocellum cellulosome, suggesting that any enzyme with a Type I dockerin 
domain can interact with any Type I cohesin domain, giving the cellulosome a plug-and-
play characterstic that makes the complex extremely versatile.  
Cellulolytic enzymes associated with the cellulosome have a variety of functions, 
and interactions between cellulotytic enzymes and structural proteins such as CipA, 
OlpA, and OlpC are illustrated in Figure 1.3B.  The most common of these are cellulases 
(CelA-CelW) that correspond to both exoglucanases, which cleave the glycoside bonds at 
the end of a carbohydrate chain, and endoglucanases, which cleave glycoside bonds in 
the middle of a carbohydrate chain.  These enzymes consist of domains corresponding to 
wide variety of glycoside hydrolase (GH) families, including GH5, GH8, GH9, GH26, 
GH44, and GH48.  GH family classification is derived from amino acid sequences of the 
enzyme, which is related to structural features of the enzyme and how the enzyme 
cleaves the glycoside bond between carbohydrates.  Cellobiohydrolases (Cbh) also play a 
major role in cellulose degradation by liberating cellobiose from cellulose, and xylanases 
(Xyn), xyloglucan hydrolases (Xgh), and mannanases (Man) hydrolyze carbohydrate 
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sources found in hemicellulose.  Of the 3,305 entries in the C. thermocellum protein 
database, 84 proteins contain either cohesin and/or dockerin domains.  Those not 
discussed include cellulosomal elements (Cse), cellulosomal proteases (Cpr), and other 
hemicellulases such as chitinases (Chi), lichenases (Lic).  This diversity of catalytic 
components and activities allows the cellulosome to extract carbohydrates from the full 
gamut of cellulose and hemicellulose constituents found in the heterogeneous cell wall, 
contributing to highly effective lignocellulose utilization and C. thermocellum’s role as a 
prime candidate for CBP153.  
1.7 Summary of Dissertation 
 Studies presented in this dissertation concentrate on using mass spectrometry-
based proteomic experiments to probe both qualitative and quantitative characteristics of 
proteins.  This dissertation is focused on technology development with the following 
goals: (1) develop methods to characterize proteins at a significantly deeper level with 
respect to sequence coverage, (2) utilize multiple peptide fragmentation techniques to 
develop a method for the blind characterization (identification without prior knowledge 
of what to expect) of PTMs, focusing in particular on microbial cellulosome proteins, (3) 
develop a mass spectrometry-based method for the absolute quantitation of structural and 
enzymatic components representative of the cellulosome to replace an existing Enzyme-
Linked Immunosorbent Assay (ELISA) method for cellulosome quantitaiton, and (4), 
exploit this method to probe C. thermocellum cellulolytic activity of the cellulosome.  
Chapter 2 of this dissertation provides experimental details related to materials used for 
experiments, protocols used for sample preparation, experimental methods, background 
related to instruments used for experiments as well as instrument settings, and parameters 
related to bioinformatics platforms related to data analysis.  Chapter 3 demonstrates the 
application of proteomics-based experiments to increase identified sequence coverage of 
a protein, Aβ, associated with Alzheimer’s disease with the ultimate aim of deriving 
structural information related to the onset of the disease.  The transition to studies 
involving C. thermocellum is made in Chapter 4, and the focus of the chapter is shifted 
from using mass spectrometry for qualitative structural analysis to qualitative PTM 
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analysis in complex mixtures containing digested peptides of several hundred proteins.  
The focus point of Chapter 5 transitions from qualitative analysis to quantitative 
proteomics in which the C. thermocellum cellulosome protein machine is quantitated in 
complex mixtures ranging from affinity-digested purified cellulosome to the whole cell 
lysate.  Chapter 6 serves as a conclusion of studies presented in this dissertation as well 
as observations of the current state of mass-spectrometry based proteomics and an 
outlook for the future.  Herein are presented methods used and developed to attack some 





MATERIALS, METHODS, AND INSTRUMENTATION 
 
 
2.1 Chemicals And Sample Preparation 
 
2.1.1 Chemicals and Biochemicals 
 Chemicals used and corresponding vendors and purities are presented in Table 
2.1.  Unless otherwise indicated, chemicals and biochemicals were used as received from 
the vendor. 
2.1.2 Bicinchoninic Acid Protein Assay 
 Protein and peptide concentrations were determined using a bicinchoninic acid 
(BCA) protein assay154, 155 (Pierce Biotechnology, Rockford, IL).  Bovine serum albumin 
(BSA), provided with the assay kit, was used to construct calibration curves for each 
experiment using concentrations of 500 µg/mL, 250 µg/mL, 125 µg/mL, 62.5 µg/mL, and 
31.3 µg/mL in 100 mM tris buffer (pH 8.0).  Blanks contained 50 µL 100 mM tris buffer.  
The volume of the sample aliquot used for the BCA assay varied between experiments 
based on rough estimates of protein content so that estimated amount of peptide or 
protein was in the concentration range used for the calibration curve.  A stock solution of 
working reagent mixture was prepared by combining Reagent A and Reagent B at a ratio 
of 50:1.  1 mL of working reagent was added to each 1.5 mL centrifuge tube containing 
sample (adjusted to 50 µL).  The volume of sample varied between experiments, but the 
final sample volume was adjusted to 50 µL for all assays by the addition of 100 mM tris 
buffer.  At least two different concentrations of each sample were analyzed.  All samples 
were incubated for 30 min in a 37° C water bath for experiments with C. thermocellum or 
60° C for experiments with Aβ.  Samples were then cooled to room temperature for 5 
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Table 2.1.  Reagents used in experiments. 
 
Chemical Vendor Purity 
1,3,6 Polytyrosine C.S. Bio Co. Reagent Grade 
Acetone BDH Laboratory Supplies ≥99.5% 
Acetonitrile Honeywell Burdick And Jackson HPLC Grade 
Acetonitrile (Aβ Experiments) Fisher Scientific HPLC Grade 
Ammonium Acetate Sigma Aldrich 99.999% 
AQUA Labeled Peptides Open Biosystems, Inc. >97% peptide purity,  
>99% isotopic purity 
Argon Gas Air Liquide Ultra High Purity 
Argon Gas (Aβ Experiments) National Welders >99.999% 
Avicel PH105 FMC Biopolymer Reagent Grade 
Aβ (1-40) Peptide Keck Biotechnology Center Reagent Grade 
Bovine Serum Albumin Sigma Aldrich ≥98% 
Calcium Chloride Sigma Aldrich 96.0% 
D-(+)-Cellobiose Sigma Aldrich ≥98% 
Dithiothreitol (DTT) Fluka Analytical ≥99.5% 
Endoproteinase Glu-C  
(from Staphylococcus aereus V 8) 
Pierce Biotechnology MS Grade 
Endoproteinase Lys-C  
(from Lysobacter enzymogenes) 
Pierce Biotechnology MS Grade 
Endoproteinase Trypsin (Porcine) Promega Co. Modified Sequencing Grade 
Formic Acid EMD Chemical 98-100% 
Formic Acid (Aβ Experiments) Sigma Aldrich 98% 
Helium Gas Air Liquide Research Grade,  
Ultra High Purity 
Iodoacetamide Sigma Aldrich ≥99% 
Methanol Honeywell Burdick And Jackson HPLC Grade 
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(Table 2.1 continued) 
 
Chemical Vendor Purity 
Nitrogen Gas Air Liquide Ultra High Purity 
Nitrogen Gas (Aβ Experiments) National Welders Prepurified Grade 
Porcine Pepsin Sigma Aldrich Reagent Grade 
Protease Type XIII Sigma Aldrich Reagent Grade 
Protease Type XVIII Sigma Aldrich Reagent Grade 
Sodium Chloride (NaCl) Sigma Aldrich 99.5% 
Sodium Dodecyl Sulfate (SDS) Sigma Aldrich ≥99.0% 
Sulfuric Acid (Concentrated) Sigma Aldrich 95-98% 
Trichloroacetic Acid (TCA) Solution Sigma Aldrich 6.1 N 
Trizma* Base Sigma Aldrich >99.9% 
Trizma* Hypochloride Sigma Aldrich ≥99.0% 
Urea Sigma Aldrich 98+% 
Water Honeywell Burdick And Jackson HPLC Grade 
Water (Aβ Experiments) Fisher Scientific HPLC Grade 
 
 
* Trizma = tris = tris(hydroxymethyl)aminomethane
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min before analyzing.  Absorbance of samples was measured at 562 nm using a Biomate 
3 spectrophotometer (Thermo Scientific, Waltham, MA) or, for Aβ experiments, a 
SpectraMax Plus microplate spectrophotometer (Molecular Devices, Sunnyville, CA).  In 
quantitation experiments described in Chapter 5, absorbance readings were taken in 
triplicate measures for three different concentrations of each sample (9 total 
measurements) following protein precipitation.  Single measurements on two 
concentrations were performed for experiments in Chapter 4 because accuracy of the 
protein measurements was not as vital as those in Chapter 5.  
2.1.3 Aβ  Sample Preparation 
For experiments described in Chapter 3, dry Aβ monomer was pretreated 
previously described156 to remove any aggregates. Samples were prepared at ~10 µM in 
2.0 mM tris buffer.  Aβ concentration was confirmed by reversed-phase HPLC (Hewlett-
Packard, Palo Alto, CA) monitoring absorbance at 215 nm against a standard curve 
produced by analysis of a Aβ (1-40) standard solution that had been quantitated using 
amino acid composition analysis157.  Monomer solutions were snap-frozen and stored at -
80° C.  Fibrils were grown in phosphate buffer and exchanged into 2 mM tris buffer as 
described previously158.  Fibril sample concentrations were equivalent to ~25 µM 
monomer. 
 1 mL of aqueous protease XIII (0.38 µg/µL) or protease XVIII (0.28 µL/µL) was 
dialyzed at 4° C against water using regenerated cellulose tubing with a molecular weight 
cut-off of 12,000-14,000 Da (Fisher Scientific, Pittsburgh, PA).  Water was changed after 
4, 8, 12, and 20 h, and dialysis was allowed to continue overnight, totaling 26 h.  200 µL 
of endothiapepsin (1 µg/µL in saturated (NH4)2SO4 solution, provided by Jonathan 
Cooper at the University of London (London, UK)) was dialyzed in the same manner.  
The final concentrations of the three dialyzed proteins were determined using a BCA 
assay.  Following dialysis, a total of 1 mL of ~0.2 µg/µL protease XIII, 1 mL of ~0.08 
µg/µL protease XVIII, and 200 µL of ~0.75 µg/µL endothiapepsin were recovered.  All 
three enzymes were adjusted to 0.5% (v/v) formic acid following dialysis. 
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 Stock solutions of pepsin were prepared daily at 2 µg/µL in 0.5% formic acid. 
Working solutions were prepared by diluting stock solutions in 0.5% formic acid so that 
the final concentrations of the enzymes in the online digestion experiments (Chapter 3) 
before mixing were ~0.05 to 0.2 µg/µL.  These relatively high concentrations were 
required to reduce the signal from unhydrolyzed monomer below detection limits.  The 
same amount of enzyme was used for both monomer and fibril proteolysis, except where 
noted (for mixed enzyme experiments). 
2.1.4  Online Proteolysis of Aβ  with a Triaxial Probe 
Online proteolysis was performed using a home-built triaxial probe159, which is 
illustrated in Figure 2.1, and three Harvard Apparatus (South Natick, MA, USA) model 
11 syringe pumps.  Sample (0.85 µL/min) and enzyme (4.25 µL/min) solutions were 
infused into a 0.25 mm i.d. Valco (Houston, TX, USA) “T” fitting using two 50 µm i.d. 
fused silica capillaries (Polymicro, Phoenix, AZ, USA).  Fibrils (when included) were 
dissolved and samples were hydrolyzed as this mixture was delivered from the third 
opening of the “T” through the innermost silica tube of the triaxial probe (50 µm i.d., 360 
µm o.d., 52 cm long); total transit and enzyme reaction time was ~12 s.  Acetonitrile with 
0.5% formic acid was infused using the third syringe pump (10 µL/min) into the middle 
stainless steel tube (410 µm i.d., 720 µm o.d.) and mixed with the samples near the tip of 
the electrospray emitter. Nitrogen nebulizing gas (50 liter/h) flowed through the stainless 
steel outer tube of the probe (860 µm i.d., 1100 µm o.d.). Reagent blanks (using enzyme 
and buffer but no substrate) were analyzed to ensure that spectral peaks were properly 
assigned to the analyte. 
2.1.5 Internal Standards for Quantitation Experiments 
BSA was used as an internal standard for quantitation experiments (Chapter 5) to 
monitor enzyme efficiency.  ~1 mg BSA was dissolved in 1 mL 100 mM tris buffer, 
diluted to approximately 100 µg/mL with 100 mM tris buffer, and the concentration of 3 
aliquots of sample (50 µL each) was determined using a BCA assay with triplicate 











correlation coefficient of the calibration curve, which was determined with BSA supplied 
with the assay kit, was greater than 0.9998 and the relative standard deviation (RSD) of 
the measured BSA concentration was less than 5%. 
34 isotopically-labeled peptides corresponding to peptide segments of 14 
cellulosome proteins and BSA were supplied (Open Biosystems, Inc.) at 5 pmol/µL in 
95% water, 5% acetonitrile.  These peptides each had 14C and 15N incorporated into the 
C-terminal amino acid (either R or K), resulting in a mass shift of +10 Da for R and +8 
Da for K relative to the unlabeled version of the peptide.  A cocktail of the labeled 
peptides was prepared so that a 68 µL aliquot consisted of 10 pmol of each labeled 
peptide (2 µL of each labeled peptide in solution provided by vendor).  
2.1.6 C. thermocellum Preparation 
C. thermocellum ATCC 2740 was grown anaerobically as previously described160. 
For PTM studies presented in Chapter 4, C. thermocellum was fermented with crystalline 
cellulose as the carbon source and harvested during the exponential growth phase.  For 
quantitation studies discussed in Chapter 5, samples were prepared using both Avicel and 
cellobiose as substrates in separate fermentations in order to develop the method used for 
quantitation.  These samples were harvested during both the exponential and stationary 
growth phases as indicated. 
Samples were collected from 5 L fermentors in 40 mL aliquots that were 
centrifuged at 4,500 g, 4° C for 1 h using a 5804 R Centrifuge (Eppendorf, Hamburg, 
Germany) to separate the whole-cell (pellet) and extracellular (supernatant) fractions. For 
studies presented in Chapter 5, the cellulosome from stationary phase samples was 
purified using affinity digestion as previously described161 to obtain the purified 
cellulosome fraction.  Cellulase activity for experiments in Chapter 5 was measured as 
previously described162. Briefly, samples were incubated in for 2 h, 60° C in 20 g/L 
Avicel, and the amount of soluble sugars produced in the course of incubation was 
measured using a glucose determination assay.  Results were expressed as international 
units (IU) = 1 µmol glucose equivalent per minute. 
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Extracellular fractions were concentrated to ~1 mL using 5 kDa spin filters 
(Sartorius Stedim Biotech GmbH, Goettingen, Germany) at 4,500 g, 4° C.  Samples were 
diluted to 20 mL with 100 mM tris buffer (pH 8.0) while still in the spin filter and 
reconcentrated to ~1 mL to remove media.  Pellet fractions were lysed by resuspending in 
5 mL 4% w/v sodium dodecyl sulfate (SDS)163 in 100 mM tris buffer, heating at 95° C 
for 5 min, and sonicating (Branson Ultrasonics, Danbury, CT) for 2 min at 20% 
amplitude (10 s on, 10 s off) in a water bath at ambient temperature.  Samples were then 
heated again at 95° C for 5 min.  The concentration of extracellular, whole cell, and 
purified cellulosome fractions was determined on an aliquot (varying volumes based on 
estimates of total protein) using a BCA assay, and samples were transferred to 1.5 mL 
centrifuge tubes so that each aliquot contained 1 mg of protein as determined from the 
BCA assay. All fractions were then snap-frozen with liquid nitrogen and stored at -80° C. 
 After thawing on ice, 1 mL lysis buffer consisting of 4% w/v SDS and 10 mM 
dithiothreitol (DTT) in 100 mM tris buffer was added to extracellular fractions and 
purified cellulosome samples163. This was followed by heating at 95° C for 5 min, and 
sonicating (Branson Ultrasonics, Danbury, CT) for 2 min at 20% amplitude (10 s on, 10 s 
off) in a water bath at ambient temperature, and heating again at 95° C for 5 min.  Whole 
cell fractions were adjusted to 10 mM DTT and heated at 95° C for 10 min after thawing. 
2.1.7 Protein Precipitation 
 Samples from all fractions were adjusted to 20% trichloroacetic acid (TCA)164, 
vortexed, and stored on ice in a 4° C refrigerator.  This was followed by centrifugation at 
21,000 g, 4° C for 15 min.  Supernatant was carefully removed so as to not disturb the 
pellet of precipitated proteins, and 1 mL of cold acetone (-80°C) was added.  The sample 
was vortexed to dislodge the cell pellet followed by centrifugation at 21,000 g, 4° C for 5 
min.  Supernatant was removed, and this process of washing the precipitated proteins 
with cold acetone was then repeated.  This was followed by air-drying to produce a dry 
pellet of proteins. 
Following drying, the pellet was brought up in 250 µL of 8 M urea in 100 mM tris 
buffer and was sonicated in an ice water bath for 2 min at 20% amplitude (5 s on, 10 s 
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off) to resuspend the proteins.  For quantitation experiments (Chapter 5), a BCA protein 
assay was performed at this point to determine the protein concentration prior to 
digestion using 5 µL and 10 µL aliquots of the solubilized sample.  Following 
resuspension, 10 pmol of each AQUA peptide and 10 pmol BSA were added to each 
sample for quantitation experiments.  For experiments in both Chapters 4 and 5, samples 
were adjusted to 5 mM DTT.  Proteins were denatured165 under these reducing conditions 
for 1 h with gentle rocking using a nutating mixer (Fisher Scientific, Pittsburg, PA). The 
sample was then adjusted to 20 mM iodoacetamide and incubated in the dark for 15 min 
at room temperature to alkylate cysteine residues123. 
2.1.8 Protein Digestion 
For trypsin digestions, the sample was adjusted to 10 mM CaCl2 using a stock 
solution of 100 mM CaCl2 in 100 mM tris buffer.  Sequencing grade modified trypsin 
was added to the sample at an enzyme:substrate ratio of 1:50 (20 µg enzyme:1 mg 
sample) by adding 250 µL of 100 mM tris buffer to a vial containing 20 µg enzyme (as 
provided by the vendor) and transferring the volume to the sample.  This also reduced the 
concentration of urea (~4 M), which inhibits enzymatic digestion. Samples were 
incubated at room temperature for 4 h with gentle rocking.  At the end of this 
predigestion, an additional 20 µg of enzyme was added to the sample using 500 µL 100 
mM tris buffer to further reduce the urea concentration (~2 M). The sample was allowed 
to continue digesting overnight at room temperature (~20 h total digest time).  Digestion 
was quenched by adjusting the sample to 200 mM NaCl, 0.1% formic acid by diluting 
with a stock solution of 4 M NaCl, 2% formic acid.  Undigested proteins and other 
cellular debris were removed by centrifugation at 21,000 g, 4° C for 30 min. with a 10 
kDa spin filter (Sartorius Stedim Biotech GmbH, Goettingen, Germany).  Concentration 
of filtrate was determined using 5 µL and 10 µL aliquots of the resulting digest with a 
BCA assay, and the remainder was transferred to 500 µL centrifuge tubes as 50 µg 
aliquots, snap-frozen with liquid nitrogen and stored at -80° C. For PTM studies (Chapter 
4), samples were also digested with Lys-C or Glu-C at the same enzyme:substrate ratio 
using the same procedure described without CaCl2. 
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2.1.9 Experiment Replication 
 Experiments were performed with two types of replication.  In Chapters 4 and 5, 
technical replicates were performed.  Technical replicates are the sequential repeat 
analysis of the processed analyte to assess instrument variation.  In these experiments, 
technical replicate denotes multiple analysis of the same sample after enzymatic 
digestion.  Biological replicates were also performed on samples in Chapter 5.  Biological 
replicates are repeat sample preparations, i.e. fermentations, of the same sample using 
identical growth conditions to assess biological variation of the sample.  For Aβ 
experiments in Chapter 3, proteolysis of the same sample was performed in online 
experiments, so the replicates were neither biological nor technical.  These replicates 
were process replicates, in which the variation of the digestion process was assessed. 
2.2 Methods 
2.2.1 Nanospray 
 With the exception of Aβ studies in Chapter 3, peptides were introduced into the 
mass spectrometer with nanospray ionization166, a form of electrospray ionization (ESI)46, 
167.  Aβ experiments were performed with electrospray.  The process of electrospray is 
illustrated in Figure 2.2.  HPLC solvents contain formic acid to induce peptide ionization. 
As the sample is injected into the source, a voltage is applied across the inlet, and a 
Taylor cone168 is formed at the end of the capillary. The end of the cone is unstable, and 
as it breaks up, a jet of small charged droplets is ejected from the capillary.  After 
ejection, the solvent in the charged droplets begins to evaporate.  As the droplets grow 
smaller, charges are forced closer together, and the charge density on the surface of the 
droplet becomes larger.  Eventually, the Coulombic repulsion between ions overcomes 
the surface tension of the droplets (the Rayleigh limit), and the charged droplets split into 
increasingly smaller droplets until only individual gas-phase ions remain167, 169, 170.  A 
second mechanism known as ion evaporation in which ions release from the surface of a 
droplet as the droplet reaches the Rayleigh limit is also believed to contribute to the 




Figure 2.2.  Illustration of electrospray ionization169. 
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gas-phase ions have been produced, the ions pass through a vacuum interface that leads 
to the mass analyzer.  In the interface, any remaining traces of solvent are removed.  The 
electrospray ionization process often produces several different multiply charged ions for 
analytes with large molecular masses, which is useful because multiply charged ions 
extend the mass range of the instrument and the presence of multiple peaks supplies 
multiple measurements of the molecular mass172. 
 The main difference between electrospray and nanospray is flow rate, which is 
typically in the µL/min – mL/min range for electrospray as opposed to the nL/min range 
used in nanospray.  In addition to consuming less LC solvent and no nebulizing gas, 
nanospray is more efficient than electrospray because there are higher electrical fields at 
a given voltage in nanospray due to the sharper tip, which leads to better ion collection 
efficiency.  Also, the initial droplet size is smaller, mainly due to the smaller capillary 
size, but also because of the higher fields. This leads to higher initial surface:volume 
ratios, and therefore faster, more efficient solvent evaporation.  Lower spray voltages can 
also be used in nanospray experiments, resulting in a decreased likelihood of discharge-
induced peptide oxidation173.  These advantages contribute to attomolar detection limits 
being reported for nanospray experiments174 compared to femtomolar-picomolar 
detection limits observed with electrospray. 
2.2.2 Preparation of Nanospray Emitters 
 Nanospray emitters were prepared in house using a laser puller (Model P-2000, 
Sutter Instrument Co., Novato, CA) with 100 µm i.d., 360 µm o.d. fused silica 
(Polymicro Technologies, Phoenix, AZ)175 using a laser puller method illustrated in Table 
2.2.  A small length of fused silica (~3 cm in the center of a ~50 cm length of fused 
silica) was acid stripped with boiling concentrated sulfuric acid to remove the polymer 
coating prior to laser pulling.  This method of removing the polymer coating does not 
induce degradation of the fused silica encountered with heat-based methods176, which 
allows for nanospray emitters with reproducibly high quality spray. After pulling, 
emitters were bomb loaded with ~15 cm (Chapter 4) or ~10 cm (Chapter 5) of C18 
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reversed phase resin (Aqua 5 µm particle size, 125 Å Pore Size, Phenomenex, Torrance, 
CA) using a pressure cell (New Objective, Woburn, MA) with helium gas. 
 
Table 2.2.  Laser puller program used for nanospray emitters. 
Step Heat Filament Velocity Delay Pull 
1 255 0 10 200 0 
2 255 0 10 200 0 
3 290 0 32 200 0 
4 235 0 14 200 0 
 
2.2.3 Column Preparation and Sample Loading 
 One-dimensional chromatography was utilized in quantitation experiments 
(Chapter 5).  After equilibrating the emitter for 10 min with 95% HPLC grade water, 5% 
acetonitrile, 0.1% formic acid, 10 µg of digested peptides were bomb loaded directly onto 
the nanospray emitter. Volumes corresponding to 10 µg of digested peptides varied 
between samples based on concentration determined with the BCA assay described at the 
end of Section 2.1.8.  After loading the sample, the column was washed for 30 min with 
95% HPLC grade water, 5% acetonitrile, 0.1% formic acid to remove trace SDS and/or 
urea.  This was followed by chromatographic separation as described below. 
In experiments utilizing two-dimensional chromatography, Back columns were 
prepared from fused silica (150 µm i.d., 360 µm o.d., Polymicro Technologies, Phoenix, 
AZ) bomb loaded with ~5 cm of strong-cation exchange resin (Luna 5 µm particle size, 
100 Å Pore Size, Phenomenex, Torrance, CA) followed by a 10 min methanol wash.  
Approximately 5 cm of C18 reversed phase resin (Aqua 5 µm particle size, 125 Å Pore 
Size, Phenomenex, Torrance, CA) was then bomb loaded onto the back end of the strong-
cation exchange resin.  The column was then cut so that the final length of the back 
column was approximately 11 cm, of which 1 cm was dead volume.  This back column 
was equilibrated for ~10 min with 95% HPLC grade water, 5% acetonitrile, 0.1% formic 
acid followed by bomb loading of 50 µg of digested sample. Volumes corresponding to 
50 µg of digested peptides varied between samples based on concentration determined 
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with the BCA assay described at the end of Section 2.1.8.  After bomb loading a sample, 
the column was washed for 30 min with 95% HPLC grade water, 5% acetonitrile, 0.1% 
formic acid to remove trace SDS and/or urea. This was followed by chromatographic 
separation as described below. 
2.2.4 Chromatography 
 For targeted proteomics experiments (Chapter 5), one-dimensional separations 
were utilized with a NanoLC-2D HPLC (Eksigent, Dublin, CA).  Solvent A consisted of 
95% HPLC grade water, 5% acetonitrile, 0.1% formic acid, and Solvent B consisted of 
30% HPLC grade water, 70% acetonitrile, 0.1% formic.  The flow rate was 300 nL/min.  
Solvents flowed from the HPLC pump through fused silica (50 µm i.d., 360 µm o.d.) into 
a PEEK MicroTee (Upchurch Scientific, Oak Harbor, WA).  One branch of the MicroTee 
was connected to a platinum electrode that provided voltage for the electrospray source 
(Proxeon Biosystems, Odense, Denmark).  A second branch of the MicroTee was 
connected to an assemply consisting of a PEEK union and inline 0.5 µm filter (Upchurch 
Scientific, Oak Harbor, WA), which in turn was connected to the column/nanospray 
emitter.  Initial experiments to select peptides for quantitation were performed using a 2 h 
gradient.  This was reduced to a 45 min gradient after peptides targeted in these 
experiments were all observed to elute within a relatively small portion of the gradient.  
All quantitative data presented from these experiments were collected using the gradient 
illustrated in Table 2.3. 
 
Table 2.3.  Gradient utilized in one-dimensional chromatography experiments. 
Time (min) %A %B 
0 98 2 
5 80 20 
45 40 60 
 
 Though the complexity of the samples used in quantitation experiments was 
similar, if not identical, to those analyzed in global proteomics experiments, targeted 
experiments make it possible to analyze complex samples with one dimension of 
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separation.  In contrast, shotgun proteomics experiments seek to detect and analyze all 
peptides introduced into the source, which greatly complicates data analysis if multiple 
dimensions of chromatography are not used.  In order to reduce sample complexity with 
maximum efficiency, two orthogonal characteristics of peptides must be exploited177, 178. 
Combinations of orthogonal properties used in two dimensional separations or peptides 
and proteins include size and isoelectric point179, hydrophobicity and charge180, and 
hydrophobicity and size181, among others. Though offline separations using fractionation 
are often performed in proteomics experiments182, for these experiments, reversed-phase 
chromatography (RPLC) and strong cation exchange chromatography (SCX) were 
combined online.  Despite the limitations with online SCX-RPLC chromatography183-185, 
these experimental setups have proved effective in the analysis of many microbial 
isolates186-188 and a wide variety of extremely complex microbial communities189-192. In 
addition, these online experiments are dependent upon instrument operators to manually 
start analysis of subsequent fractions or autosamplers, which also have associated 
problems such as carryover between experiments and the introduction of bubbles that 
interfere with chromatography reproducibility. 
 For two-dimensional online separations, MudPITs (multi-dimensional protein 
identification technology)193, 194 were performed using an Ultimate 3000 HPLC (Dionex, 
Sunnyvale, CA).  Solvent A and B compositions were identical to those used in one-
dimensional separations, and Solvent C consisted of 500 mM ammonium acetate in 
Solvent A.  The plumbing of the MudPIT system in illustrated in Figure 2.3.  Solvents 
flowed from the HPLC through PEEK tubing (0.02" i.d., 1/16” o.d.) into a stainless steel 
union that was connected to fused silica (100 µm i.d., 360 µm o.d.).  An alligator clip 
connected the stainless steel union to ground.  The fused silica was connected to a PEEK 
MicroTee that split flow from the HPLC to either waste or the mass spectrometer.  The 
waste branch of the MicroTee was connected to fused silica (100 µm i.d., 360 µm o.d.), 
which flowed to a second MicroTee.  The first branch of this T union was connected to a 
platinum electrode that provided voltage from the nanospray source, and the second 
branch was connected to fused silica (50 µm i.d., 360 µm o.d.) that flowed to waste.  The 















Figure 2.3.  MudPIT experimental setup. 
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was approximately 65-70 bar at a flow rate of 100 µL/min, resulting in a flow rate at the 
nanospray emitter of approximately 500 nL/min.  The second branch of the first 
MicroTee was connected to the back column, which was connected to the nanospray 
emitter with a PEEK union and 0.5 µm inline filter.  For extracellular fractions, a 4-step, 
7 h MudPIT was performed utilizing the gradients presented in Table 2.4.  For more 
complex samples such as whole cell lysates discussed in Chapter 5, a 12-step, 23 h 
MudPIT was performed.  The first and last steps of the MudPIT were identical to those in 
Table 2.4, and the intermediate steps were resembled steps 2 and 3 except that the 
fraction of Solvent C successively increased from 5%, 7.5%, 10%, 12.5%, 15%, 17.5%, 
20%, 25%, 35%, to 50% Solvent C over 10 steps.   
 Following MudPIT experiments, the back column was removed, and the 
nanospray emitter was washed three times with the gradient presented in Table 2.5.  For 
quantitation experiments, a new nanospray emitter was used for each sample so washes 
were not necessary between experiments.   
2.2 Mass Spectrometry Instrumentation 
2.3.1 Triple Quadrupole Mass Spectrometry 
 Triple quadrupole mass spectrometers (QqQ) are tandem-in-space mass 
spectrometers, meaning multiple mass analyzers are utilized separately at different stages 
in an experiment.  Linear quadrupole mass analyzers utilize four parallel rods with 
opposing rods connected to each other as well as to RF and DC voltages, as illustrated in 
Figure 2.4.  The ramping of the RF and DC voltages results in the quadrupole acting as a 
variable band-pass filter.  As ions pass from the source into a quadrupole, oscillating 
electrical fields across the rods filter ions based on the stability of their trajectories.  For 
an ion to pass through the quadrupole, its trajectory must be stable in both the x and y 
dimensions.  The potential distribution of an ion, which is a description of ion motion in 




Table 2.4.  Chromatography utilized in 4-step MudPIT experiments. 
Time (min) % Solvent A % Solvent B % Solvent C Flow Rate (µL/min) 
First Step 
0 100 0 0 100 
23.00 0 100 0 100 
25.00 100 0 0 100 
30.00 100 0 0 100 
Step 2 
0 100 0 0 100 
5.00 100 0 0 100 
5.01 75 0 25 200 
7.50 75 0 25 200 
7.51 100 0 0 200 
10.00 100 0 0 200 
10.01 100 0 0 100 
15.00 90 10 0 100 
120.00 50 50 0 100 
Step 3 
0 100 0 0 100 
5.00 100 0 0 100 
5.01 50 0 50 200 
7.50 50 0 50 200 
7.51 100 0 0 200 
10.00 100 0 0 200 
10.01 100 0 0 100 
15.00 90 10 0 100 
120.00 50 50 0 100 
Last Step 
0 100 0 0 100 
5.00 100 0 0 100 
5.01 0 0 100 200 
12.00 0 0 100 200 
12.01 100 0 0 200 
20.00 100 0 0 200 
20.01 100 0 0 100 
25.00 90 10 0 100 
120.00 50 50 0 100 
130.00 0 100 0 100 
135.00 0 100 0 100 
145.00 100 0 0 100 
145.10 100 0 0 200 
150 100 0 0 200 
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Table 2.5.  Gradient utilized for washing nanospray emitters (flow rate = 300 µL/min). 
Time (min) %A %B 
0.50 75 25 
5.00 75 25 
5.01 50 50 
10.00 50 50 
10.01 25 75 
15.00 25 75 
15.01 0 100 
20.00 0 100 
25.00 100 0 





Figure 2.4.  Illustration of a quadrupole51.
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Φ = [U + Vcos(ωt)]*[(x2-y2)/r02]  Equation 2.1 
where Φ is the potential distribution, U is the magnitude of the DC potential applied to 
the rods, V is the magnitude of the RF potential applied to the rods, t is a given time, ω is 
the angular frequency of the RF, x and y are the distances along the axes, and r0 is 
distance from the z axis.  By transforming the variables of Equation 2.1, the equation of 
ion motion can be simplified to the Mathieu equations: 
ax = -ay = (4eU) / (m2r02)   Equation 2.2 
qx = -qy = (2eV) / (m2r02)   Equation 2.3 
where a is a parameter related to the DC voltage, q is a parameter related to RF voltage, e 
is charge state of the ion, and m is the mass of the ion.  Analysis of these equations shows 
that stable ion trajectory is a function of both an ion’s mass and charge, and solving for 
the a and q parameters allows for the determination of the stable x-z and y-z ion 
trajectories through the quadrupole, which can be summarized by the stability diagram 
illustrated in Figure 2.5.  The DC:RF ratio determines the mass resolution, whereas the 
overall range of the scan determines the range of m/z scanned.  By varying DC and RF 
voltages, either a wide or small mass range can be scanned, depending on the goal of the 
experiment61.  
The QqQ consists of three sets of quadrupoles.  The first quadrupole serves as a 
mass filter for the precursor, the second quadrupole is an RF-only collision cell where 
precursors are fragmented, and the third quadrupole is a mass filter for fragment ions.  
Selected reaction monitoring (SRM) is the process whereby a very small window of m/z 
values (mDa) is allowed to pass through the first quadrupole, and after fragmentation, an 
equally small window of m/z values is allowed to pass through the third quadrupole.  In 
this process, the quadrupoles essentially serve as static mass filters as opposed to 
scanning mass filters, which increases sensitivity by up to 2 orders of magnitude195.  The 
combination of precursor m/z and fragment m/z, termed a transition, allows for increased 
selectivity and sensitivity, and monitoring only a narrow region of m/z in two 
quadrupoles allows background ions to be filtered out195.  Several hundred transitions can 





Figure 2.5. Quadrupole stability diagram.  Only the shaded region of stability diagram 
corresponds to solutions of the Mathieu’s equations with stable trajectories.  The inset of 
the figure shows that only those ions corresponding to m+1 will have a stable trajectory 




Because QqQs are tandem-in-space mass spectrometers, ions are scanned in real 
time rather than accumulated; this allows for QqQs to be used in quantitation 
experiments.  By spiking in known amounts of isotopically-labeled peptides 
corresponding to peptides of interest, a process referred to as absolute quantitation 
(AQUA)116, peptides can be quantitated by determing the ratio of the peak areas of the 
peptide of interest and the labeled peptide and calculating the concentration of the peptide 
of interest based on the amount of labeled peptide spiked into the sample.  This is 
illustrated in Figure 2.6. 
A TSQ Quantum Discovery MAX QqQ mass spectrometer (Thermo Scientific, 
Waltham, MA) was used for quantitation experiments.  The instrument was operated 
using a nanospray source (Proxeon Biosystems, Odense, Denmark) with a spray voltage 
of 1.75 kV.  Data were acquired in SRM mode, and three transitions were specified for 
each peptide.  Data were acquired in positive ion mode.  Peak widths for both Q1 and Q3 
were set to 0.7 Da, meaning a m/z range of ±0.35 Da from the specified precursor (Q1) or 
fragment (Q3) m/z value was allowed to pass through both respective sets of quadrupoles.  
A scan width of 0.002 m/z was used, meaning that intensity values were recorded for a 
m/z range of  ±0.001 Da of the fragment m/z specified for the transition.  A scan time of 
0.020 s, 1 microscan, and a chromatography filter (signal processing alrorithm that filters 
high frequency noise in chromatographic peak profiles) value of 5 s were also specified.  
Peaks were centroided.  Skimmer offset was set to 15 V, and the transfer capillary 
temperature was optimized at 275° C using the instrument auto-tune function with a mass 
calibration solution consisting of 1, 3, 6 polytyrosine.  Collision gas was 1.5 mtorr argon.  
In the peptide selection process, normalized collision energies, which compensate for the 
mass dependency of energy needed to induce fragmentation, were calculated using the 
following empirically-derived equation70:  













Collision energies and tube lens voltages were optimized for each transition with 
breakdown curves performed on each isotopically-labeled peptide.  Peptides, tube lens 
voltages, collision energies, and fragments relevant to quantitation experiments are 
presented in Table 2.6. 
A Micromass Quattro II (Manchester, UK) mass spectrometer equipped with a Z-
spray source operated in the positive ion mode (capillary voltage 3.5 kV, cone voltage 20 
V) was used for Aβ studies. Source and desolvation temperatures were 100 °C and 110 
°C, respectively. Nitrogen was used as drying gas (300 liter/ h). Spectra were acquired for 
1 min (1 scan/s) from 300 to 1200 m/z in the multichannel accumulation mode, then 
centroided and normalized. Triplicate spectra were collected and averaged for each 
sample. 
2.3.2 Linear Ion Trap – Orbitrap Mass Spectrometry 
In contrast to the QqQ, the linear trapping quadrupole (LTQ) is a tandem-in-time 
instrument, meaning that all ions are injected into the same volume of space (ion trap), 
followed by expulsion of all ions but those of interest.  Following storage in the trap, ions 
of interest are fragmented in the same volume of space, and the fragments are then 
analyzed.  Ion accumulation, ion selection, dissociation, and detection all occur within the 
trap but at different times.  Similar to the transmission quadrupole, the LTQ consists of 
four elongated electrodes in a parallel configuration, and the Mathieu equations are used 
to determine ion trajectories in such a way that ions of interest are trapped while other 
ions are ejected from the trap.  Mass spectra are obtained as ions are radially ejected from 
the ion trap61. 
 For PTM analysis, an LTQ-Orbitrap54 hybrid196 mass spectrometer was used due 
to high resolution and has mass accuracy of precursor ions afforded by the Orbitrap and 
high duty cycle of fragment ion scans (which don’t require the high resolution needed by 
precursor scans) afforded by the LTQ.  As illustrated in Figure 2.7A, precursor ions are 
guided from the LTQ through a C-trap into the Orbitrap.  The Orbitrap, illustrated in 
Figure 2.7B, consists of an inner axial electrode and an outer coaxial electrode.  Constant 
electric potential is applied to both electrodes.  Because opposing surfaces in the Orbitrap 
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Table 2.6.  Peptides and parameters used in quantitation experiments. 













































Cthe_3077 cellulosome anchoring protein VEIPITLK 
124 456.791 460.798 y6 y5 y3 
684.4649 571.3808 361.2440 692.4791 579.3950 369.2582 
6 7 14 6 7 14 
 
Cthe_3077 cellulosome anchoring protein SFDTAIYPDR 
173 592.782 597.786 y5 y4 y3 
663.3455 550.2614 387.1981 673.3538 560.2697 397.2064 
7 8 10 7 8 10 
 
Cthe_3077 cellulosome anchoring protein NDWSNYTQSNDYSFK 
190 934.889 938.896 y9 y8 y7 
1089.4840 988.4365 860.3779 1097.4980 996.4507 868.3922 
11 11 13 11 11 13 
 
Cthe_3077 cellulosome anchoring protein VTNTGSSAIDLSK 
172 646.838 650.845 y11 y10 y9 
1092.5530 978.5102 877.4625 1100.5670 986.5239 885.4762 
13 11 13 13 11 13 
 
Cthe_0269 glycoside hydrolase, family 8 GIVDGYTIQGSK 
148 619.324 623.331 y9 y8 y6 
968.468 853.4409 633.3561 976.4820 861.4551 641.3702 
8 9 12 8 9 12 
 
Cthe_0269 glycoside hydrolase, family 8 TAVDYSWFGDQR 
143 722.828 727.832 y7 y5 y2 
895.405 622.2938 303.1770 905.4134 632.3021 313.1852 




(Table 2.6 continued) 
 













































Cthe_0269 glycoside hydrolase, family 8 DSEYYGYYGNSLR 
145 793.841 798.845 y9 y6 y5 
1092.510 709.3622 546.2989 1102.5190 719.3705 556.3071 
9 7 12 9 7 12 
 
Cthe_0269 glycoside hydrolase, family 8 LWGSSGAINYGQEAR 
138 804.891 809.896 y13 y7 y5 
1309.613 837.3844 560.2787 1319.6210 847.3927 570.2864 
20 9 16 20 9 16 
 
Cthe_2089 glycoside hydrolase, family 48 ATFINTFQR 
124 549.290 554.294 y7 y6 y5 
925.4885 778.4200 665.3360 935.4968 788.4283 675.3443 
8 10 10 8 10 10 
 
Cthe_2089 glycoside hydrolase, family 48 DMAAELVNR 
167 509.752 514.757 y7 y6 y5 
772.4306 701.3935 630.3564 782.4389 711.4018 640.3647 
9 7 8 9 7 8 
 
Cthe_2089 glycoside hydrolase, family 48 SGISINTDNADLNEDGR 
185 895.911 900.915 y7 y6 y5 
818.3633 703.3364 590.2523 828.3716 713.3447 600.2606 
8 22 24 8 22 24 
 
Cthe_2089 glycoside hydrolase, family 48 AIQAVYWANK 
134 582.314 586.321 y7 y5 y3 
851.4410 681.3355 332.1928 859.4547 689.3491 340.2065 
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Cthe_0412 glycoside hydrolase, family 9 VNQVGYLPFAK 
125 618.342 622.349 y8 y7 y4 
894.5078 795.4394 462.2705 902.5220 803.4536 470.2848 
9 8 15 9 8 15 
 
Cthe_0412 glycoside hydrolase, family 9 FEDPTITAAVK 
131 596.316 600.323 y9 y8 y7 
915.5140 800.4871 703.4343 923.5282 808.5013 711.4485 
10 12 16 10 12 16 
 
Cthe_0412 glycoside hydrolase, family 9 SGISINTDNADVNADGR 
151 859.900 864.904 y12 y7 y6 
1261.5400 746.3422 631.3152 1271.5480 756.3505 641.3235 
8 28 28 8 28 28 
 
Cthe_0412 glycoside hydrolase, family 9 DGGMNIPER 
158 494.729 499.733 y5 y4 y3 
628.3408 514.2979 401.2137 638.3490 524.3061 411.2220 
10 7 8 10 7 8 
 
Cthe_0413 glycoside hydrolase, family 9 SNVVAYGNEFLK 
165 670.845 674.852 y9 y8 y6 
1040.5410 941.4722 707.3717 1048.5550 949.4863 715.3859 
12 13 12 12 13 12 
 
Cthe_0413 glycoside hydrolase, family 9 VNQVGYLPEGK 
150 602.322 606.329 y8 y7 y4 
862.4664 763.3979 430.2291 870.4805 771.4121 438.2438 
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Cthe_3078 cellulosome anchoring protein YGPTPVAGNDIK 
153 616.319 620.326 y8 y7 y5 
813.4459 716.3932 546.2877 821.4601 724.4074 554.3019 
11 14 17 11 14 17 
 
Cthe_3078 cellulosome anchoring protein EGDVIIATIR 
182 543.811 548.815 y6 y5 y4 
686.4554 573.3713 460.2873 696.4637 583.3796 470.2955 
10 10 8 10 10 8 
 
Cthe_0736 cellulosome anchoring protein YDPAVLQAVNPVTGEPMSDK 
182 1066.022 1070.029 y11 y10 y5 
1174.5409 1060.4979 577.2650 1182.5550 1068.5120 585.2787 
15 14 10 15 14 10 
 
Cthe_0736 cellulosome anchoring protein SGTLAIIGFK 
119 503.800 507.807 y7 y6 y5 
761.4915 648.4073 577.3702 769.5056 656.4216 585.3845 
8 10 7 8 10 7 
 
Cthe_0821 coagulation factor 5/8 type-like protein INSTDLGMLNR 
150 617.316 622.320 y9 y6 y5 
1006.4980 703.3914 590.3074 1016.5060 713.3997 600.3156 
13 17 14 13 17 14 
 
Cthe_0821 coagulation factor 5/8 type-like protein LVILDDNLK 
154 521.810 525.817 y7 y6 y5 
830.4612 717.3772 604.2932 838.4755 725.3914 612.3073 
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Cthe_0821 coagulation factor 5/8 type-like protein NIDILQATGPYLINADPDK 
199 1036.038 1040.046 y10 y6 y3 
1145.583 659.2990 359.1920 1153.5970 667.3132 367.2061 
5 25 20 5 25 20 
 
Cthe_1838 glycoside hydrolase, family 10 GPETVELTTEEAYSGR 
158 869.910 874.914 y11 y9 y5 
1255.5801 1013.4534 553.2729 1265.5880 1023.4610 563.2806 
16 21 15 16 21 15 
 
Cthe_1838 glycoside hydrolase, family 10 SISDFPTPEGK 
144 589.290 593.297 y9 y6 y4 
977.4575 628.3301 430.2296 985.4711 636.3437 438.2433 
8 9 19 8 9 19 
 
Cthe_0625 glycoside hydrolase, family 9 SQIDYALGSNPDNR 
153 775.365 780.369 y9 y7 y2 
943.4586 759.3375 289.1613 953.4669 769.3457 299.1696 
14 11 31 14 11 31 
 
Cthe_1307 cellulosome anchoring protein EGIVVGSGDIINPR 
132 713.388 718.382 y4 y3 y2 
499.2987 386.2146 272.1717 509.3064 396.2224 282.1794 
11 13 14 11 13 14 
 
Cthe_0543 glycoside hydrolase, family 9 ELFTFADTTR 
161 600.798 605.802 y8 y6 y3 
958.4629 710.3468 377.2143 968.4706 720.3545 387.2220 
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Cthe_3080 cellulosome anchoring protein DIAEGVIYHSYK 
196 697.851 701.858 y8 y6 y3 
966.5043 810.4145 397.2082 974.5180 818.4281 405.2218 
18 12 18 18 12 18 
 
Cthe_3079 cellulosome anchoring protein FENTPVMPGAK 
130 595.797 599.804 y9 y7 y4 
914.4764 699.3858 372.2241 922.4901 707.3995 380.2378 
9 9 18 9 9 18 
 
Bovine Serum Albumin YLYEIAR 
152 464.250 469.254 y5 y4 y3 
651.3455 488.2822 359.2396 661.3538 498.2904 369.2479 
8 8 14 8 8 14 
 
Bovine Serum Albumin LGEYGFQNALIVR 
142 740.401 745.405 y9 y7 y6 
1017.5830 813.4936 685.4350 1027.5920 823.5018 695.4432 


















Figure 2.7.  The LTQ-Orbitrap hybrid mass spectrometer with ETD capabilities197 (A) 
and the Orbitrap mass analyzer54 (B). 
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are nonparallel, the electric field between the two electrodes varies along the z-axis.  Ions 
are injected and trapped in the Orbitrap by the combination of centrifugal forces and 
attraction to the inner electrode due to electrostatic forces.  Ions thus cycle around the 
inner electrode but also oscillate along the z-axis of the Orbitrap.  Oscillations are 
monitored with image current detection with components on the outer electrode.  The 
frequency of oscillation along the z-axis is described by the following equation: 
ω = [(z/m)k]1/2    Equation 2.5 
where ω is the frequency of axial oscillation, z is the ion’s charge, m is the ion’s mass, 
and k is field curvature.  Because these frequencies are mass and charge dependent, fast 
Fourier transform can be used to convert time-domain signal into mass spectra with high 
resolution (70,000+) and high mass accuracy (2-5 ppm)61.  After detection of the 
precursor, ions can be fragmented, and resulting fragments can be detected either in the 
LTQ or the Orbitrap, depending on the needs of the experiment. 
Fragment ions are typically produced by the collision of the precursor ion with 
high pressure inert gas, usually nitrogen or argon.  This process is referred to as 
collisionally activated dissociation (CAD) in ion trap mass spectrometers198.  In peptide 
analysis this often results in the breaking of the bond between the carbonyl carbon and 
the amide nitrogen, generating what are referred to as b- and y- ions, depending on 
whether the fragment contains the N- or C- terminus of the peptide, respectively.  
Nomenclature relevant to peptide fragmentation199 is presented in Figure 2.8.   
Recently, the LTQ-Orbitrap hybrid mass spectrometer has been combined with an 
electron transfer dissociation (ETD) source197, 200.  ETD is a chemical fragmentation 
initiated by the transfer of an electron from a radical anion to a multiply-charged peptide, 
resulting in nonergodic fragmentation along the peptide backbone as illustrated in Figure 
2.9201-203.  Briefly, fluoranthene radical anions are generated in a negative chemical 
ionization source on the back end of the instrument (opposite of the sample inlet), and 
these radical anions are transferred to the LTQ, where they interact with multiply-
protonated peptides197.  This typically results in more gentle fragmentation compared to 
CAD and has been shown to preserve modifications to amino acid side chains204. LTQ-







































mode, or decision tree mode whereby a fragmentation approached for a given peptide is 
selected based on both the charge of the peptide and the m/z value of the peptide205. 
Because of the difficulty in fragmenting doubly charged peptides with ETD, 
supplemental activation energy can also be applied to +2 peptides in order to increase the 
efficiency of ETD206. 
 An LTQ-Orbitrap hybrid (Thermo Scientific, Waltham, MA) with electron 
transfer (ETD) capabilities was used for PTM analysis (Chapter 4).  The instrument was 
operated using a nanospray source (Proxeon Biosystems, Odense, Denmark) with a spray 
voltage of 3.80 kV.   The instrument was operated with precursors being scanned in the 
Orbitrap and fragments scanned in the LTQ.  Precursor scans were performed in the 
Orbitrap in positive ion mode with full scans ranging from 400-1700 m/z and resolution 
of 30,000.  Fragment scans were performed in the LTQ with 5 data dependent scans.  In 
data dependent scans, the 5 most intense peaks in a precursor scan are subjected to 
subsequent fragmentation.  Once a precursor is fragmented in a data dependent scan, the 
m/z value is placed on a dynamic exclusion list, meaning that particular m/z value will not 
be fragmented again until one of the conditions (list size or duration) of the dynamic 
exclusion list expires.  The dynamic exclusion list had an exclusion list size of 100 m/z 
values, an exclusion duration of 60.0 s, and an exclusion mass width of 1.50000 Da.  For 
CAD activation experiments, the isolation width was 3.0 Da, the normalized collision 
energy was 35.0%, the activation Q (RF value used for ion fragmentation) was 0.250, and 
activation time was 30 ms.  For ETD activation experiments, preview mode was enabled 
for FTMS master scans, charge state screening was enabled, charge state dependent ETD 
time was enabled, and precursors with a +1 charge state were rejected.  Isolation width 
was 3.0 m/z, activation time was 100 ms, and supplemental activation energy was enabled 
for +2 peptides (amplitude for this paramter was not adjustable and could only be enabled 
for +2 peptides).  For experiments that utilized the decision tree, ETD was performed on 
precursor ions less than 650 m/z in the +3 charge state, less than 900 m/z +4 charge state, 
less than 950 m/z +5 charge state, and all precursors in the +6 or higher charge state.  All 
other precursor ions were subjected to CAD activation.  Technical replicates were 
performed for each experiment. 
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A standalone LTQ (Thermo Scientific, Waltham, MA) was used for protein 
selection in C. thermocellum quantitation studies (Chapter 5).  Peptides were fragmented 
with CAD, and experimental parameters were identical to those used for experiments 
with the LTQ-Orbitrap with ETD capabilities described above with the exception of 
precursor scans, which were generated in the LTQ rather than the Orbitrap. 
2.3.3 Data Analysis 
For Aβ experiments, spectra were interpreted manually and verified with MS/MS.  
Briefly, precursor ions were selected for fragmentation, and the fragmentation spectra 
were manually assigned to deduce the amino acid sequence of the fragment ion. 
For all of the LTQ and LTQ-Orbitrap measurements, the Thermo .RAW files 
were composed of DTA files that contain lists of precursor m/z and fragment m/z values 
for each scan.  For PTM analysis, DTAs were extracted from .RAW files and merged into 
database-searchable merged DTA files using DTA Generator207. Data were searched 
using the Open Mass Spectrometry Search Algorithm (OMSSA)208 version 2.1.8 with 
average precursor ion m/z values, monoisotopic product ion m/z values, a precursor ion 
mass tolerance of 3 Da, a product ion mass tolerance of 0.5 Da, and 3 missed cleavages 
allowed.  For CAD searches, b- and y- ions were searched, and for ETD searches, c-, z·-, 
and y- ions were searched.  Prior to searching ETD data, spectra were preprocessed to 
remove the precursor ion as well as charge reduced species209.  A reversed database was 
concatenated to the C. thermocellum ATCC 27405 database (GenBank Accession 
#CP000568.1) along with common contaminants, and peptides were filtered at a 1% false 
discovery rate124 based on E values. All searches were performed with a fixed 
modification of carbamidomethylation123. Six searches were performed with each dataset:  
no modifications other than carbamidomethylation of cysteine, methylation (mono- 
(K,R,E) and di- (K,R), and tri- (K,R) methylation), oxidation (mono- (C,M,W,Y), di- 
(C,M), and tri- (C) oxidation), acetylation (K), phosphorylation (H,S,T,Y), and 
computationally predicted cleavage of signal peptides using a database generated with 
SignalP-3.0210, 211. Identification of the new protein N-terminus was required for the 
identification of a protein as having its signal peptide cleaved.  Two unique peptides were 
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required for each protein identification212.  Modifications other than 
carbamidomethylation of cysteine were searched as variable modifications.  These 
targeted modifications were selected to represent those prevalent in bacterial systems213.  
A strategic exception was phosphorylation, which was included as a test for false 
positives; the degree of phosphorylation should be minimal for these extracellular 
fractions 214.  Modifications were searched one at a time to minimize search space.  
Ambiguous identifications (i.e., cases where a single peptide MS/MS spectrum was found 
to be consistent with two or more possible modifications) were excluded from the results.  
Surviving identifications were merged, and a modification site was confirmed if it was 
identified in experiments using at least two of the nine different conditions (3 
fragmentations methods each performed on 3 different digests). Each individual search 
took approximately 30 min on a desktop computer; multiple searches were performed 
simultaneously on the same computer.  Venn diagrams presented in the results section 
were created using Venn Diagram Plotter from PNNL, available at omics.pnl.gov. 
For quantitation experiments, LTQ data used for preliminary protein and peptide 
selected were searched using DBDigger215.  A precursor ion mass tolerance of 3 Da and a 
product ion mass tolerance of 0.5 Da was specified.  Results were scored with 
MASPIC216 and filtered with DTASelect217.  A ΔCN value of 0.08 was used by 
DTASelect, and cross correlation (Xcorr) values of 20, 25, and 40 were specified for +1, 
+2, and +3 ions, respectively.  Data acquired on the QqQ for quantitation experiments 
were analyzed using Skyline218 v. 0.7. This software determines peak area in 
chromatograms and then derives the ratio of unlabeled peptide peak to labeled peptide 






INVESTIGATING COMPLEMENTARY PEPTIDE SEQUENCE 
COVERAGE USING ONLINE PROTEOLYSIS 
 
 
All of the data presented below has been adapted from the following published journal 
article219: 
 
Andrew B. Dykstra, Maolian Chen, and Kelsey D. Cook.  Complementary Peptide 
Sequence Coverage Using Alternative Enzymes for On-Line Digestion with a Triaxial 
Electrospray Probe.  Journal of the American Society of Mass Spectrometry 2009, 20 
(11), 1983-1987.  Sample preparation and experiments were performed by Maolian Chen.  
Data analysis was performed by Andrew B. Dykstra. 
3.1 Introduction 
Amyloid beta (Aβ) is a hydrophilic peptide ranging from 39 to 43 amino acids in 
length that is thought to be one of the primary constituents in the formation of amyloid 
plaques found in the brains of patients diagnosed with the neurodegenerative Alzheimer’s 
disease220. These plaques are conglomerates mostly composed of fibrils, which in turn 
form from the Aβ peptide221. In order to better understand the onset of Alzheimer’s 
disease, it is critical to gain structural information pertaining to Aβ fibrils.  However, Aβ 
fibrils are non-crystalline and exhibit short NMR relaxation times.  These intrinsic 
properties of fibrils have made examination of the higher order structure difficult with 
conventional means such as x-ray crystallography (requires crystalline structure) and 
multi-dimensional NMR (short relaxation times lead to broad, unresolved peaks in NMR 
spectra)158. Hydrogen-deuterium exchange (HDX) mass spectrometry has proven fruitful 
in the structural analysis of these fibrils. 
HDX mass spectrometry depends upon the incorporation of deuterium from a 
buffer solution prepared with D2O into the protein structure.  By measuring the mass 
shifts caused by deuterium incorporation and the rates at which they occur, structural 
information relevant to the protein can be deduced based on which sites in the protein are 
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protected from or exposed to exchange.  Hydrolysis followed by tandem mass 
spectrometry is widely used for “bottom up” sequencing and localization of sites 
susceptible or resistant to exchange222.  For HDX studies, pepsin is a preferred enzyme 
because it tolerates the low pH that minimizes artifactual exchange during sample 
processing.  There are cases where sequence coverage using pepsin is suboptimal, 
especially in the short hydrolysis times used to reduce artifactual exchange.  This 
challenge was amplified in HDX studies of Aβ (1-40) fibrils158, 223 because of the need to 
accomplish both hydrolysis and rapid fibril dissolution with minimal scrambling and 
artifactual exchange.  A triaxial probe was previously reported to address this by online 
mixing of a fibril suspension with a solution that quenched HDX and initiated dissolution 
and hydrolysis, followed ~12 s later by addition of acetonitrile to provide a strong and 
stable electrospray signal159.  Previous studies of myoglobin employed a similar mixing 
apparatus to probe denaturation via oxidative labeling, but coupled it with conventional 
LC/MS rather than attempting online hydrolysis224.  The probe utilized in this study was 
designed for the specialized application requiring online hydrolysis; it was therefore of 
interest to determine whether it might be usable with other enzymes compatible with low 
pH constraints. This study examines the efficacy of using alternative pepsin-like enzymes 
and their mixtures for improving sequence coverage with online hydrolysis of Aβ (1-40). 
3.2 Complementary nature of multiple proteases 
Initial online proteolysis experiments of Aβ (1-40) monomer using pepsin-like 
enzymes were performed using the protease XIII and protease XVIII as provided by the 
vendor.  Preliminary results from these experiments with unpurified alternative enzymes 
gave poor signal/background (S/B) and required very high enzyme concentrations 
(enzyme:substrate > 40:1 in some cases) to achieve hydrolysis, as illustrated in Figure 
3.1a (protease XIII) and Figure 3.2a (protease XVIII).  It was unclear whether unassigned 
peaks in these spectra were the result of enzyme autolysis or contaminants present in the 
enzyme as provided, so mass spectra were obtained for the enzymes in solutions prepared 
at 0.1 µg/µL in 0.5% formic acid (Figures 3.1b and 3.2b).  In these figures, peptides are 





Figure 3.1.  Mass spectra obtained from (a) online protelysis of Aβ (1-40) monomer 
using unpurified protease type XIII at an enzyme:substrate ratio of 45:1 and (b) protease 






Figure 3.2.  Mass spectra obtained from (a) online protelysis of Aβ (1-40) monomer 
using unpurified protease type XVIII at an enzyme:substrate ratio of 25:1 and (b) 
protease type XVIII as provided by the vendor.
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terminus, of the amino acid in the peptide sequence, and this notation is used henceforth 
for simplicity.  Peaks observed in Figures. 3.1b and 3.2b correlate to some of the 
enzymes were purified with dialysis to remove contaminants.  Spectra representative of 
the online proteolysis of Aβ (1-40) monomer with purified proteases XIII and XVIII are 
presented in Figure 3.3.  Purifying enzymes with dialysis allowed for the reduction of 
enzyme:substrate ratios, and contaminant peaks from Figures 3.1a and 3.2a were not 
observed in Figure 3.3.   
Results from online proteolysis from all four enzymes are summarized in Figure 
3.4.  Like pepsin, none of the pepsin-like proteases is highly specific, but the digestion 
patterns were distinctive and reproducible based on triplicate measurements.  The 
enzymes preferentially cleave hydrophobic residues (e.g., phenylalanine (F), leucine (L), 
methionine (M), and valine (V)) on the N- and/or C-terminal sides225.  Significantly, all 
three alternative enzymes provide more coverage than “normal” pepsin, but the coverage 
is complementary; of the seven fragments observed with pepsin, only four are among the 
14 observed with protease XIII, three are among the 12 observed with protease XVIII, 
and two are among the 12 obtained with endothiapepsin. 
The case is even more striking when sampling fibrils (Figure 3.5; due to the 
limited availability of endothiapepsin, fibrils were not digested with this enzyme).  The 
relatively slow dissolution of fibrils affects the spectra in two ways. Both spectra in 
Figure 3.5 contain signals for intact Aβ (1–40) plus six protons (5% of the base peak for 
protease XIII and 20% for protease XVIII), reflecting incomplete hydrolysis (the peak is 
designated [1-40]6+ in the figure).  Nevertheless, fibril spectra contain more fragments 
than those from the monomer.  For protease XIII, there are six additional fragments (20-
33, 20-34, 23-33, 23-34, 35-40, and 36-40).  Conversely, fragments 1-23, 21-40, and 23-
40 fragments, which were detected in the monomer spectrum, are absent when examining 
fibrils.  Similarly, when treating fibrils with protease XVIII, seven additional fragments 
appear (2-4, 4-19, 17-19, 20-34, 20-40, 23-34, and 36-40); 23-40 is again absent.  While 
some of the additional peaks derive from relatively large fragments that may be further 
digested in the monomer experiments, this cannot account for all differences.  For 





Figure 3.3. Mass spectra obtained from online digestion of Aβ (1-40) monomer with (a) 
purified protease XIII and (b) purified protease XVIII. Only peaks of identified fragments 






Figure 3.4. The peptides obtained from the online digestion of Aβ (1-40) using the 
indicated enzymes are shown as underlining bars under and above the Aβ (1-40) 
sequence. Residues highlighted in orange are those thought to be engaged in hydrogen-
bonded beta sheets in fibrils (protected from H/D exchange). Dotted vertical lines 
indicate the expected cleavage sites. Digests using endothiapepsin were performed only 
on Aβ (1-40) monomers whereas digests using pepsin and protease XIII and XVIII were 
performed separately on both the monomer and fibrils. For the latter three enzymes, solid 
lines indicate peptides found in the digest of both monomer and fibrils, double lines 
indicate peptides found only in the digest of the monomer, and triple lines indicate 





Figure 3.5. Mass spectra obtained from online digestion of Aβ (1-40) fibrils with (a) 
purified protease XIII and (b) purified protease XVIII. Only peaks of identified fragments 




fibril spectrum ([1-19]5+ in Figure 3.5b versus [34-40]+ in Figure 3.3b), the average 
number of residues in an assigned ion (not weighted by relative intensity) is actually less 
in Figure 3.5b (12.3) than in Figure 3.3b (13.8). This difference is even larger (11.7 
versus 14.1) for protease XIII (Figure 3.5a and Figure 3.3a, respectively). Moreover, 
most of the additional fragments derive from fragmentations at sites “protected” from 
H/D exchange in the fibrils157, 158, 226 (indicated by orange letters in Figure 3.4). 
There are some interesting implications of these observations.  Clearly, the 
kinetics of dissolution decrease the time available for hydrolysis when sampling fibrils.  
While this can account for the observation of residual monomers and the greater relative 
abundance of some larger fragments, the simultaneous appearance of more and smaller 
fragments from fibrils suggests additional kinetics distinctions—the fibrils appear to 
present Aβ structure(s) more amenable to hydrolysis.  Cleavages at “protected” sites may 
suggest that these structures entail stepwise dissolution from fibrils to protofibrils or other 
relatively reactive conformations.  Such distinctions would not be observable in 
experiments where dissolution and hydrolysis are sequential and on a slower timescale.  
Although detailed understanding would require experiments beyond the scope of this 
limited study, clearly the triaxial probe is providing insight complementary to that in 
conventional experiments.  
In cases where sample quantities are limited, it is useful to combine enzymes to 
gain broad structural information in a single experiment227. This requires that the 
enzymes not inhibit or digest one another on the timescale of the experiments—a 
requirement potentially facilitated by the short exposure time characteristic of the triaxial 
probe.  As a test of the feasibility of such an operation, digestion of fibrils using all 
binary and tertiary combinations of protease XIII, protease XVIII, and pepsin was 
conducted.  The spectrum acquired with the ternary mixture is presented for illustration in 
Figure 3.6; Table 3.1 summarizes the results of all single and mixed enzyme experiments.  
The hydrolyses are not strictly additive; for the ternary mixture and the binary protease 
XVIII/pepsin mixture, the [1-23] fragment was not detected, while for the protease 






Figure 3.6. Digestion of Aβ (1-40) fibrils with an enzyme mixture composed of pepsin 
and proteases XIII and XVIII. Only peaks of fragments with S/B ≥ 5 are labeled. Charge 




Table 3.1. Summary of results from digestion of Aβ(1-40) fibrils using individual 
enzymes and enzyme mixtures.  Signal-to-background ratio (S/B) is based on the base 
peak.  Background was assessed as the average intensity between m/z 1100 and m/z 
1200.  The master list includes the combined fragments obtained from the digestion using 
all the following enzymes either individually or in combination. 
 
Enzyme Weight Ratio Observed Fragment (#) 
Relative intensity of 
intact peptide peak 
(+6) to the base peak 
(S/B) 
Pepsin Wpep:Wfib = 8 : 1 1-19, 4-19, 20-33, 20-34, 34-40,35-40, 20-40 (7) 
8%  
(45) 
XIII WXIII:Wfib = 5 : 1 
1-4, 1-16, 1-19, 1-20, 2-4, 4-19, 
17-19, 20-33, 20-34, 20-40, 21-
40, 23-33, 23-34, 23-40, 24-33, 
24-40, 34-40, 35-40, 36-40 (19) 
5%  
(139) 
XVIII WXVIII:Wfib = 5 : 1 
1-4, 1-16, 1-19, 1-20, 1-23, 2-4, 
4-19, 17-19, 20-33, 20-34, 20-
40, 23-33, 23-34, 24-33, 24-40, 





WXIII:Wfib = 1.25 : 1 
Wpep:Wfib = 2.5 : 1 
 
1-4, 1-16, 1-19, 1-20, 2-4, 4-19, 
17-19, 20-33, 20-34, 20-40, 21-
40, 23-33, 23-34, 23-40, 24-33, 





WXVIII:Wfib = 2.5 : 1 
Wpep:Wfib  = 1.25 : 1 
 
1-4, 1-16, 1-19, 1-20, 2-4, 4-19, 
17-19, 20-33, 20-34, 20-40, 23-
33, 23-34, 24-33, 24-40, 34-40, 
35-40, 36-40 (17) 
5%  
(42) 
XIII + XVIII 
 
WXVIII:Wfib = 5 : 1 
WXIII:Wfib = 0.425 : 1  
 
1-4, 1-16, 1-19, 1-20, 1-23, 2-4, 
4-19, 17-19, 20-33, 20-40, 21-
40, 23-33, 23-40, 24-33, 24-40,  
34-40, 35-40, 36-40 (18) 
33%  
(15) 
XIII + XVIII + 
Pepsin 
 
WXVIII:Wfib = 2.5 : 1 
WXIII:Wfib = 0.625 : 1 
Wpep:Wfib = 0.3 : 1 
 
1-4, 1-16, 1-19, 1-20, 2-4, 4-19, 
17-19, 20-33, 20-34, 20-40, 21-
40, 23-33, 23-34, 23-40, 24-33, 





These absences may be partly attributable to further digestion of these fragments.  More 
interestingly, there is evidence of potential synergy in the use of enzyme mixtures.  For 
example, when mixing protease XIII and pepsin together, less enzyme (3.75:1 total, 
enzyme:fibril weight ratio) is needed to attenuate the intact peptide peak to roughly the 
same relative abundance (5%) as for either enzyme alone (5-8:1, Table 3.1). This might 
justify the use of the mixture in preference to protease XIII alone, even though the same 
fragments are produced.  In contrast, when combining protease XIII and protease XVIII 
there is a ~50% increase in the relative abundance of the peak ascribed to the intact 
peptide, although its absolute intensity (reflected in the signal-to-background (S/B) ratios 
in Table 3.1) decreases.  Detailed interpretation of such quantitative aspects is often 
complicated by ion suppression and other interference effects. 
3.3 Conclusions 
While it is not surprising that additional peptide fragments (relative to those 
obtained with pepsin) are generated by the pepsin-like enzymes, the timeframe accessible 
with the triaxial probe appears to enhance complementarity for fibril analysis. 
Furthermore, the probe may facilitate synergistic effects from use of enzyme mixtures on 
a timeframe that minimizes interference from digestion of the proteases. 
Although it is beyond the scope of this study, observation of fragments 34-40, 35-
40, and 36-40 suggests that use of the alternative enzymes in HDX studies could clarify 
whether the C-terminus is exposed or protected in fibrils of Aβ (1-42)228-230. Earlier 
efforts were complicated because the C-terminal [35-42]+ fragment is isobaric with the 
internal [20-34]2+ fragment, complicating assessment of the D-labeling of the C- terminal 
peptide in HDX studies. If use of the alternative enzymes with Aβ (1-42) yields 
fragments analogous to 34-40 and 36-40 (i.e., 34-42 and 36-42), interference from [20-
34]2+ would be mitigated. Although the material needed for such studies was no longer 






CHARACTERIZING PROTEIN POST-TRANSLATIONAL 
MODIFICATIONS BY A COMBINED CAD AND ETD APPROACH 
 
 
All of the data presented in this chapter has been adapted from the following journal 
article in preparation: 
 
Andrew B. Dykstra, Miguel Rodriguez, Jr., Babu Raman, Kelsey D. Cook, Robert L. 
Hettich.  Characterizing Extracellular Protein Post-translational Modifications in a 
Cellulose-degrading Bacteria by a Combined CAD and ETD Approach.  In preparation 
for submission to the Journal of Proteome Research.  Fermentations were performed by 
Miguel Rodriguez, Jr. and Babu Raman.  Sample preparation for proteomics experiments, 
collection of experimental data, and data analysis were performed by Andrew B. Dykstra. 
4.1 Introduction 
The role of post-translational modifications (PTMs) in systems biology has 
become increasingly evident as studies have linked PTMs to a wide variety of cellular 
functions including protein activation231, tumorigenesis232, chemotaxis233, redox 
signaling234, and protein secretion into the extracellular matrix235.  Despite increasing 
awareness of the importance of PTMs in biological environments, large-scale 
identification of modifications remains difficult.  Traditional methods of PTM 
identification have relied upon gel stains specific to particular modifications236, 237, 
immunochemistry238, and selective mass spectrometry239.  However, these methods are 
typically limited by the requirement of purified proteins in quantities that are often not 
available240, the limited specificity and availability of antibodies241, 242, and/or the 
capability to identify only a single targeted modification per experiment243. 
Proteomics has made strides in the identification of PTMs240, but most proteomics 
experiments are dependent upon database searches.  While the genome sequences of 
many organisms have been completed, database searching is complicated by the wide 
variety of known PTMs, exemplified by the 673 known modifications currently deposited 
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in the Unimod database244.  The addition of multiple PTMs to search parameters 
exponentially increases search space245, which in turn increases search time as well as the 
false discovery rate of the results. 
To probe the PTM signature of a particular organism, a multi-faceted approach 
must be utilized in order to increase the number of protein identifications, the number of 
modified peptide identifications, and confidence in these results.  The value of using 
multiple proteases in proteomic experiments has been demonstrated in multiple studies219, 
246-248.  In addition to multiple proteases, the introduction of alternate peptide 
fragmentation methods has given rise to another dimension in PTM identification.  
Electron transfer dissociation (ETD)202, 203 induces peptide fragmentation that is distinct 
compared to collisionally-activated dissociation (CAD).198  In addition to producing 
distinctive ions, ETD has also been shown to more effectively preserve labile PTMs that 
may be removed from a modified peptide when fragmented by CAD249. 
 Sequence overlap and independent identification of sequences in separate 
experiments increases the confidence of assignment.  Peptides identified both in separate 
decision tree205 and CAD or ETD experiments can be considered to be identified with 
multiple fragmentation techniques despite the fact that decision tree experiments utilize 
CAD and ETD fragmentation.  This is because in a CAD or ETD experiment, all peptides 
are being subjected to the particular fragmentation without bias, whereas in decision tree 
runs, a peptide is selected to undergo a particular fragmentation based on physical 
characteristics.  Though the distinction is subtle, it is one worth making.    
As noted in Chapter 1, Clostridium thermocellum is an organism of particular 
interest to bioenergy research due to its ability to break down cellulosic biomass into 
carbohydrates used for biofuel production153.  Key to microbial cellulose utilization in C. 
thermocellum is the cellulosome, an extracellular protein machine consisting of proteins 
with a variety of enzymatic functions such as endoglucanases, exoglucanases, 
cellobiohydrolases, xylanases, etc.250-252  As C. thermocellum approaches stationary 
growth phase, cellulosomes begin releasing from the cell surface149, making study of the 
protein complex more feasible during stationary growth phase. However, during the more 
biologically relevant exponential phase, the cellulosome remains surface-attached.  Up to 
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9 different enzymes can attach to the scaffoldin protein CipA, through high affinity Type 
I dockerin-cohesin interactions253, 254.  In turn, CipA binds to proteins anchored into the 
cell surface through Type II dockerin-cohesin interactions255. The utilization of these 
cellulosome complexes by C. thermocellum results in one of the highest observed growth 
rates on cellulosic biomass148.   
It is important to detect and analyze PTMs associated with the cellulosome in 
order to better understand both the structure and function of the protein complex.  
Identification of cellulosome PTMs has broad implications in bioenergy research in that 
modifications could be incorporated into studies involving computational cellulosome 
modeling256, engineering of artificial cellulosomes257-259, structural characterization of the 
cellulosome260, and cellulosome metabolic activity187.  To that end, this study seeks first 
to establish whether multiple fragmentation methods and enzymes yield a deeper dive 
into the organism’s proteome and/or a significant increase in sequence coverage of the 
extracellular proteins.  Once the extracellular protein catalog has been established, PTMs 
will be mined from these results to assess the utility of multiple fragmentation methods 
and enzymes for probing the PTM signature of the C. thermocellum cellulosome. 
4.2 Results of PTM Analysis with Multiple Proteases and 
Fragmentation Techniques 
 Initial experiments using multiple fragmentation methods and enzymatic digests 
were performed with the extremely thermophilic bacterium Caldicellulosiruptor 
obsidiansis (strain ATCC BAA-2073) using guanidine as a denaturing agent, solid phase 
extraction sample cleanup following digestion, and the Proteome Discoverer 1.0 (Thermo 
Scientific) software suite for database searching.  However, these experiments were 
discontinued for a number of reasons.  While the Caldicellulosiruptor obsidiansis (strain 
ATCC BAA-2073) genome had been drafted, a complete version of the genome was not 
released in a time frame reasonable for this dissertation.  A complete genome is of vital 
importance to PTM analysis because errors in the genome could lead to significant 
incorrect peptide identifications and missed identifications.  The sample prep method 
using guanidine as a denaturant and solid phase extraction for sample cleanup was 
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abandoned because approximately 3 times as many oxidized peptides were observed 
using this method compared to the sample preparation method outlined in Chapter 2 that 
was used for the data presented in these experiments.  In addition, significant losses of 
peptides to solid phase extraction were observed.  Proteome Discoverer, which allowed 
searching of data with SEQUEST261 (CAD and ETD data), Mascot262 (CAD and ETD 
data), or ZCore263 (ETD Data), was abandoned as a software suite because the program 
would crash when large datasets from MudPIT experiments were searched.  For these 
reasons, the bacterium, sample preparation method, and informatics platform outlined in 
Chapter 2 were used for data presented in this chapter. 
 In order to verify that the use of multiple fragmentation methods and proteolytic 
digests were a viable approach for analyzing PTMs, the identification of unique 
unmodified peptides was compared across the different conditions.  Venn diagrams in 
Figure 4.1A and 4.1B illustrate the overlap of the 18,688 peptides identified as a function 
of fragmentation mechanism and enzymatic digest, respectively.  Fragmentation methods 
(Figure 4.1A) exhibited a large degree of convergence, with 63% of unmodified peptides 
being identified with more than one fragmentation technique.  This high degree of 
overlap was mostly due to peptides being identified with a particular fragmentation 
method and then again with the same fragmentation technique in a decision tree 
experiment.  Peptides identified only in CAD experiments may be missed in ETD 
experiments due to the slower ETD duty cycle.  Peptides identified only with decision 
tree experiments may be the result of more stringent criteria necessary for fragmentation 
selection.  For example, in a CAD experiment, peptides that would be selected for ETD 
fragmentation in a decision tree experiment may not fragment efficiently with CAD, 
yielding spectra unassigned by database searching.  However, similar results have been 
previously reported205, and the identification of peptides with CAD in decision tree 
experiments but not in a CAD only experiments may also be the result of sampling issues 
during chromatographic separation.  Notable in these results was the fact that although 
18% of all peptides were identified with ETD (reflecting its intrinsic selectivity), 1% of 
peptides were identified only with ETD.  This is most likely due to a combination of 





Figure 4.1.  Venn diagram of all proteins identified in the extracellular fraction based on 
(A) indicated fragmentation methods (data summed for all three digestion methods), and 




fragmentation, and scrambling of c- and z·- fragments to c·- and z- fragments due to 
supplemental activation energy264, which would result in the wrong fragments being 
searched. 
 Much less overlap was observed when analyzing peptides identified with different 
enzymatic digests (Figure 4.1B).  The overlap between trypsin and Lys-C is reasonable 
considering that both enzymes cleave peptides at the C-terminus of lysine.  That this 
overlap is relatively small, whereas many peptides are identified with only one or the 
other enzyme, is also reasonable in light of the fact that trypsin also cleaves at the C-
terminus of arginine.   Similarly, the orthogonality of Glu-C digested peptides is 
consistent with cleavage only by Glu-C at the C-terminus of glutamic acid.   
 When results from using all fragmentation methods and enzymes were merged, a 
total of 1,058 distinct unmodified proteins were identified in the extracellular fraction.  
However, in individual experiments, the number of proteins identified averaged for all 
enzymatic digests was 543, 210, and 587 for CAD experiments, ETD experiments, and 
decision tree experiments, respectively.  Additional proteins were identified due to the 
complementarity of the fragmentation methods and different enzymes used for digestion, 
but some of these proteins are intracellular proteins found in the extracellular fraction as a 
result of cell lysis.  Included among these were 60 cellulosome proteins that were 
identified as unmodified.  These proteins are the focus of the remainder of the discussion. 
 The detailed sequence coverage for individual cellulosome proteins is presented 
in the Appendix.  The average sequence coverage for the 48 cellulosome proteins 
identified with conventional CAD/trypsin experiments was 29.43% (averaged across all 
identified proteins).  When results from all fragmentations methods and digests are 
considered, an additional 17.07% of sequence coverage is identified (averaged across all 
identified proteins) for these proteins and an additional 12 proteins are identified.  Results 
from all experiments yield the identification of 60 cellulosome proteins identified with an 
average sequence coverage of 40.11% (averaged across all identified proteins).  
Likewise, when sequence coverage of the 48 cellulosome proteins identified with 
CAD/trypsin experiments is compared to results for the same proteins from Lys-C and 
Glu-C experiments, 22.21% sequence overlap (averaged across all identified proteins, 
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defined as the percentage of amino acid sequence identified with at least two enzymatic 
digests) is observed. This enhanced coverage, combined with the substantial sequence 
coverage overlap afforded by multiple enzymes, should increase the probability of 
identifying PTMs 
 Having confirmed the viability of the multimethod approach for C. thermocellum 
proteins, the next step was to search the data to identify PTMs.  Figure 4.2 illustrates the 
power of the decision tree method, whereby a particular modification, dimethylation of 
K652 of protein CelK, was identified in a decision tree run of a Lys-C digest where the 
+4 form of the peptide was identified with ETD (Figure 4.2A) and the +2 form of the 
peptide was identified with CAD (Figure 4.2B).  This modification was also observed in 
a CAD experiment on the same digest, thus meeting the criterion that the modification be 
identified in at least two different experimental conditions.  Figure 4.3 illustrates an 
example where a single modification, oxidation of M1883 of protein CipA, was identified 
in both an ETD run of a Glu-C digest (Figure 4.3A) and a CAD run of a trypsin digest 
(Figure 4.3B).  In this case, the charge states, the fragmentation methods, the enzymes 
used for digestion, and the lengths of the peptides were different, but the same 
modification was identified.  The identification and verification of this modification in 
independent experiments greatly increases the confidence that this particular methionine 
was oxidized.   
 Figure 4.4 illustrates the overall performance of the methods for the representative 
protein CipA.  Overall, the sequence coverage increased from ~32% using conventional 
CAD/trypsin experiments to ~49% when data from additional fragmentation methods and 
digests were included. Particularly noteworthy are the 8 identified PTMs (highlighted by 
circling) and the enhanced sequence coverage afforded by extending beyond the 
conventional (CAD/trypsin) methodology. Sequence segments indicated with yellow 
highlighting in Figure 4.4A are those identified conventionally, whereas segments 
highlighted with additional colors in Figure 4.4B were identified by one or more of the 
other approaches.  Acetylation and trimethylation modifications such as those illustrated 
in Figure 4.4B were not identified unambiguously in these experiments; more focused 














Figure 4.2.  Modified peptide (CelK dimethylation of K652) identified with both ETD 




















Figure 4.3.  Modified peptide (CipA M1883) identified with both a Glu-C/ETD 



























Figure 4.4.  Sequence coverage of CipA as identified by trypsin/CAD (A) and all 
fragmentations and enzymes (B).  Also indicated are PTMs identified with at least two 
fragmentation methods and/or enzymes.  
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needed to differentiate these modifications with higher confidence.  Though 2 distinct 
peptides are generally adequate to identify a peptide with database search algorithms, the 
small percentage of sequence afforded by two tryptic peptides yields little insight into 
protein function.  The increase in sequence coverage resulting from the use of multiple 
fragmentation methods has allowed for the high confidence identification of multiple 
CipA PTMs, including methylations and/or acetylations that may have critical structural 
or functional significance to the cellulosome scaffoldin protein and the protein complex 
in general. 
 Cellulosomal protein PTM sites identified as described above are summarized in 
Table 4.1; proteins detected without modification are listed in Table 4.2.  Of the 61 (total) 
cellulosomal proteins identified (comprising ~73% of the known cellulosome proteins), 
nearly half (28) were identified with at least one modification.  Signal peptide cleavage 
was prevalent across this set of proteins, consistent with the fact that signal peptides are 
indicative of proteins marked for export into the extracellular matrix, where these 
proteins function.  Some of the many oxidations observed on cysteine, tyrosine, and 
tryptophan amino acids could be related to biological function or oxidative damage 
incurred during fermentation, but most methionine oxidiations were probably induced by 
sample preparation conditions or voltage applied to the nanospray emitter.  These 
oxidations may not be biologically important, but many would have been overlooked in a 
conventional one-method experiment.  No phosphorylations were identified in any of the 
cellulosome proteins, which was expected because phosphorylations are generally 
associated with intracellular processes214.   
 In view of the extracellular function of cellusome proteins, it is surprising that so 
many were detected without signal peptide cleavage.  However, in order to verify signal 
peptide cleavage, identification of a peptide containing the protein’s computationally 
predicted new N-terminus in search results was necessary.  Not identifying the new N-
terminus could be the result of inaccurate computational prediction, poor ionization 
efficiency of the peptide containing the protein’s new N-terminus, or N-terminal PTMs 
that weren’t taken into consideration in this study.  As such, not identifying the protein’s 
new N-terminus is not necessarily indicative of lack of signal peptide cleavage. 
 
 84 
Table 4.1.  Modified cellulosome proteins identified, their function, and experiments in which particular PTMs were identified. 
 
Glu-C Digest Lys-C Digest Trypsin Digest Locus Gene Description Modification 
CAD DT ETD CAD DT ETD CAD DT ETD 
Cthe_0043 CelN Endoglucanase SigP Cleaved x   X X X    
M345 Oxidation    X X  X   
SigP Cleaved X X X X X  X X  
W205 Oxidation       X X  Cthe_0269 CelA Endoglucanase 
Y215 Oxidation       X X  
Cthe_0405 CelL Cellulase/      beta-glucanase SigP Cleaved X X   X   X  
C53 Oxidation    X X  X X X 
K240 
Acetylation/ 
Trimethylation     X X    
K652 
Dimethylation    X X     
M132 Oxidation    X X  X X  
R411 
Dimethylation     X X    
SigP Cleaved X X X       
W241 Oxidation    X X  X X  
W653 Oxidation X X  X X  X X  
W806 Oxidation X X        
Cthe_0412 CelK Cellobiohydrolase 
W94 Oxidation       X X  
SigP Cleaved X X  X X  X X X 
Y662 Oxidation    X X     Cthe_0413 CbhA Cellobiohydrolase 
M720 Oxidation       X X  
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(Table 4.1 continued) 
 
Glu-C Digest Lys-C Digest Trypsin Digest Locus Gene Description Modification 
CAD DT ETD CAD DT ETD CAD DT ETD 
Cthe_0433  Cellulase/beta-glucanase SigP Cleaved    X X     
Cthe_0452  Anchor protein SigP Cleaved    X X     
Cthe_0536 CelB Endoglucanase K202 Methylation    X X   X  
Cthe_0543 CelF Endoglucanase SigP Cleaved    X X  X   
SigP Cleaved    X X  X X  
M40 Oxidation    X X  X X  Cthe_0578 CelR Endoglucanase 
W339 Oxidation    X   X   
Cthe_0624 CelJ Cellulase W1601 Oxidation X X        
SigP Cleaved    X X  X X  Cthe_0625 CelQ Endoglucanase M158 Oxidation    X   X X  
Cthe_0660  Hemicellulase M760 Oxidation    X   X X  
Cthe_0735  Anchor protein K143 Methylation    X X     
Cthe_0736  Anchor protein K76 Methylation    X   X X  
SigP Cleaved    X X  X X  









(Table 4.1 continued) 
 
Glu-C Digest Lys-C Digest Trypsin Digest Locus Gene Description Modification 
CAD DT ETD CAD DT ETD CAD DT ETD 
SigP Cleaved X X X X X X X X   
M122 Oxidation X X   X X X X X X 
M239 Oxidation X X   X X X X X X 
M104 Oxidation             X X X 
M257 Oxidation X X X             
W279 Oxidation X X               
M56 Oxidation       X X         
M501 Oxidation   X           X   
W403 Oxidation   X           X   
M171 Oxidation               X X 
M181 Oxidation               X X 
W83 Oxidation             X X   
Cthe_0821   Endoglucanase 
K119 
Acetylation/ 
Trimethylation X X        
Cthe_1398 XghA Xyloglucanase SigP Cleaved X X         X   X 
SigP Cleaved   X   X   X X X X 
K612 
Methylation             X X X 
M435 Oxidation   X   X X   X X   
M332 Oxidation       X       X   
W141 Oxidation             X X   
M82 Oxidation    X X     
W78 Oxidation    X X     
Cthe_1838 XynC Xylanase 




(Table 4.1 continued) 
 
Glu-C Digest Lys-C Digest Trypsin Digest Locus Gene Description Modification 
CAD DT ETD CAD DT ETD CAD DT ETD 
SigP Cleaved X X X       X X X 
W472 Oxidation X X X X X   X X   
M552 Oxidation X X         X     
W266 Oxidation X X   X X     X   
W595 Oxidation X X         X     
M290 Oxidation       X X X       
M451 Oxidation             X X   
W493 Oxidation       X X  
W469 Oxidation   X     X  
M298 Oxidation       X X  
Cthe_2089 CelS Exoglucanase 
Y265 Oxidation             X X   
Cthe_2760 CelV Cellulase/              beta-glucanase SigP Cleaved X     X X   X X   
Cthe_2761   Cellulase/              beta-glucanase SigP Cleaved   X X             
Cthe_2809 LicA Endoglucanase SigP Cleaved       X X         
Cthe_2811 ManA Mannanase SigP Cleaved   X   X X X   X   
M167 Oxidation       X X   X   X 
M200 Oxidation       X     X     Cthe_2872 CelG Endoglucanase 









(Table 4.1 continued) 
 
Glu-C Digest Lys-C Digest Trypsin Digest Locus Gene Description Modification 
CAD DT ETD CAD DT ETD CAD DT ETD 
SigP Cleaved       X X         
K80 Acetylation/ 
Trimethylation X X               
E1267 
Methylation       X X   X X   
M60 Oxidation       X     X X X 
M1883 
Oxidation X X         X X   
W485 Oxidation         X     X   
K663 
Acetylation/ 
Trimethlation X X        
Cthe_3077 CipA Scaffoldin 
Y1571 Oxidation         X X       
Cthe_3078 OlpB Anchor protein SigP Cleaved       X X   X X X 
   M91 Oxidation       X X         




Table 4.2.  Unmodified cellulosome proteins identified, their function, and experiments in which they were identified. 
 
Glu-C Digest Lys-C Digest Trypsin Digest Locus Gene Description CAD DT ETD CAD DT ETD CAD DT ETD 
Cthe_0032  Hemicellulase X X  X    X  
Cthe_0040 CelI Endoglucanase X X     X X  
Cthe_0190  Serpin X X X X X X X X X 
Cthe_0211 LicB Lichinase       X   
Cthe_0239  Unknown Function X   X X  X X  
Cthe_0246  Putative Pectinase     X   X  
Cthe_0258  Unknown Function X   X X  X X  
Cthe_0270 ChiA Chitinase X X     X X  
Cthe_0274 CelP Cellulase/beta-glucanase X X  X X  X X X 
Cthe_0435  Unknown Function  X        
Cthe_0640  Unknown Function X X   X  X X  
Cthe_0661  Putative Glycosidase X X     X X  
Cthe_0797 CelE Endoglucanase        X  
Cthe_0825 CelD Endoglucanase X X  X X  X X X 
Cthe_0912 XynY Xylanase X X  X X  X X  
Cthe_1271  Putative Glycosidase     X  X X  
Cthe_1307 SbdA Anchor protein X X X X X X X X X 
Cthe_1400  Other Hemicellulase  X     X X  
Cthe_1472 CelH Endoglucanase    X X  X X  
Cthe_1806  Unknown Function X X  X X  X X  
Cthe_1963 XynZ Xylanase X X  X X  X X  
Cthe_2038  Putative Pectinase        X  
Cthe_2147 CelO Cellobiohydrolase X X  X X  X X X 
Cthe_2193  Cellulase/beta-glucanase X X  X X  X X X 
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(Table 4.2 continued) 
Glu-C Digest Lys-C Digest Trypsin Digest Locus Gene Description CAD DT ETD CAD DT ETD CAD DT ETD 
Cthe_2590 XynD Xylanase X X X  X  X X X 
Cthe_2807 CelC Cellulase/beta-glucanase X X   X     
Cthe_2812 CelT Endoglucanase X X  X X X X X X 
Cthe_2879  
Putative Carbohydrate 
Esterase        X  
Cthe_2950  Putative Pectinase        X  
Cthe_2972 XynA/U Xylanase    X X X X X  
Cthe_3012  Other Hemicellulase  X   X   X  
Cthe_3080 OlpA Anchor protein X X X X X  X X  
Cthe_3132  Unknown Function        X  
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 With respect to the large number of modified peptides identified in Table 4.1, it 
could be argued that the large number of peptides are the result of either larger proteins or 
more abundant proteins.  Larger proteins yield more peptide fragments following 
digestion, and this could lead to the identification of more modified peptides.  Peptides 
corresponding to more abundant proteins will be sampled more during the course of an 
experiment, so the identification of a modification could be more likely for a peptide 
sampled more often.  However, as illustrated in Table 4.2, more proteins are identified 
without modifications than those identified with modifications in Table 4.1. The vast 
majority of proteins in Table 4.2 were identified using both multiple fragmentation 
methods and enzymatic digestions with no modifications, and combining these results 
with the high rate of modification observed in Table 4.1 and the 1% peptide-level FDR 
used for all searches indicates that the random identification of modifications was 
minimal.   
 A total of 1,353 scans from all experiments were identified with modified 
peptides that corresponded to cellulosome proteins.  Of these, 1,239 scans (~92%) 
correspond to the 85 modified peptides presented in Table 4.1.  The remaining 114 
peptides (~8%) did not meet criteria outlined previously for identifying a peptide as 
modified.  The 114 scans had already passed the 1% peptide level FDR, so E-values from 
OMSSA search results were typically very low (ranging as low as 9.3060 E-13), 
indicating high confidence in the peptide identification.  Despite the low E-values for 
scans that did not meet criteria for confirmation as a modified peptide in this study, that 
such a small percentage of scans identified as modified that were not corroborated by 
additional experiments suggests high confidence in the assignment of peptides in Table 
4.1. 
4.3 Conclusions 
 Several informatics platforms were considered for this study, including 
SEQUEST261, Mascot262, X!Tandem265.  Most search algorithms were originally 
developed to search data generated through CAD experiments, so algorithms to better 
accomodate ETD data still require development.   Even though Mascot and Protein 
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Prospector have been reported to have high performance when searching ETD data266-268, 
OMSSA is also used widely with ETD data fnord and was selected because it offers 
superior performance with CAD data269 (between decision tree and conventional CAD 
experiments, roughly 65% of the mass spectral scans in this study were generated using 
CAD).   
 De novo algorithms270, 271 were also considered; they offer a means of avoiding 
cumbersome manual searching and verification of multiple modifications.  However, 
their reported accuracies are as low as 30%272, discouraging their use in this study.  
Sequence tag search algorithms273, 274 show a great deal of promise with respect to PTM 
searches, but these search platforms require significant development in their abilities to 
accommodate ETD data. 
 Despite these informatics limitations, utilizing multiple fragmentation methods 
and enzymatic digests has allowed for a deep dive into the global PTM signature of the 
C. thermocellum cellulosome.  85 modified peptides corresponding to 28 cellulosome 
proteins were identified in these experiments; these modification sites would not have 
been detected had multiple variable modifications not been incorporated into database 
search parameters.  Furthermore, by using multiple fragmentation methods and enzymatic 
digests, the modifications identified were all independently verified. Some of the more 
heavily modified proteins identified in this study such as CipA, CelK, and CelS are 
critical to the function of the cellulosome, and extent of modification observed in these 
experiments suggests these modifications may have impact on the utilization of cellulose 
by the protein complex.  Such results may ultimately guide biochemical validation of 
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Andrew B. Dykstra, Lois A. St. Brice, Babu Raman, Miguel Rodriguez, Jr., Joel Kreps, 
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Rodriquez, Jr.  Affinity digestions and activity measurements were performed by Lois A. 
St. Brice.  Sample preparation for proteomics experiments, collection of experimental 
data, and data analysis were performed by Andrew B. Dykstra. 
5.1 Introduction 
 As quantitation of proteins and protein complexes becomes increasingly 
important to studies of biological systems, sensitive and selective methods must be 
developed with high accuracy and precision to gain insight into biological problems.  
However, quantitating specific proteins in a mixture cannot be achieved using optical 
assays such as Bradford275, BCA154, 155, and Lowry276 assays because these assays 
quantitate all proteins present and lack any sort of selectivity toward proteins of interest.  
One of the most common methods of quantitating a single protein in a complex mixture 
is an enzyme-linked immunosorbent assay (ELISA)277 in which an antibody is developed 
specific to the protein of interest (antigen), the protein mixture is exposed to the antibody 
(bonded to stationary support), nonspecific binding is washed away, and after treating the 
antibody-bound protein with a substance that induces color change, the protein of interest 
is quantified optically.  Steps involved in a typical ELISA experiment are illustrated in 
Figure 5.1.  This method has gained widespread use for quantitating proteins of interest, 





Figure 5.1.  Illustration of the general steps involved in an ELISA experiment278.  In this 
figure, circles bound to the surface of the well represent the antigen of interest (antigen 




diagnoses of certain conditions ranging from pregnancy279 to diseases such as human 
immunodeficiency virus (HIV)280 and malaria281.  However, antibodies specific to a 
protein of interest may not be commercially available at cost-effective prices or at all, and 
development of an antibody is a difficult, labor-intensive processes.  Furthermore, 
specificity of antibodies toward antigens varies, and binding of proteins with domains 
similar to the protein of interest cannot be completely prevented.  In addition, ELISA is a 
single point measurement based on a single peptide sequence.  This may be useful if only 
a single protein is targeted for quantitation, but quantitating multi-component protein 
complexes requires a large degree of approximation if a single peptide corresponding to a 
single protein is used to quantitate an entire complex. 
 The use of mass spectrometry for protein quantitation has become increasingly 
prevalent.  The use of label-free (Normalized Spectral Abundance Factor (NSAF)96, 
Protein Abundance Index (PAI)97, and Exponentially Modified Protein Abundance Index 
(emPAIs)98) and label-based (Isotope-Coded Affinity Tag (ICAT)113, Stable Isotope 
Labeling by Amino acids in Cell culture (SILAC108, 109), Isobaric Tag for Relative and 
Absolute Quantitation (iTRAQ)114, and Tandem Mass Tag (TMT)115) methods of 
quantitation have gained widespread use in relative quantitation studies where levels of 
upregulation and downregulation are approximated.  However, mass spectra are not 
inherently quantitative, so all of these methods provide only for the relative quantitation 
of proteins of interest under the specified sets of conditions. 
 In order to determine the actual amount of a protein or number of proteins, 
internal standards must be employed.  Absolute quantification (AQUA) utilizes 
isotopically-labeled peptides with very accurately known concentrations116.  By 
comparing the ratio of chromatographic peak areas from unlabeled peptides to those of 
labeled peptides with precisely and accurately known amounts that have been spiked into 
the sample, the amount of the unlabeled peptide, and thus the unlabeled protein, can be 
derived.  Operating triple quadrupole (QqQ) mass spectrometers in selected reaction 
monitoring (SRM) mode increases the sensitivity and selectivity of these quantitation 
experiments, thereby allowing for the quantitation of multiple proteins in a single 
experiment with high accuracy and precision.  
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 To establish microbial cellulose utilization rates in C. thermocellum, it is 
necessary to independently determine the amount of cell, cellulose, and cellulase148.  
Cells are quantitated using conventional cell counting methods282, and cellulose is 
quantitated using quantitative saccharification283.  The previously developed method for 
quantitating the amount of cellulase for C. thermocellum employed ELISA284.  A single 
structural protein, CipA, was quantitated, and the amount of CipA present in the sample 
was used to approximate the amount of cellulase to determine the microbial cellulose 
utilization rates under certain conditions.  Because of limitations associated with ELISA, 
it was deemed critical to develop a mass spectrometry-based method that takes advantage 
of SRM to absolutely quantitate multiple cellulosomal proteins.  This method was sought 
to replace the ELISA-based method of quantitation due to the high precision, ease of use, 
high throughput, and ability to quantitate a protein machine in samples ranging in 
complexity from relatively simple affinity-digested purified cellulosome samples to 
extremely complex whole cell lysates containing up to thousands of proteins afforded by 
SRM-based quantitation. 
5.2 Development of a Mass Spectrometry-Based Cellulosome 
Quantitation Assay 
5.2.1 Initial Assay Development 
 Development of a mass-spectrometry-based cellulosome quantitation assay was 
one of the milestone projects outlined in the 5-year proposal for the BioEnergy Science 
Center, a partnership consisting of over 19 companies, national laboratories, and 
universities funded by the United States Department of Energy and driven by the goal of 
making large-scale production of bioenergy from lignocellulosic biomass more cost-
effective.  C. thermocellum samples were fermented on multiple substrates to verify 
differences in cellulosome expression induced by different substrates285 could be 
detected.  The ELISA method that was developed to quantitate the C. thermocellum 
cellulosome used affinity purified samples to quantitate a single protein CipA284, so the 
goal of this project was to develop a multi-protein measurement that could be used to 
 
 97 
quantitate the cellulosome with precision of technical replicates comparable similar to or 
better than the precision that observed using the ELISA method in purified samples (~6% 
relative standard deviation (% RSD))284. 
Initial development of the assay was performed by collaborators who eventually 
left the project to pursue other job opportunities.  30 peptides corresponding to 10 
cellulosome proteins (1-4 peptides per protein) had been acquired to continue 
development of the assay.  Details relating to the reasoning for protein and peptide 
selection, storage conditions, and handling of the peptides (i.e. number of freeze-thaw 
cycles to which peptides had been subjected) were unavailable.  Initial evaluation of the 
provided AQUA peptides was done by spiking them into samples listed in Table 5.1, 
which outlines the culture age, the culture fraction, substrate used for fermentation, and 
growth phase for each sample analyzed in this chapter, after trypsin digestion. Avicel, 
which is crystalline cellulose, and cellobiose, which is a β-1,4 linked glucose dimer that 
serves as the primary repeating unit of cellulose, were selected as representative carbon 
sources for initial method development.  Whole cell fractions were analyzed to determine 
the amount of cell-associated cellulosome, extracellular fractions were analyzed to 
determine the amount of unbound cellulosome, and affinity purified cellulosome samples 
were analyzed because affinity digested samples were used for ELISA-based quantitation 
in the previous study284.   Two representative time points were analyzed, one from 
exponential growth phase (mid-log time point) and one from late stationary growth 
phase.  Biological replicates were performed for each fermentation. 
 SRM experiments were performed, and of the 30 peptides provided, 
approximately half yielded what was deemed poor signal quality. Peptides considered 
usable for these experiments exhibited sharp chromatographic peaks, high signal intensity 
(total ion current >103 counts), high signal-to-noise ratio (SNR>3), and coelution of the 
labeled and unlabeled versions of the peptide whereas unusable peptides failed to 
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Table 5.1.  Samples used for the development of the cellulosome quantitation method.  The Fermentation column provides labels 
for each sample that are referred to throughout this chapter.  For example, F85.P5.S refers to Fermentation #85 (F85), the fifth 
time point sampled (P5) during fermentation, supernatant fraction (S).  C and P in the Fermentation column refer to purified 
cellulosome samples and whole-cell samples, respectively.  Only a single time point representative of the exponential phase (mid-
log, P5 for all samples) and stationary phase (late stationary phase, P10 for F85 and F86, P8 for F87 and F88) were used in 
method development. 
 
Fermentation Culture Age (h) Culture Fraction Substrate Growth Phase 
F85.C 36.25 Purified Extracellular Cellulosome Avicel Stationary 
F86.C 36.25 Purified Extracellular Cellulosome Avicel Stationary 
F87.C 32.25 Purified Extracellular Cellulosome Cellobiose Stationary 
F88.C 32.25 Purified Extracellular Cellulosome Cellobiose Stationary 
F85.P5.S 15 Extracellular Avicel Exponential 
F86.P5.S 15 Extracellular Avicel Exponential 
F87.P5.S 15 Extracellular Cellobiose Exponential 
F88.P5.S 15 Extracellular Cellobiose Exponential 
F85.P10.S 36.25 Extracellular Avicel Stationary 
F86.P10.S 36.25 Extracellular Avicel Stationary 
F87.P8.S 32.25 Extracellular Cellobiose Stationary 
F88.P8.S 32.25 Extracellular Cellobiose Stationary 
F85.P5.P 15 Whole Cell Avicel Exponential 
F86.P5.P 15 Whole Cell Avicel Exponential 
F87.P5.P 15 Whole Cell Cellobiose Exponential 
F88.P5.P 15 Whole Cell Cellobiose Exponential 
F85.P10.P 36.25 Whole Cell Avicel Stationary 
F86.P10.P 36.25 Whole Cell Avicel Stationary 
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(Table 5.1 continued) 
 
Fermentation Culture Age (h) Culture Fraction Substrate Growth Phase 
F87.P8.P 32.25 Whole Cell Cellobiose Stationary 





exhibit one or more of these characteristics.  Figure 5.2A illustrates signal quality 
considered usable for quantitation experiments in contrast to Figure 5.2B, which 
illustrates poor signal quality. Peptides considered unusable exhibited poor signal quality 
for both the unlabeled and labeled versions, indicating that the peptide itself was not ideal 
for quantitation, perhaps due to poor ionization efficiency.  Of the remaining peptides, 
some were not unique to the protein that was targeted for quantitation, and others were 
not unique within the protein sequence of interest (i.e. several copies of the same peptide 
sequence occur within the protein sequence).  A peptide sequence that occurs multiple 
times within a proteome (i.e. redundant peptide) cannot be accurately quantitated because 
the ratio of unlabeled:labeled peptide will be inflated due to contributions to unlabeled 
signal intensity originating from multiple protein domains.  One of the peptides exhibited 
an internal tryptic cleavage site, which could lead to inaccurate quantitation because 
some copies of the peptide may contain the missed cleavage while other copies of the 
peptide may be fully tryptic.  Although 12 of the 30 peptides were considered useable for 
quantitation, after this screening none was used because the rate of degradation and 
storage and handling conditions for the set were unknown.  However, these initial 
experiments provided useful insight into criteria that should be used to select potential 
peptides for quantitation experiments.  Design and assessment of a systematic method to 
identify a more appropriate set of standard peptides for development of a cellulosome 
quantitation assay was thus undertaken. 
5.2.2 Protein Selection 
 84 proteins in the C. thermocellum proteome exhibit either cohesin or dockerin 
domains associated with cellulosome function160, 286, but obtaining AQUA peptides 
necessary to quantitate all of these proteins was cost-prohibitive (~$600 for 10 nmol of a 
single peptide, at least two peptides per protein recommended).  Global experiments were 
performed using an LTQ mass spectrometer to determine which cellulosome proteins 
were most abundant.  Two stationary phase (arbitrarily selected over exponential phase) 
extracellular samples corresponding to the two substrates (F85.P10.S and F87.P8.S in 































Figure 5.2.  Illustration of (A) high signal quality and (B) poor signal quality. Total ion current is plotted for 3 transitions for each 
peptide in this and following chromatograms 
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with a 4-step, 7 h MudPIT, and whole cell lysates corresponding to the same substrates 
and growth phases (F85.P10.P and F87.P8.P) were analyzed with a 12-step, 23 h 
MudPIT.  Different MudPITs were used to analyze extracellular and whole cell fractions 
to accommodate different levels of sample complexity that have been empirically 
observed.  Results were searched using DBDigger215 first with a database that consisted 
only of cellulosome proteins and then with the entire C. thermocellum protein database.  
Data were searched independently with the two databases to probe both the abundance of 
candidate proteins relative to only cellulosome proteins and relative to all detected 
proteins.  NSAFs were used to quantitate which cellulosome proteins were most 
abundant.  Though abundance was the primary factor for protein selection, protein 
function was also given consideration.  NSAFs calculated by searching the full database 
allow for an approximation of the abundance of proteins selected for quantitation under 
biological conditions. 
Results from these experiments are presented in Table 5.2, which illustrates 
NSAFs for the proteins selected for quantitation from all four experiments. Though 
abundance was the primary factor for protein selection, protein function was also given 
consideration.  Multiple proteins, such as SbdA, OlpA, and Orf2p, had relatively low 
NSAFs (<1% in extracellular fractions searched with the database containing only 
cellulosome proteins).  While cellulases with higher NSAFs were detected, these low 
abundance proteins were selected for quantitation due to their critical role in cellulosome 
function as anchoring proteins that link CipA to the cell surface151. 
Complexity of the samples used for quantitation is illustrated in Table 5.3, which 
reports the numbers of nonredundant peptide and protein identifications for the four 
samples based on database searches performed using the organism’s entire protein 
database.  Based on results in Table 5.2, the 14 proteins selected for quantitation 
constitute 67.12% - 68.20% of the cellulosome detected in extracellular samples and 
75.82% - 75.96% of the cellulosome detected in whole cell lysate samples.  Though 
results from these experiments were only rough estimates of relative protein abundance, 
they were consistent with previous semi-quantitative global proteomic studies of C. 
thermocellum160, 287. These 14 proteins correspond to 9.00% - 9.70% of all proteins in 
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Table 5.2.  NSAFs for representative samples used to select proteins for targeted quantitation.  Data were searched with a 
database that consisted only of cellulosome proteins as well as the organism’s entire protein database. 
 

















Cthe_3077 CipA 6.62% 0.18% 6.10% 0.11% 10.27% 1.40% 10.85% 1.57% 
Cthe_0269 CelA 3.01% 0.08% 2.26% 0.04% 4.46% 0.58% 4.14% 0.57% 
Cthe_2089 CelS 7.16% 0.19% 4.32% 0.08% 12.49% 1.71% 7.87% 1.12% 
Cthe_0412 CelK 7.59% 0.20% 6.68% 0.12% 6.62% 0.90% 5.07% 0.71% 
Cthe_0413 CbhA 2.58% 0.07% 2.08% 0.04% 2.40% 0.33% 1.66% 0.23% 
Cthe_3078 OlpB 4.29% 0.10% 5.61% 0.09% 4.12% 0.56% 1.89% 0.27% 
Cthe_0821 20.05% 0.52% 21.90% 0.38% 10.99% 1.52% 17.15% 2.49% 
Cthe_0736 0.53% 0.02% 0.30% 0.01% 1.28% 0.18% 2.69% 0.37% 
Cthe_1838 XynC 5.25% 0.11% 9.29% 0.11% 5.52% 0.60% 8.99% 1.25% 
Cthe_0625 CelQ 2.65% 0.05% 1.89% 0.02% 4.26% 0.61% 3.99% 0.58% 
Cthe_1307 SbdA 2.28% 0.06% 5.33% 0.08% 0.98% 0.13% 0.75% 0.10% 
Cthe_0543 CelF 0.93% 0.02% 1.72% 0.03% 2.12% 0.30% 2.75% 0.40% 
Cthe_3080 OlpA 9.94% 0.25% 5.92% 0.11% 0.50% 0.05% 0.13% 0.01% 
Cthe_3079 Orf2p 2.93% 0.08% 2.56% 0.04% 1.12% 0.15% 0.28% 0.04% 
Total NSAF 75.82% 1.91% 75.96% 1.25% 67.12% 9.00% 68.20% 9.70% 
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Table 5.3.  Complexity of samples used for protein selection as illustrated by total 





Assigned Spectra Nonredundant 
Proteins 
F85.P10.P 15,484 58,652 1,382 
F87.P8.P 16,975 57,163 1,540 
F85.P10.S 6,336 14,883 593 
F87.P8.S 5,693 17,259 597 
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extracellular samples and 1.25% - 1.91% in whole cell lysate samples.  When 
extracellular fractions were searched with the whole database, few (4-5) non-cellulosome 
proteins were observed with NSAFs higher than the most abundant cellulosome proteins.  
Non-cellulosome proteins with relatively high NSAFs such as extracellular solute binding 
proteins and ATP binding cassette (ABC) transporter proteins are known to function in 
the extracellular medium.  When the entire database was searched, a low amount of 
cellulosome was expected to be observed in stationary phase whole cell fractions because 
the cellulosome has been shown to detach from the cell surface in the stationary phase149.  
Not only do these proteins represent the majority of the cellulosome in terms of NSAFs, 
but these proteins also represent a wide variety of cellulosomal function, including the 
scaffoldin protein, anchoring proteins, and a range of cellulolytic enzymes of varying 
functions. 
5.2.3 Peptide Selection 
 Given the high cost of AQUA peptides, peptide selection must be carefully 
planned once candidate proteins have been selected.  In order to be considered for 
quantitation, potential peptides must have met all of the following conditions: the peptide 
sequence must be unique both to the protein of interest and unique within the protein 
sequence (i.e. the peptide occurs only once in the entire proteome), the peptide can 
contain no missed cleavage sites, the peptide must not contain either the protein N- or C- 
terminus due to the relatively high potential for protein degradation affecting the two 
termini, and the peptide must yield high signal quality across all substrates, growth 
phases, and cell fractions.  
The amino acid sequence of the cellulase CelA and peptides selected for 
quantitation (as described below) are shown in Figure 5.3A as an illustrative example.  
Figure 5.3B shows peptides selected for quantitation in the 3-dimensional structure of the 
protein, indicating that the peptides selected for quantitation correspond to different 
domains of the protein.  These conditions for peptide selection were designated after 






Figure 5.3.  Illustration of peptide selection criteria in a representative protein (CelA).  The protein’s amino acid sequence is 
shown in (A) with trypsin cleavage sites in red and peptides selected for quantitation highlighted in yellow.  Each peptide selected 
for quantitation is unique to its associated protein and within that protein’s amino acids sequence.  Peptides have no missed 
cleavage sites.  The positions of the peptides selected for quantitation in the protein’s three-dimensional structure are also 
highlighted in yellow in (B). 
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protein selection, experiments were performed to establish an optimal set of peptides 
corresponding to the selected proteins that meet these criteria.  
Eight of the samples outlined in Table 5.1 (F85.P5.S, F85.P5.P, F85.P10.S, 
F85.P10.P, F87.P5.S, F87.P5.P, F87.P8.S, F87.P8.P) were selected to represent data for 
both substrates, both growth phases, and both culture fractions, thereby ensuring that 
peptides selected for quantitation were robust and detectable in all conditions used for 
method development.  F85 and F87 fermentations were chosen arbitrarily to represent the 
Avicel and cellobiose fermentations, respectively, as opposed to F86 and F88 
fermentations.  The samples were digested as described in Chapter 2.  Using peptides 
identified in global experiments described in the previous section as a guide to what 
peptides may be present in the sample, SRMs were performed on all eight samples to 
determine the best set of peptides corresponding to the particular proteins of interest.  
Doubly charged peptides were selected for all experiments, and up to 9 different fragment 
ions were monitored for each precursor ion.  All SRM chromatograms were manually 
inspected, and the 3 fragment ions for each precursor that exhibited the highest signal 
quality across different sample conditions were selected for potential quantitation.  A list 
of candidate peptides was compiled, and these were consolidated to a three-tiered list of 
proteins illustrated in Figure 5.4, based on protein NSAF, protein function, and 
availability of peptides meeting all selection criteria.  As described in section 5.2.5, two 
peptides that were ordered did not pass preliminary evaluation and were not included in 
the results; these peptides are not presented in Figure 5.4.  Tier 1 consists of the four 
proteins (CipA and 3 cellulases) that yielded high NSAF values in Table 5.2 and were 
considered to be most biologically relevant to the cellulosome160, 287.  4 AQUA peptides 
were ordered for each of these proteins due to their abundance and importance.  2-3 
AQUA peptides were ordered for Tier 2 proteins, which included two anchoring proteins, 
a xylanase, and two cellulases.  These proteins were of particular biological interest but 
were either not as abundant or did not provide as many peptides meeting all selection 
criteria.  Only 1 AQUA peptide was ordered for each protein in Tier 3, which includes 3 
low abundance anchoring proteins and two cellulases with glycoside hydrolase families 
























Figure 5.4.  Proteins and corresponding peptides selected for quantitation.  For labeled peptides, the isotopically labeled amino acid is 




assay could have been developed using only the proteins in Tier 1, peptides 
corresponding to proteins in Tiers 2 and 3 were ordered to obtain better cellulosome 
representation and to probe stoichiometric ratios of proteins in the cellulosome, i.e. how 
many CelA cellulases are observed per CipA scaffoldin protein under different biological 
conditions (deferred to future experiments).  In total, 34 AQUA peptides were ordered 
corresponding to 14 cellulosome proteins and bovine serum albumin (BSA). 
5.2.4 BSA as an internal standard 
 Though commercially purchased trypsin is quality controlled, it is still possible 
that activity of trypsin may vary between individual batches and even individual vials 
from the same batch.  Variation in enzyme efficiency may also result from slight 
differences in conditions used for replicate fermentations or sample preparation or 
interferents in different sample fractions.  Bovine serum albumin (BSA) was selected as 
an internal standard to monitor trypsin activity because it is a non-microbial protein 
unrelated to C. thermocellum, and therefore any signal detected from a peptide 
corresponding to BSA should only be the result of BSA spiked into the sample.  Physical 
characteristics of the protein (molecular weight, isoelectric point, and hydrophobicity 
determined through the Bull-Breese scale288) for BSA and the cellulosome proteins are 
presented in Table 5.4.  Molecular weight, hydrophobicity, and isoelectric point for BSA 
all fell within the standard deviation of the average of the cellulosome proteins.  The 
presence of 17 disulfide bonds289 suggests that BSA is a very stable protein, which is 
expected because it is a plasma protein.  Because of this stability and because physical 
properties of the protein were similar to cellulosome proteins, BSA was chosen to ensure 
that proteins from difference samples were digested with the same efficiency.  By spiking 
a known amount of intact BSA into the protein along with the AQUA peptides, the extent 
of the protein digestion can be monitored. 
5.2.5 Evaluation of Cellulosome Quantitation Assay 
The point in sample preparation at which the AQUA peptides are spiked into the 
sample is a critical component of experimental design because this defines how the 
concentration of cellulosome is derived.  Possibilities for when to spike the AQUA 
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Table 5.4.  Physical properties of BSA compared to other cellulosome proteins selected for quantitation. 
 
Protein Average Molecular Weight (Da) Isoelectric Point Bull-Breese Index 
Cthe_3077 CipA 196,833 4.4 -105,620 
Cthe_0269 CelA 52,594 6.3 -16,300 
Cthe_2089 CelS 83,559 5.3 -43,980 
Cthe_0412 CelK 100,622 5.1 -42,460 
Cthe_0413 CbhA 137,117 4.9 -51,350 
Cthe_3078 OlpB 248,168 4.0 57,950 
Cthe_0821 63,023 4.7 -79,480 
Cthe_0736 140,562 5.2 -92,050 
Cthe_1838 XynC 69,518 5.0 -71,710 
Cthe_0625 CelQ 79,811 5.0 -54,000 
Cthe_1307 SbdA 68,619 5.4 -38,710 
Cthe_0543 CelF 82,089 5.2 -51,560 
Cthe_3080 OlpA 48,530 5.0 -21,600 
Cthe_3079 Orf2p 74,971 5.6 -32,120 
Average 103,287 ± 58,181 5.1 ± 0.5 -45,928 ± 40,300 
BSA 69,324 4.7 -22,540 
 
 111 
peptides into the sample include prior to trichloroacetic acid (TCA) precipitation, prior to 
trypsin digestion, or after trypsin digestion.  Addition of AQUA peptides after trypsin 
digestion would provide the most accurate quantitation in terms of how much of each 
peptide is actually present after digestion, but the goal of the assay is to measure how 
much cellulosome is present under biological conditions, not after very harsh sample 
preparation conditions and enzymatic digestion.  Sample preparation-induced losses of 
peptides and proteins may not be systematic, which could lead to skewed quantitation.  
Addition of AQUA peptides prior to TCA precipitation was dismissed because TCA 
precipitation is used to isolate proteins from complex samples.  Chemical properties of 
peptides and proteins are obviously different, and there is no guarantee that peptides 
would precipitate as efficiently proteins, and this would also lead to inaccurate 
quantitation. For experiments described in Section 5.2.1, AQUA peptides were added 
after digestion because the goal of those initial experiments was to evaluate the provided 
AQUA peptides given the uncertainty of their history.  For the remaining experiments 
discussed in this chapter, peptides were spiked into the sample after TCA precipitation 
but before denaturation, reduction, alkylation, and digestion, as described in Chapter 2.  
In these experiments, a bicinchoninic acid (BCA) protein assay was performed on an 
aliquot of the sample immediately after resolubilization.  By spiking AQUA peptides into 
the sample at this point, the mass of cellulosome protein determined using SRMs per 
mass of total protein in a particular fraction (purified cellulosome, extracellular fraction, 
whole-cell fraction) determined from the BCA assay can be determined.  Peptides spiked 
into the sample at this point experience all denaturing, reducing, alkylating, and digesting 
conditions that the actual samples experience, and sample preparation-induced sample 
losses should affect both the AQUA peptides and the proteins.  This should allow for 
accurate quantitation of proteins as they exist under biological conditions to the extent 
that these steps affect proteins and peptides similarly.  
 After receiving AQUA peptides, experiments were performed to evaluate the 
quality of the peptides as provided as well as their performance and integrity under 
experimental conditions. Initial experiments evaluating the peptides were performed 
using a 2 h gradient with 50 µg of digested peptides loaded onto a back column packed 
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with ~5 cm of C18, which was connected to a nanospray emitter packed with 15 cm of 
C18.  The 4 peptides corresponding to a representative protein (CipA) were evaluated for 
signal quality, as illustrated in Figure 5.5.  Likewise, individual peptides were evaluated 
for signal quality across the different substrates and different cell fractions, illustrated 
with a representative peptide (ATFINTFQR from CelS) in Figure 5.6.  These figures 
show that multiple peptides corresponding to the same protein yield high signal quality 
(Figure 5.5) and individual peptides yield high signal quality in the different samples 
used for method development (Figure 5.6).  
 After empirical observations that all peptides of interest eluted within a window 
of ~15 min under the conditions of Figures 5.5 and 5.6, the gradient was shorted to 45 
min, and just 10 µg of peptides were loaded directly onto a nanospray emitter packed 
with ~10 cm of C18.  These modifications to the experimental design doubled the 
throughput, increasing the number of samples analyzed in a typical day from 4 to 8.  
These final experimental conditions were utilized for all results discussed in later sections 
of this chapter.  However, because the possibility of AQUA peptide degradation over 
time was a concern, a sample prepared and initially analyzed in May 2010 was stored in a 
-80° C freezer and reanalyzed in October 2010 using the final set of experimental 
conditions.  Despite the use of a different gradient, different amounts of peptides loaded 
onto the column, and different amounts of C18 used in the column, unlabeled:labeled 
ratios of peptides remained relatively stable (% RSD for ratios from the two experiments 
ranged from 0.38%-18.96%, similar to those discussed for technical replicates in the next 
section) over ~6 months (Figure 5.7).  These results indicate the robustness of both the 
SRM method and the AQUA peptides and provide confidence that peptide ratios will 
remain stable over extended periods of time. 
 Sensitivity and selectivity of the SRM method is illustrated in Figure 5.8, which 
depicts the chromatograms of the same whole cell lysate examined with a 12-step, 23 h 
MudPIT experiment and a 45 min SRM experiment.  The left side of the figure illustrates 
the 11 base peak chromatograms290 obtained from the MudPIT (2 h chromatogram shown 
for each step in the MudPIT).  Parameters for both the MudPIT experiment and SRM 




Figure 5.5.  Illustration of signal quality of the four peptides selected for quantitation corresponding to the scaffoldin protein 
CipA.  Chromatograms from the F85.P5.S sample are shown.  The unlabeled versions of peptides are shown as red peaks, and the 
labeled versions of peptides are shown as blue peaks.  Background signal (i.e. small peaks at ~73 min for peptide 
VTNTGSSAIDLSK and ~62 min for peptide SFDTAIYPDR) could are likely due to contaminants.  Presence of only one version 




Figure 5.6.  Illustration of signal quality of a single peptide (ATFINTFQR from CelS) in different cellular fractions of 




















Figure 5.7.  Robustness of quantitation is demonstrated by comparing ratios of peptides that were analyzed in experiments with 
different chromatographic gradients, different column conditions, different loading amounts separated by approximately 6 months 






















Figure 5.8.  Sensitivity of SRM illustrated by comparing base peak chromatograms for a whole cell lysate analyzed with a 
discovery-based experiment on an LTQ to a targeted experiment on the same sample.   
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wash step to move peptides from the C18 in the back column to the SCX phase, so a 
chromatogram is not included for the first step of the MudPIT.  The right side of the 
figure illustrates the chromatogram resulting from total ion currents for the 204 
transitions used for quantitation (Table 2.6).  All transitions are monitored over the 
course of the entire chromatogram.  Chromatographic peak widths were typically ~0.5 
min in SRM experiments and ~1 min in MudPIT experiments.  Table 5.3 indicates that 
for this whole cell lysate, 16,975 nonredundant peptides corresponding to 1,540 proteins 
were indentified in this sample.  This does not include peptides with post-translational 
modifications or single nucleotide polymorphisms that weren’t identified, which would 
make the number of peptides actually present in the sample significantly larger.  Sharp 
chromatographic peaks are obtained in targeted experiments for a whole cell lysate 
analyzed using a gradient ~30 times shorter than that used to analyze the sample using 
global experiments.  That these 32 targeted peptides can be detected and quantitated with 
minimal chromatographic separation in a sample containing at least 500 times as many 
peptides demonstrates the sensitivity of SRM experiments and the selectivity for these 
particular peptides gained by using SRMs.  
 Reproducibility of peptide retention times was monitored across all samples 
outlined in Table 5.1, and averaged retention times and standard deviations for each 
peptide are presented in Figure 5.9.  Standard deviations for peptide retention times were 
typically under 1.5 min (average of standard deviations across all peptides was 1.22 min, 
average of precision across all peptides was 7.28% RSD).  The average retention time 
was used to increase confidence in identification of a chromatographic peak assignment 
used for quantitation when peptide signal approached the limit of quantitation (LOQ at 
total ion current of 103 counts based on measurements of blanks). It should be noted that 
averaged retention times were calculated using retention time data from all fractions.  If 
instead retention times of peptides only from whole cell lysates and extracellular fractions 
were compared, the average difference between retention times from the two fractions 
was 0.15 min.  This was expected because whole cell fractions and extracellular fractions 
were analyzed within a relatively short period of time.  However, when retention times of 


























Figure 5.9.  Retention times of all peptides averaged over all experiments. 
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samples, the average difference in retention time from the two fractions was 1.75 min.  
Purified samples were analyzed almost a month after extracellular and whole cell lystates 
samples, so evaporation of acetonitrile from the mobile phase solvent reservoir is 
suspected.  Evaporation of acetonitrile over the course of a month would shift retention 
times slightly higher due to the decreased amount of organic solvent in the mobile phase; 
this was observed for all peptides in the purified cellulosome samples.  The standard 
deviation of retention times observed in technical replicates was 0.49 min (averaged for 
all peptides across all fractions), indicating a high level of reproducibility when sample 
complexity is identical and samples are analyzed within a relatively short period of time 
(on the order of a few days). 
 Two peptides, NIDILQATGPYLINADPDK from Cthe_0821 and 
LGEYGFQNALIVR from BSA, did not yield reproducible signals.  In most experiments, 
SRM chromatograms for these peptides were qualitatively indistinguishable from noise.  
It was unclear why these peptides did not exhibit stronger signal.  These peptides were 
deemed unsuitable for quantitation and were excluded from results in this chapter.  The 
remaining 32 peptides were considered usable.  
5.3 Cellulosome Quantitation Results 
 Initial data analysis focused on the SNR and precision of unlabeled:labeled ratios 
of chromatographic peak areas for unlabeled:labeled peptides. Three transitions were 
monitored for each peptide, and Skyline reports an average unlabeled:labeled ratio for 
each peptide based on ratios of the three transitions.  Two technical replicates were 
measured for each sample. SNRs were determined for each peptide in each experiment by 
dividing average unlabeled:labeled peptide ratio from the two technical replicates by the 
standard deviation of the replicates.  SNRs were averaged for each peptide across all 
samples.  These ratios ranged from 3 (DIAEGVIYHSYK from OlpA) to 311 
(LVILDDNLK from Cthe_0821).  The SNR averaged across all peptides and all samples 
was 53.  Curiously, while unlabeled:labeled ratios and signal intensity typically decreased 
with increasing sample complexity (decreasing up to two orders of magnitude as sample 
complexity increased from purified samples to whole cell lysates), SNR ratios did not 
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always follow this trend (unlabeled:labeled chromatographic peak area ratios for each 
peptide in each experiment and SNR for technical replicates are presented in the 
Appendix).   
Precision for ratios was determined as % RSD for technical replicates of each 
experiment for each peptide by dividing the standard deviation of the technical replicates 
by the average value and expressing the result as a percentage.  These values ranged 
0.02% RSD for peptide LVILDDNLK (Cthe_0821) in sample F85.P10.P to 138.40% for 
peptide DIAEGVIYHSYK (OlpA) in sample F85.P5.S.  The % RSD for this peptide was 
so high because it corresponds to a low abundance protein (standard deviation for the 
unlabeled:labeled ratio for this peptide was 0.06).  The % RSD values for each technical 
replicate were averaged across all samples corresponding to a particular cell fraction and 
are presented in Table 5.5.  An overall average % RSD is also reported for each peptide 
in Table 5.5.  The overall precision for all peptides ranges from 10.59% RSD for peptides 
in purified samples to 22.66% RSD in whole cell fractions, which is not unexpected 
considering the drastic increase in peptides present in whole cell fractions compared to 
purified samples.  The overall precision for all peptides across all samples was 16.94%.  
Because the relatively high %RSD values were observed in technical replicates, the 
variation results from either sampling or detection.  In purified cellulosome samples 
signal intensities (total ion currents) were typically in the 105-106 counts range; this 
suggests that poor precision is not because peptide signal is near the limit of detection.  
This is illustrated by a representative peptide in the purified cellulosome fraction, 
NDWSNYTQSNDYSFK from CipA.  The ratios for this peptide in the F88.C fraction 
were 66.5233 and 85.2432 for the two technical replicates, respectively, which 
corresponds to precision of 16.62% RSD despite a signal intensity of 106 counts.  
Isotopically-labeled amino acids were +8 and +10 Da for peptides that have K and R 
amino acids at the N-terminus, respectively, so the labeled version of the peptide is not 
interfering with MS/MS signal of the unlabeled peptide. 
 Peak heights, background, and peak area ratios (unlabeled:labeled) were analyzed 
for the four peptides corresponding to a representative protein (CelA) in a single 
experiment on a whole cell sample (F85.P5.P).  Peak heights for transitions were well 
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Table 5.5.  Overall precision of peptide ratios determined from technical replicates across different fractions. 
 








VEIPITLK 2.56% 5.53% 9.18% 6.40% 
SFDTAIYPDR 15.61% 23.21% 34.02% 26.01% 
VTNTGSSAIDLSK 13.33% 7.38% 22.74% 14.71% Cthe_3077 CipA 
NDWSNYTQSNDYSFK 9.25% 9.80% 22.52% 14.78% 
LWGSSGAINYGQEAR 4.08% 4.98% 9.37% 6.56% 
TAVDYSWFGDQR 2.26% 4.80% 5.59% 4.60% 
GIVDGYTIQGSK 7.53% 12.84% 20.52% 14.85% Cthe_0269 CelA 
DSEYYGYYGNSLR 5.33% 4.69% 10.01% 6.95% 
ATFINTFQR 5.88% 3.49% 9.15% 6.23% 
AIQAVYWANK 6.87% 8.63% 22.21% 13.71% 
DMAAELVNR 13.15% 11.44% 24.46% 16.99% Cthe_2089 CelS 
SGISINTDNADLNEDGR 13.60% 18.03% 20.21% 18.02% 
VNQVGYLPFAK 6.22% 3.96% 6.23% 5.32% 
DGGMNIPER 25.00% 32.19% 32.30% 30.80% 
FEDPTITAAVK 6.89% 6.14% 6.17% 6.30% Cthe_0412 CelK 
SGISINTDNADVNADGR 17.19% 11.38% 28.87% 19.54% 
VNQVGYLPEGK 10.14% 11.43% 31.23% 19.09% Cthe_0413 CbhA 
SNVVAYGNEFLK 2.26% 21.91% 39.36% 24.96% 
YGPTPVAGNDIK 10.09% 10.53% 23.44% 15.60% Cthe_3078 OlpB 
EGDVIIATIR 14.34% 34.65% 54.08% 38.36% 
INSTDLGMLNR 5.24% 19.16% 15.87% 15.06% Cthe_0821 
LVILDDNLK 4.21% 11.09% 20.72% 13.56% 
SGTLAIIGFK 8.79% 8.07% 20.63% 13.24% Cthe_0736 
YDPAVLQAVNPVTGEPMSDK 3.99% 16.87% 33.68% 21.02% 
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 (Table 5.5 continued) 
 








Cthe_0625 CelQ SQIDYALGSNPDNR 10.52% 10.19% 23.07% 15.41% 
GPETVELTTEEAYSGR 9.41% 8.11% 20.73% 13.42% Cthe_1838 XynC 
SISDFPTPEGK 6.72% 5.93% 21.19% 12.19% 
Cthe_1307 SbdA EGIVVGSGDIINPR 12.81% 25.11% 7.42% 15.58% 
Cthe_0543 CelF ELFTFADTTR 3.67% 11.36% 36.27% 19.79% 
Cthe_3080 OlpA DIAEGVIYHSYK 60.10% 58.26% 36.98% 50.12% 
Cthe_3079 Orf2p FENTPVMPGAK 15.64% 25.62% 24.10% 23.02% 
BSA YLYEIAR 6.21% 13.61% 32.66% 19.75% 










above the limit of quantitation, typically at least 1-2 orders of magnitude above the limit 
of quantitation, and peak height values for transitions corresponding to the same peptide 
were all within an order of magnitude of each other.  Signal-to-background (S/B) ratios 
ranged from 10-6000 with an average of ~1000 for the 24 transitions (3 transitions per 
peptide, 4 peptides per protein, unlabeled and labeled versions of each peptide).  When 
peak area ratios for the three transitions corresponding to each peptide were analyzed, 
%RSD values ranging from 10.56% (GIVDGYTIQGSK) to 37.70% 
(NDWSNYTQSNDYSFK) were observed.  This suggests that the variance in 
measurements occurs at the level of the transitions.  The peak heights and S/B ratios 
eliminate concentration effects and the possibility that the intensity of a single transition 
is swamping the intensities of other transitions as possible causes of the variation.  That 
this variation is observed is a single experiment excludes sampling issues.  The source of 
this variation remains elusive. 
 Though actual measurements were made at the peptide level, it is the protein level 
information that is of interest.  Tables 5.6, 5.7, and 5.8 report quantitation results for 
individual proteins and the ng cellulosome proteins/ µg total protein for purified samples, 
extracellular fractions, and whole cell fractions, respectively.  Ratios of unlabeled:labeled 
peptide are determined from chromatographic peak areas for each transition for each 
peptide, and these values are averaged to determine a single unlabeled:labeled ratio for 
each peptide.  These ratios are converted to pmol of unlabeled peptide by multiplying the 
area ratio by the amount of labeled peptide spiked into the sample prior to digestion (10 
pmol for whole cell and extracellular fractions, 20 pmol for purified cellulosome samples 
due to the increased amounts of cellulosome proteins observed in these samples).  Pmol 
of unlabeled peptide were in turn converted to protein µg values (assuming a 1:1 
peptide:protein ratio), and resulting µg values for each peptide corresponding to a 
particular protein were averaged to deduce a µg value for each protein.  Protein µg values 
and corresponding standard deviations resulting from technical replicates are reported for 
each protein in Tables 5.6-5.8.  The total µg amount of cellulosome protein for each 
sample was determined by summing the µg values for each protein.  The cellulosome 
mass concentration was determined by dividing the total µg of cellulosome proteins by 
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Table 5.6.  Cellulosome quantitation results for stationary phase purified cellulosome samples. 
 
Purified Stationary Phase Cellulosome (µg) 
Avicel Cellobiose Cellulosome Proteins 
F85.C (µg) F86.C (µg) F87.C (µg) F88.C (µg) 
Cthe_3077 CipA 34.90±2.72 64.03±3.34 151.97±15.17 174.83±9.36 
Cthe_0269 CelA 33.45±0.01 42.81±0.80 84.97±4.57 81.51±5.16 
Cthe_2089 CelS 82.69±1.29 108.64±5.25 101.86±7.64 80.48±5.47 
Cthe_0412 CelK 26.59±0.94 35.91±1.20 107.26±11.07 86.41±15.31 
Cthe_0413 CbhA 3.08±0.13 2.85±0.13 7.65±0.15 9.48±1.25 
Cthe_3078 OlpB 3.78±0.22 4.57±0.32 7.72±0.23 13.63±2.61 
Cthe_0821 5.12±0.08 10.66±0.28 31.36±1.62 38.03±1.24 
Cthe_0736 2.48±0.23 4.58±0.17 19.94±1.02 16.41±1.32 
Cthe_1838 XynC 2.37±0.06 5.14±0.35 20.43±2.82 20.38±1.71 
Cthe_0625 CelQ 4.57±0.00 8.44±0.00 14.24±0.00 13.68±0.00 
Cthe_1307 SbdA 0.03±0.00 0.06±0.00 0.06±0.01 0.07±0.02 
Cthe_0543 CelF 3.69±0.17 7.48±0.08 23.23±1.56 9.24±13.07 
Cthe_3080 OlpA 0.00±0.00 0.01±0.00 0.00±0.01 0.01±0.01 
Cthe_3079 Orf2p 0.02±0.00 0.10±0.00 0.08±0.11 0.10±0.02 
Total µg Cellulosome 202.76 295.27 570.78 544.24 
ng Cellulosome Protein/µg Total Protein 
(Technical Replicates) 306.04±1.81 351.70±0.97 349.83±5.11 340.58±1.36 
ng Cellulosome/µg Total Protein  
Technical Replicate % RSD 0.59% 0.28% 1.46% 0.40% 
ng Cellulosome Protein/µg Total Protein 
(Biological Replicates) 328.87±26.38 345.21±6.15 
ng Cellulosome/µg Total Protein  
Biological Replicate % RSD 9.82% 1.89% 
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Table 5.7.  Cellulosome quantitation results for extracellular fractions. 
 
Exponential Phase 
Avicel Cellobiose Cellulosome Proteins 
F85.P5.S F86.P5.S F87.P5.S F88.P5.S 
Cthe_3077 CipA 7.30±0.99 5.05±0.07 12.90±0.09 17.21±0.73 
Cthe_0269 CelA 2.22±0.16 1.46±0.00 4.75±0.18 6.56±0.15 
Cthe_2089 CelS 3.73±0.03 2.15±0.05 6.20±1.00 9.67±0.25 
Cthe_0412 CelK 4.07±0.03 2.78±0.09 7.81±1.36 9.00±1.28 
Cthe_0413 CbhA 0.21±0.02 0.12±0.01 0.42±0.03 0.81±0.03 
Cthe_3078 OlpB 0.66±0.21 0.57±0.10 0.98±0.12 1.58±0.07 
Cthe_0821 1.18±0.23 0.82±0.09 3.19±0.03 4.31±0.36 
Cthe_0736 0.76±0.01 0.46±0.01 2.62±0.31 3.08±0.03 
Cthe_1838 XynC 0.96±0.09 0.65±0.01 1.97±0.14 2.20±0.02 
Cthe_0625 CelQ 0.51±0.07 0.34±0.07 0.91±0.12 1.06±0.02 
Cthe_1307 SbdA 0.12±0.03 0.05±0.01 0.07±0.01 0.05±0.01 
Cthe_0543 CelF 0.34±0.06 0.27±0.06 1.42±0.08 2.32±0.16 
Cthe_3080 OlpA 0.02±0.03 0.02±0.01 0.05±0.01 0.01±0.00 
Cthe_3079 Orf2p 0.05±0.01 0.03±0.00 0.04±0.00 0.05±0.00 
Total µg Cellulosome 22.12±1.06 14.78±0.21 43.33±1.74 57.91±1.56 
ng Cellulosome Protein/µg Total Protein 
(Technical Replicates) 63.53±2.08 60.26±0.40 92.16±0.96 96.18±0.60 
ng Cellulosome/µg Total Protein  
Technical Replicate % RSD 3.28% 0.66% 1.04% 0.62% 
ng Cellulosome Protein/µg Total Protein 
(Biological Replicates) 61.90±2.25 94.17±2.41 
ng Cellulosome/µg Total Protein  
Biological Replicate% RSD 3.74% 3.02% 
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(Table 5.7 continued) 
 
Stationary Phase 
Avicel Cellobiose Cellulosome Proteins 
F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
Cthe_3077 CipA 14.69±1.79 16.60±0.74 17.16±0.17 6.02±0.05 
Cthe_0269 CelA 3.64±0.37 4.40±0.28 5.05±0.12 0.58±0.04 
Cthe_2089 CelS 18.88±2.18 15.28±0.06 5.11±0.39 1.68±0.10 
Cthe_0412 CelK 10.26±2.33 11.99±0.94 7.65±0.31 2.82±0.09 
Cthe_0413 CbhA 1.13±0.07 1.43±0.26 0.68±0.04 0.26±0.02 
Cthe_3078 OlpB 2.39±0.29 2.86±0.40 1.16±0.00 0.35±0.04 
Cthe_0821 2.44±0.16 2.99±0.25 3.16±0.52 1.86±0.19 
Cthe_0736 1.17±0.14 1.26±0.23 2.46±0.02 1.03±0.05 
Cthe_1838 XynC 1.20±0.03 1.32±0.19 1.86±0.07 0.97±0.09 
Cthe_0625 CelQ 0.89±0.15 0.98±0.00 0.83±0.04 0.29±0.04 
Cthe_1307 SbdA 0.08±0.01 0.12±0.01 0.03±0.00 0.00±0.00 
Cthe_0543 CelF 1.15±0.06 1.11±0.13 1.64±0.02 0.57±0.11 
Cthe_3080 OlpA 0.04±0.02 0.02±0.02 0.01±0.00 0.00±0.00 
Cthe_3079 Orf2p 0.11±0.02 0.13±0.01 0.03±0.00 0.01±0.01 
Total µg Cellulosome 58.07±3.70 60.48±1.39 46.83±0.75 16.44±0.09 
ng Cellulosome Protein/µg Total Protein 
(Technical Replicates) 118.24±4.20 115.08±1.09 97.98±1.90 114.91±1.37 
ng Cellulosome/µg Total Protein  
Technical Replicate % RSD 3.56% 0.94% 1.94% 1.19% 
ng Cellulosome Protein/µg Total Protein 
(Biological Replicates) 116.66±3.10 106.45±9.87 
ng Cellulosome/µg Total Protein  
Biological Replicate% RSD 1.92% 11.25% 
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Table 5.8. Cellulosome quantitation results for whole cell fractions. 
 
Exponential Phase 
Avicel Cellobiose Cellulosome Proteins 
F85.P5.P F86.P5.P F87.P5.P F88.P5.P 
Cthe_3077 CipA 6.35±0.16 6.97±0.89 2.16±0.44 3.55±0.33 
Cthe_0269 CelA 1.90±0.22 2.28±0.18 0.66±0.01 0.96±0.03 
Cthe_2089 CelS 3.91±0.07 5.99±1.41 1.15±0.02 2.46±0.34 
Cthe_0412 CelK 3.33±0.60 5.20±1.49 2.48±0.31 3.06±0.76 
Cthe_0413 CbhA 0.24±0.04 0.26±0.23 0.05±0.01 0.16±0.17 
Cthe_3078 OlpB 1.52±0.02 1.53±0.15 0.85±0.02 1.01±0.18 
Cthe_0821 0.83±0.01 0.90±0.02 0.43±0.09 0.79±0.26 
Cthe_0736 0.30±0.01 0.35±0.08 0.11±0.02 0.13±0.06 
Cthe_1838 XynC 0.45±0.17 0.60±0.06 0.35±0.01 0.49±0.10 
Cthe_0625 CelQ 0.39±0.02 0.34±0.06 0.14±0.05 0.38±0.04 
Cthe_1307 SbdA 0.15±0.01 0.17±0.00 0.16±0.02 0.27±0.01 
Cthe_0543 CelF 0.44±0.14 0.77±0.28 0.20±0.13 0.35±0.17 
Cthe_3080 OlpA 0.63±0.14 0.86±0.22 0.19±0.06 0.45±0.29 
Cthe_3079 Orf2p 0.10±0.01 0.16±0.00 0.06±0.01 0.12±0.01 
Total µg Cellulosome 20.55±0.71 26.36±2.29 8.99±0.57 14.17±1.03 
ng Cellulosome Protein/µg Total Protein 
(Technical Replicates) 40.45±0.40 43.93±0.98 19.83±0.14 16.63±0.81 
ng Cellulosome/µg Total Protein  
Technical Replicate % RSD 0.99% 2.24% 0.70% 4.90% 
ng Cellulosome Protein/µg Total Protein 
(Biological Replicates) 42.19±2.10 18.23±1.91 
ng Cellulosome/µg Total Protein  
Biological Replicate% RSD 5.83% 12.42% 
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(Table 5.8 continued) 
 
Stationary Phase 
Avicel Cellobiose Cellulosome Proteins 
F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
Cthe_3077 CipA 3.06±0.15 3.01±0.49 1.51±0.19 1.21±0.33 
Cthe_0269 CelA 1.03±0.08 0.90±0.04 0.64±0.03 0.45±0.00 
Cthe_2089 CelS 4.47±0.03 4.47±0.12 1.60±0.35 0.82±0.02 
Cthe_0412 CelK 9.67±0.34 3.04±0.21 2.47±0.13 0.59±0.03 
Cthe_0413 CbhA 0.13±0.14 0.27±0.06 0.08±0.01 0.11±0.02 
Cthe_3078 OlpB 0.59±0.29 0.88±0.19 0.94±0.11 0.58±0.06 
Cthe_0821 0.73±0.01 0.67±0.05 0.60±0.16 0.29±0.04 
Cthe_0736 0.16±0.07 0.17±0.02 0.15±0.02 0.11±0.02 
Cthe_1838 XynC 0.30±0.08 0.32±0.08 0.24±0.03 0.26±0.00 
Cthe_0625 CelQ 0.35±0.10 0.24±0.04 0.12±0.01 0.11±0.06 
Cthe_1307 SbdA 0.27±0.03 0.25±0.03 0.20±0.02 0.14±0.00 
Cthe_0543 CelF 0.50±0.06 0.39±0.02 0.29±0.06 0.19±0.14 
Cthe_3080 OlpA 0.74±0.24 1.30±0.82 0.35±0.08 0.13±0.04 
Cthe_3079 Orf2p 0.19±0.07 0.11±0.03 0.07±0.01 0.02±0.02 
Total µg Cellulosome 22.17±0.58 16.02±1.02 9.26±0.47 5.02±0.37 
ng Cellulosome Protein/µg Total Protein 
(Technical Replicates) 33.03±0.97 22.94±0.04 14.39±0.26 10.79±0.08 
ng Cellulosome/µg Total Protein  
Technical Replicate % RSD 2.93% 0.17% 1.83% 0.78% 
ng Cellulosome Protein/µg Total Protein 
(Biological Replicates) 27.98±5.85 12.59±2.08 
ng Cellulosome/µg Total Protein  
Biological Replicate% RSD 23.04% 22.60% 
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the µg of total protein prior to digestion, which was calculated from averaged 
concentration values from a BCA assay performed at three different concentrations with 
three replicate measurements per concentration.  Cellulosome mass concentrations are 
reported as ng cellulosome proteins per µg of total protein.  The average cellulosome 
mass concentration is reported in Tables 5.6-5.8 as well as precision for both technical 
replicates and biological replicates. 
 Despite the variability for individual peptides in technical replicates, precision for 
the cellulosome mass concentration was remarkably high.  Precision for technical 
replicates ranged from 0.17% to 4.90% RSD, and the average precision for all technical 
replicates across all fractions and growth states was 1.52% RSD.  These values indicated 
a high level of precision for the cellulosome mass concentration.  Particularly surprising 
was the level of precision in complex whole cell fractions which averaged 1.82% RSD 
across all eight whole cell lysate samples in Table 5.8.  High precision of technical 
replicate measurements of cellulosome mass concentration suggests that even though 
measurements at the peptide level lacked high precision (Table 5.5), variation at the 
cellulosome complex level is minimal and this method can be used to quantitate the 
cellulosome with high confidence. 
As expected, precision for biological replicates was generally worse compared to 
technical replicates, ranging from 1.89% RSD to 25.50% RSD.  The average precision 
for biological replicates across all cell fractions was 9.56%.  Higher % RSD values were 
observed in whole cell lysate samples compared to extracellular fractions (15.99% RSD 
averaged for all whole cell fraction biological replicates compared to 4.98% RSD 
averaged for all extracellular fraction biological replicates).  However, variability for 
biological replicates was actually lower for whole cell lysate fractions compared to 
extracellular fractions (4.41 average biological replicate standard deviation for 
extracellular fractions versus 2.99 average biological replicate standard deviation for 
whole cell lysate fractions). The difference in precision between extracellular fractions 
and whole cell fractions results from cellulosome mass concentrations in extracellular 
fractions that were on average approximately 5 times larger than those from 
corresponding whole cell lysate samples.  Variation in cellulosome mass concentration 
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reflects variability both in the amount of substrate used for fermentation, fermentation 
conditions, recovery from TCA precipitation, trypsin digestion, and most importantly, 
natural biological variation, so overall precision of <10% RSD is reasonable for 
biological replicates. 
To determine whether differences observed between different fermentations and 
different growth states were statistically significant or simply due to biological variation, 
t-tests were performed using cellulosome mass concentrations (two technical replicates 
on two biological replicates for a total of four measurements per condition) for different 
combinations of samples.  Samples compared, t statistic values, and confidence intervals 
are presented in Table 5.9.  These results indicate results from different growth states and 
different substrates were statistically different (confidence interval >99%) in whole cell 
fractions.  Extracellular fractions exhibited similar confidence intervals with the 
exception of the comparison of results from stationary phase samples from the two 
carbon sources, for which the confidence interval is >90%, indicating that differences 
observed in the cellulosome mass concentration from these samples may be due to 
biological variations.  The low confidence interval resulting from the t-test on purified 
cellulosome fractions indicates that differences in cellulosome mass concentration in 
purified samples are most likely due to biological variation or lack of precision in the 
affinity digestion. 
 As mentioned above, the ELISA-based method for cellulosome quantitation 
previously developed284 determined the amount of cellulosome present in a particular 
sample by analyzing the amount of CipA bound to an antibody.  The assumption in this 
method is that CipA, as the scaffoldin protein that binds to cellulose, cellulolytic 
enzymes, and anchoring proteins, is representative of the cellulosome in general.  This 
was tested by plotting the mass concentration of CipA (ng CipA/µg total protein) as 
determined by the method developed in this dissertation as a function of the mass 
concentration of total cellulosome in Figure 5.10.  For extracellular fractions and whole 
cell fractions, the observation of an R2 value of 0.93543 indicates strong correlation 
between CipA mass concentration and total cellulosome mass concentration, which 
suggests the assumption that CipA is representative of the cellulosome as a whole 
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Table 5.9.  Results from t-tests comparing ng cellulosome/µg total protein measurements 
from the four replicates (2 technical replicates, 2 biological replicates) from specified 
fermentation to those measurements from another specified fermentation. 6 degrees of 
freedom were used in all calculations.   
 
Samples Used in t-Test t statistic Confidence Level 








































































generally holds true in whole cell and extracellular fractions.  However, the correlation 
between CipA and total cellulosome protein is much weaker for the purified cellulosome 
fractions, indicated by an R2 value of 0.47504.  Upon visual inspection of this graph, the 
three data points corresponding to purified samples with the highest cellulosome mass 
concentration appeared to have a strong negative correlation.  When the purified 
cellulosome data point with the lowest cellulosome mass concentration is treated as an 
outlier, the R2 value of the correlation is 0.86442.  However, the trend line (not shown) 
for these three data points has a negative slope, indicating that as cellulosome mass 
concentration increases, the CipA mass concentration decreases.  Regardless of whether 
the lowest purified data point was treated as an outlier, the correlation (or lack thereof) 
between CipA mass concentration and total cellulosome concentration in purified 
samples indicated that using CipA to represent total cellulosome in purified cellulosome 
fractions, as had been done with previously ELISA-based quantitation method284, was an 
inaccurate means of quantitating the cellulosome. 
 Cellulosome mass concentration results for purified cellulosome samples from 
Table 5.6 were compared to initial cellulase activity measurements for the same samples.  
The R2 for this comparison was 0.34932.  However, when a t-test is performed 
comparing the two biological replicates of F85.C to F86.C, the t-statistic for this 
comparison was 31.5402, which suggests that results from these two samples are 
statistically different with >99% confidence despite the fact that these two samples are 
biological replicates.  When measurements for the F86.C sample was treated as an outlier 
and removed from this comparison (Figure 5.11), the R2 value increases to 0.95912, 
suggesting a strong correlation between cellulosome mass concentration and cellulolytic 
activity. 
5.4 Conclusions 
The precisions of peptide ratio measurements presented in Table 5.5 were 
compared to peptide physical properties such as molecular weight, isoelectric point, and 
hydrophobicity to determine whether increased precision was related to peptide physical 




Figure 5.11.  Comparison of cellulolytic activity as a function of cellulosome mass concentration for purified cellulosome 
samples.  Measurements for the F86 sample were outliers compared to the other samples and were not included.
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studies that may focus on other organisms.  However, no strong correlation was found 
between any of these three properties and reported precision values (R2 values <0.6 for 
all, data not shown). 
Cellulosome mass concentration results were generally consistent with 
expectations. In Table 5.7, higher cellulosome mass concentrations were observed in 
stationary phase extracellular fractions compared to exponential phase samples in Avicel 
fermentations.  Conversely, in Table 5.8, (slightly) higher cellulosome mass 
concentrations were observed in the exponential phase whole cell lysates compared to 
stationary phase whole cell lysates in Avicel fermentations.  These results were expected 
because as the bacterial growth phase in C. thermocellum proceeds from exponential 
phase to stationary phase, cellulosome complexes have been shown to detach from the 
cell surface149 and so should be enriched in extracellular fractions and depleted in whole 
cell fractions.  The overall enrichment in extracellular fractions compared to whole cell 
fractions is also expected because the cellulosome is an extracellular protein complex.  
Purified cellulosome fractions exhibited significantly higher cellulosome mass 
concentrations compared to both extracellular fractions and whole cell lysates, which was 
also expected considering the cellulosome had been affinity digested.  Structural proteins 
such as Orf2p, OlpA and SbdA that anchor into the cell surface were observed in 
extremely small amounts (if at all) in purified cellulosome samples, with µg amounts 
approximately 2 orders of magnitude less than the least abundant cellulolytic enzymes.  
This was another expected result because the affinity digestion used to purify the 
cellulosome only isolates those proteins that bind to cellulose, and the anchoring proteins 
do not bind the cellulose. 
The difference between cellobiose-fermented stationary phase extracellular 
fractions and exponential phase samples was not nearly as pronounced as the difference 
observed in Avicel fermentations.  Similarly, the difference between exponential phase 
samples and stationary phase samples in cellobiose fermentations was much smaller than 
the difference observed in Avicel fermentations.  Avicel is crystalline cellulose similar to 
that found in cellulolytic biomass.  The primary repeating unit of the cellulose 
biopolymer is cellobiose, a soluble β-1,4 linked glucose dimer.  C. thermocellum 
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generally extracts energy from cellulosic material first by degrading cellulose into 
cellobiose and then degrading cellobiose into glucose.  Though t-test results from Table 
5.9 suggests that cellulosome mass concentrations between stationary phase and 
exponential phases samples are statistically different for both extracellular and whole cell 
fractions, the results presented in Tables 5.7 and 5.8 suggest the amount of cellulosome 
changes very little regardless of the organism’s growth phase.  These results lead to 
speculation that C. thermocellum expresses a base level of cellulosome in the presence of 
soluble substrates such as cellobiose, but in the presence of insoluble substrates such as 
Avicel, cell signaling pathways in the organism are triggered that lead to the increased 
production of cellulosome. 
The ELISA-based method of cellulosome quantitation previously developed was 
developed using free cellulase, pellet cellulase, cellulose-bound cellulase, and cell-
associated cellulase284.  These four cellulase fractions were all obtained using the affinity 
digestion method161 that was also used to obtain purified cellulosome samples in this 
dissertation.  However, results presented in Figure 5.10 suggest that while CipA is 
representative of the cellulosome in extracellular and whole cell fractions, the assumption 
does not hold for samples purified with affinity digestion.  ELISA quantitation is 
dependent upon binding affinities between antibody and antigen, and it is reasonable that 
this binding would be affected by sample composition.  Given the weak correlation 
between CipA mass concentration and total cellulosome correlation presented in Figure 
5.10, the results obtained in ELISA-based cellulosome quantitation are suspect.  These 
results suggest that the previously developed ELISA-based method of cellulosome 
quantitation161 that uses the abundance of a single protein to quantitate the entire 
cellulosome lacks in accuracy compared to the multi-point mass spectrometry-based 
method of cellulosome quantitation described in this dissertation.  Quantitation of 
cellulosome in purified cellulosome, extracellular and whole cell fractions is needed for 
the determination of microbial cellulose utilization rates, and the use of multiple proteins 
for quantitation compensates for variation in individual proteins that may result from 
biological conditions or cellulosome purification. 
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The initial comparison of cellulase activity as a function of cellulosome mass 
concentration presented in Figure 5.11 shows a strong correlation between cellulosomal 
mass and activity.  The F86.C cellulosome mass concentration measurement was higher 
than expected, as illustrated by the results from the t-test between the F85.C and F86.C 
biological replicates that indicated that the cellulosome mass concentrations from the 
biological replicates were statistically different.  The high precision of technical replicate 
measurements of cellulosome mass concentration from the samples indicates that either 
the biological variation in the Avicel fermentations is higher than that in the cellobiose 
fermentations, that small differences in fermentation conditions may have led to 
quantitatable differences between biological replicates, or that recovery from the affinity 
digestion process is not as reproducible as the quantitation measurements. 
 A method has been described that can be utilized to quantitate cellulosome mass 
concentration in samples ranging in complexity from purified cellulsome samples 
consisting of under 100 proteins to whole cell fractions consisting over 1,500 proteins.  
However, the cellulosome mass concentration is determined by cellulosome peptides 
after digestion in mixtures that are perhaps an order of magnitude more complex than the 
protein samples, assuming each protein yields 10 peptides after digestion.  The 14 
proteins selected for this method correspond to the majority of cellulosome as determined 
by NSAFs.  Precision for this method of quantitation is under 5% RSD for all technical 
replicates and on average below 10% RSD for biological replicates.  Robustness and 
reproducibility over results over time has been demonstrated.  As such, the method 
demonstrated in this chapter is suitable to replace the previously described284 ELISA 










A number of goals for this dissertation were outlined in Section 1.7.  
Development of methods to increase sequence coverage for protein characterization has 
been accomplished using multiple proteases for online digestion of Aβ as described in 
Chapter 3 and multiple proteases/fragmentation methods for C. thermocellum in Chapter 
4.  In discovery-based experiments, the identification of two distinct peptides is 
statistically adequate to identify a protein, but increasing sequence coverage allows for a 
broader view of the protein and greater insight into protein structure and function. 
Building on these experiments, development of a method used for blind characterization 
of a selected set of PTMs has been accomplished as described in Chapter 4.  The use of 
multiple proteases and multiple fragmentation methods yields increased sequence 
coverage and overlap of sequence coverage.   This complementarity allows for 
identification and verification of large numbers of PTMs in C. thermocellum cellulosome 
proteins that may be related cellulolytic activity or structure of the cellulosome.  
Development of a mass spectrometry-based assay for the absolute quantitation of the C. 
thermocellum cellulosome has been accomplished as described in Chapter 5.  
Demonstration of this method allows for studies of cellulosome activity under a variety 
of conditions as well analysis of stoichiometries of enzymatic and structural cellulosome 
components.  Efficacy of exploiting this method to answer questions related to 
cellulolytic activity has also been demonstrated in Chapter 5 by showing correlation 
between cellulolytic activities of purified samples and the amount of cellulosome in the 
sample.  By allowing for the determination of amount of cellulase in a sample 
independently of the total amount of cell and cellulose in the sample, this method will 
allow accurate determination of cellulose utilization rates in C. thermocellum. 
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The accomplishment of goals outlined in Section 1.7 has been demonstrated in 
Chapters 3-6.  This chapter outlines future studies that should follow those described in 
this dissertation as well as proteomics studies that should follow in a broader sense.  Also 
presented in this chapter are limitations to methods presented in this dissertation as well 
as broad challenges that remain to be addressed in proteomics.  Finally, a discussion will 
be presented regarding what has been accomplished in this dissertation as well as what 
has been added to science in general. 
6.2 Status of Aβ  Characterization 
 Determination of the structure of Aβ fibrils is critical to understanding, treatment, 
and prevention of Alzheimer’s disease.   While the work presented in this dissertation has 
illustrated the utility of using multiple proteases (both separately and mixtures of 
enzymes) in online proteolysis of Aβ, future studies should utilize the multiple proteases 
and/or combination of multiple proteases described in this dissertation to probe the 
structure of Aβ fibrils using HDX mass spectrometry.  The experiments should not be 
limited to fibrils produced from the (1-40) Aβ peptide but should also incorporate fibrils 
resulting from the (1-41) and (1-42) versions of the Aβ peptide.  Though samples 
relevant to this research are no longer available to this research group, research groups 
currently analyzing Aβ structure should incorporate HDX mass spectrometry 
experiments coupled with online proteolysis to further probe fibril structure. 
6.3 Status of PTM Studies and Remaining Challenges 
 Utilizing multiple proteases in sample digestion and multiple fragmentation 
methods has allowed for the identification of a variety of PTMs in C. thermocellum 
cellulosome proteins with verification through independent experiments.  Future studies 
related to C. thermocellum should probe the role that the oxidations, methylations, and 
acetylations identified in this dissertation have in the structure of cellulosome proteins as 
well as cellulolytic activity of the cellulosome.  Data acquired using multiple proteases 
and multiple fragmentations presented in this dissertation could also be mined for other 
PTMs of interest that were not previously considered.  Of particular interest is the 
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glycosylation signature of cellulosome proteins.  Glycans can be released from proteins 
using a reagent such as Peptide: N-glycosidase F (PNGase F), and mass spectrometry can 
be used to study protein glycosylation by comparing data from samples treated with 
PNGase F to data from untreated samples.  In addition, the composition of glycans 
released from these samples can be deduced with mass spectrometry.  Though PTMs are 
generally overlooked due to difficulties related to their identification, further study of 
PTMs associated with cellulosome proteins is critical to optimizing the cellulose 
utilization for consolidated bioprocessing. 
 In more broad applications, the use of multiple proteases should become more 
widespread in the field of proteomics.  In this dissertation, the complementarity of 
multiple proteases has been exploited both to elucidate additional fibril structural 
information as well as to increase confidence in PTM identifications.  Multiple 
fragmentation methods should also be used in proteomics experiments.  The decision tree 
method of fragmenting peptides in particular shows great promise for global proteomics 
experiments, and the use of both CAD and ETD in proteomics experiments should 
become more common.  Proteins and peptides possess a wide variety of physical 
properties, and though CAD fragmentation of tryptic peptides has proven successful in 
proteomics, multiple proteases and methods of fragmentation should be used to increase 
sequence coverage of proteins and to independently verify PTMs.  The method for 
identifying PTMs described in this dissertation should be utilized in future proteomics 
experiments to deduce of broad view of what proteins are potentially modified in a 
particular organism. 
 Though ETD has great potential for increasing identifications of both unmodified 
and modified peptides, ETD sources currently commercially available are not very 
efficient at fragmenting peptides.  Precursor ions are typically approximately an order of 
magnitude more intense than fragment ions.  In order to make ETD a more efficient 
process, supplemental activation energy is often added to help fragment peptides, 
particularly +2 peptides.  However, supplemental activation induces random scrambling 
of c- and z·- fragments to c·- and z- fragments.  This scrambling complicates database 
searching because the fragment ions are computationally matched to the wrong type of 
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ion.  Recent studies in which peptides were photoactivated with an infrared laser in the 
ion trap showed that doing so prevented peptide folding, which in turn increased ETD 
efficiency without supplemental activation energy264.  Upgrades to ETD sources 
incorporating photoactivation should be considered for future studies utilizing ETD.  
Reagent ions in addition to fluoranthene with a wide variety of electron affinities should 
also be probed to further optimize ETD efficiency. 
 Cellulosome proteins function in relatively harsh extracellular environments, so 
some degree of oxidative damage is expected in these proteins.  However, the large 
number of oxidations observed in Chapter 4 of this dissertation leads to speculation that 
some portion of these oxidations result from sample handling.  Initial experiments that 
utilized guanidine for protein denaturation exhibited a much larger degree of oxidation, 
suggesting that some aspect of the sample oxidation is due to digest conditions.  Though 
the oxidation was greatly reduced when proteins were denatured with urea, future 
experiments should examine sample preparation methods for causes of preparation-
induced oxidation.  Spray voltages used in MudPIT experiments (3.8 kV) are relatively 
high for mass spectrometry experiments, but these voltages were used to minimize the 
formation of droplets on the nanospray emitter after salt pulses.  Solutions high in 
ammonium acetate do not spray very efficiently, and if these droplets inhibit the recovery 
of nanospray after the salt pulse, large portions of the chromatogram can be lost due to 
poor spray.  However, the high voltages used to prevent droplet formation are also 
suspected of inducing peptide oxidation.  Future studies should focus on methods to 
reduce potential sample handling-induced oxidations from both sample preparation and 
introduction of samples into the mass spectrometer.  Oxidations related to biological 
function are indistinguishable from those caused by sample handling, and precautions 
should be taken to minimize these sample handling-induced oxidations so that research is 
not invested into oxidations that are not biologically relevant. 
 Although a method for identifying a wide variety of PTMs with high confidence 
has been demonstrated in this dissertation, the primary challenge associated with PTM 
identification is one of informatics.  Average mass values are specified in database search 
parameters for precursor ions, which is necessary for massive peptides as they have a 
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higher number of 13C atoms, but fragment ions are typically searched as monoisotopic.  
One issue arises with the parameters used for database searching (3 Da tolerance 
specified for precursor ions, 0.5 Da tolerance for fragment ions).  When considering a 
larger peptide, i.e. a +4 charge state with a neutral mass of ~5000 Da, the precursor ion 
may be 1.4 Da different than the average mass, so the experimental peptide would be 
matched to a theoretical peptide.  However, because this is a large peptide, the more 
intense peaks in the isotopic packet would be shifted to the higher m/z values.  When a 
peptide from a higher m/z in the isotopic packet is selected for fragmentation, the 
fragments could be up to a few Da higher than the fragments from the monoisotopic 
peak.  If the algorithm tries to match a theoretical fragment spectrum to the theoretical 
peaks with a +/-0.25 Da tolerance, this peptide isn't going to be identified due to the 
heavier mass due to isotopes.  As such, identifications will be biased against larger 
peptides.  The most obvious way to adjust for this is to search the product ions using 
average mass, which is the average mass of all isotopes, but this would result in having to 
use a larger mass tolerance as the average mass is actually not the mass of any product 
ion, only the average of several ions.  This is an issue that affects all database search 
results and is one that should be further investigated.  
 Though large numbers of peptides can be identified in discovery-based 
proteomics experiments, a large portion of mass spectra obtained in the course of these 
experiments remain unassigned after database searching.  For experiments presented in 
Chapter 4, a total of approximately 483,000 MS/MS scans were collected for all 
experiments.  Of these, 140,462 were identified as unmodified peptides, and another 
1,352 were identified as modified peptides.  As such, roughly 71% of the scans obtained 
for these experiments remain unidentified.  Some portion of these spectra are likely of 
poor quality (~20 minutes of each MudPIT step are lost to poor spray during salt pulses), 
but many that remain unassigned are likely due to unsearched PTMs, mutations, and/or 
single nuclueotide polymorphisms (SNPs).  To this end, informatics platforms must be 
developed to greatly decrease the portion of unassigned quality spectra.  The platform 
outlined by the combination of MyriMatch291 and TagRecon292 shows great promise.  
Under this platform, data is analyzed with both MyriMatch, a database search algorithm, 
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and TagRecon, a sequence tag algorithm.  Results are then merged with IDPicker293.  
This method of searching combines the high accuracy obtained with database search 
algorithms with the flexibility with respect to PTMs and SNPs that is afforded by a 
sequence tag algorithm.  Perhaps future algorithms will combine a database search 
algorithm, a sequence tag algorithm, and a de novo algorithm so that spectra unassigned 
by a database search algorithm are searched with a sequence tag algorithm and remaining 
spectra are then searched with the de novo algorithm.  Such a platform of data mining 
would allow for maximum accuracy in results and maximum identification of quality 
spectra.  Though this platform may be computationally taxing, some method of data 
mining must be developed to greatly increase the number of assigned quality spectra, 
which will inherently increase PTM identifications, while maintaining low FDRs. 
6.4 Status of Absolute Quantitation Studies and Remaining Challenges 
 A method has been described in Chapter 5 of this dissertation that allows for mass 
spectrometry-based absolute quantitation of 14 proteins that correspond to majority of the 
C. thermocellum cellulosome.  This method can be used to quantitate the cellulosome in 
order to probe critical biological questions relative to biofuel production.  Future studies 
should utilize the method developed in this dissertation to probe microbial cellulose 
utilization rates of C. thermocellum under a wide variety of conditions to deduce optimal 
conditions for CBP.  Likewise, by comparing total cellulase activity of a sample to the 
total amount cellulosome in the sample, future studies can determine whether increased 
cellulolytic activity is related to an increase in cellulosome mass or if certain enzymes 
function more efficiently under certain circumstances.  Additional future studies should 
compare C. thermocellum fermented on different bioenergy-relevant substrates and 
prepared with different pretreatment methods such as acid pretreatment and ammonia 
fiber expansion294 (AFEX) pretreatment to determine whether certain cellulases or 
structural proteins are differentially expressed as a function of substrate.  Stoichiometric 
results from such a study could have wide implications, particularly among research 
groups pursuing the assembly of artificial cellulosomes.  For the development of the 
quantitation method described in this dissertation, 10 nmol of each peptide were obtained.  
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These peptides appear to be relatively stable when stored at -80° C, and because only 10-
20 pmol of each peptide are used in each digest, this method could be used to probe a 
large number of fermentation conditions, fermentation substrates, and sample preparation 
conditions in the optimization of conditions for CBP. 
 In results presented in Chapter 5, the ng of cellulosome proteins per µg of total 
protein was measured with high precision among technical replicates.  However, 
biological replicates exhibited a wider degree of variation.  Though some of this variation 
was biological resulting from different fermentations, most variation was due to 
inaccuracies in the BCA assay that was used to determine the amount of total protein 
prior to digestion.  In performing BCA assays on samples prior to digestion, 
measurements were recorded for three concentrations of the sample in triplicate.  For 
these 9 measurements, the average precision for whole cell lysate samples was 15.35% 
RSD.  This suggests that precision for the biological replicates could have been much 
higher if the method of determining the total amount of protein prior to digest was more 
accurate.  Amino acid analysis (AAA) is considered the “gold standard” for quantitation 
of the total amount of protein in a sample.  In AAA, proteins are hydrolyzed using high 
temperatures (>100° C) and strong acids (6 N HCl).  Resulting amino acids are then 
quantitated using gas chromatography mass spectrometry, and the amount of protein is 
then approximated using abundances of each amino acid295.  A study comparing 
reproducibility of AAA of purified protein samples among several facilities routinely 
performing AAA found accuracy of the measurements had error percentages ranging up 
to 58.9% with an average error of 11.9%296.  Comparisons of various colorimetric assays 
to AAA for purified samples showed that the BCA assay most closely resembles the 
results obtained by AAA297, 298.  Even though use of the BCA assay was recommended in 
these studies297, 298, error percentages up to 17.7% were reported when results from the 
BCA were compared to AAA297.  Experiments similar to the study in Chapter 5 are 
inherently limited by the accuracy of total protein determination, and future studies must 
focus on developing more accurate methods of quantitating total protein amounts. 
 Though technical replicates showed high precision of the total amount of 
cellulosome per mass of total protein, the ratios of unlabeled:labeled peptides in technical 
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replicates exhibited an overall precision of 16.84% RSD.  This value was calculated by 
determining % RSD values for technical replicates of each peptide across all conditions, 
and these values for each peptide were then averaged.  The RSD was determined from 
two technical replicates, and it is likely that this value could be reduced by increasing the 
number of technical replicates.  However, possible causes of this variation, whether 
they’re due to instrument error or chromatographic conditions, should be probed in future 
experiments. 
 When multiple peptides corresponding to the same protein were compared, the 
overall precision of the associated ratios of unlabeled:labeled peptide was 43.09% for all 
proteins in which more than one peptide was analyzed.  Related to this, the average 
unlabeled:labeled ratio for the BSA internal standard across all samples and conditions 
was 0.55±0.13.  Ideally, the ratio should have been 1 because equimolar amounts of 
intact BSA protein and labeled peptide corresponding to BSA were added to the sample.  
The recovery of BSA (55%) and precision of the unlabeled:labeled BSA peptide ratio 
across all samples (13.53% RSD) are consistent with values reported in which peptides 
corresponding to 10 proteins were spiked into human plasma and quantitated using a 
similar method299.  However, the large variation between ratios for peptides 
corresponding to the same protein and the recovery of the internal standard suggest that 
the sample is not being completely digested.  This could be due to variation of trypsin 
activity from vial to vial, incomplete denaturation, or incomplete digestion.  Experimental 
parameters such as the digestion time, the enzyme:substrate ratio, the digestion 
temperature, the concentration of DTT used to denature the proteins, the amount of time 
samples were incubated under denaturing conditions, the chemical used to denature 
proteins (DTT or guanidine), the concentration of iodoacetamide used to alkylate the 
sample, and the amount of time samples were incubated with iodoacetamide were varied 
in the course of the studies presented in Chapter 5 in the attempt to achieve higher BSA 
recovery and higher precision for peptides corresponding to the same protein (data not 
shown).  However, none of these factors seems to lead to more complete protein 
digestion.  Future studies should focus on the development of sample preparation 
methods that ensure more complete protein digestion.  These methods would be helpful 
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not only to quantitation experiments but also proteomics experiments in general because 
missed cleavages make database searching more difficult due to the increased complexity 
of the sample. 
6.5 Concluding Perspective 
 Despite the limitations and remaining challenges acknowledged in the previous 
sections, the development of analytical methods utilizing mass spectrometry to further the 
development of science have been demonstrated.  Prior to these developments, 
determination of whether the structure of Aβ (1-42) fibrils consisted of a solvent 
accessible or inaccessible C-terminus was not possible.  This could potentially have 
broad implications in the study of how Aβ fibrils form during the onset of Alzheimer’s 
disease.  Before experiments presented in this dissertation were developed, a broad view 
of the PTM signature of C. thermocellum had not been established.  Though the PTMs 
presented in this dissertation are by no means an exhaustive list, the method developed to 
elucidate these PTMs allows for a much broader study of function and structure of 
cellulosomal proteins.  This could have potential implications in studies of C. 
thermocellum cellulase activities as well as much broader studies in bioenergy research 
that focus on how the cellulosome functions in biological settings.  The cellulosome 
quantitation method described in this dissertation replaced a labor-intensive method for 
quantitation based on a single cellulosome protein that required extensive sample 
purification with a high-throughput method that allows for the quantitation of multiple 
proteins that constitute the vast majority of the cellulosome with no sample purification.  
This method allows for the determination of C. thermocellum microbial cellulose 
utilization rates, which is critical for the determination of optimal conditions for biofuel 
production.  Though the end point of these methods is based heavily in biology, the 
questions posed by these biological projects could not be answered without the 
development of analytical methods.  
 As stated in Chapter 1, mass spectrometry has grown into an invaluable tool in the 
field of proteomics.  Studies presented in this dissertation illustrate multiple examples of 
biological problems serving as drivers for the development of methods and techniques in 
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analytical chemistry.  The need to understand how fibrils related to Alzheimer’s disease 
form has prompted the development of methods for online proteolysis of fibrils so that 
structure of the fibrils can be elucidated.  The need to produce ethanol from cellulose 
more efficiently has driven the development of methods to quantitate a multi-faceted 
protein machine in extremely complex mixtures and means of identifying large numbers 
of PTMs in discovery based experiments with high confidence.   
 The incorporation of mass spectrometry into biological studies has revolutionized 
microbiology, and though much progress has been made in mass spectrometry 
instrumentation, sample handling methods, and informatics platforms, great hurdles still 
remain in the development of mass spectrometry to the address myriad of challenges 
associated with complex biological problems ranging from disease prevention and 
treatment to energy independence.  The studies presented in this dissertation are 
multidisciplinary in that contributions have been made to the field of analytical chemistry 
as the result of problems based in biology.  With bioanalytical chemistry investigations 
such as those presented in this dissertation, developments are made in one field to address 
problems in another field, and this leads to breakthroughs that benefit science as a whole 
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Sequence coverage for unmodified proteins using trypsin/CAD, additional sequence coverage gained using all enzymes and 
fragmentation methods, the percentage of sequence coverage identified with more than one enzyme, and total sequence coverage 












Cthe0032   0.00% 25.59% 1.69% 25.59% 
Cthe0040 CelI 5.86% 20.07% 0.00% 25.93% 
Cthe0043 CelN 27.63% 7.68% 18.33% 35.31% 
Cthe0190   34.33% 35.00% 33.50% 69.33% 
Cthe0211 LicB 12.28% 0.00% 0.00% 12.28% 
Cthe0239   12.75% 8.75% 4.95% 21.50% 
Cthe0246   0.00% 5.73% 0.00% 5.73% 
Cthe0258   26.87% 16.63% 22.81% 43.50% 
Cthe0269 CelA 48.64% 11.53% 33.96% 60.17% 
Cthe0270 ChiA 14.67% 20.04% 5.79% 34.71% 
Cthe0274 CelP 40.85% 10.66% 33.21% 51.51% 
Cthe0405 CelL 15.78% 25.29% 10.27% 41.06% 
Cthe0412 CelK 45.25% 13.52% 26.93% 58.77% 
Cthe0413 CbhA 38.07% 24.18% 29.25% 62.25% 
Cthe0433   33.71% 20.79% 26.49% 54.50% 
Cthe0435   0.00% 10.29% 0.00% 10.29% 
Cthe0452   0.00% 45.91% 0.00% 45.91% 
Cthe0536 CelB 45.29% 13.14% 43.52% 58.44% 
Cthe0543 CelF 32.07% 21.38% 27.60% 53.45% 
Cthe0578 CelR 55.16% 16.17% 41.17% 71.33% 
Cthe0624 CelJ 53.72% 25.61% 45.78% 79.33% 
Cthe0625 CelQ 65.35% 12.11% 41.55% 77.46% 
Cthe0640   16.67% 16.32% 2.23% 32.99% 
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Cthe0661   19.26% 7.01% 1.75% 26.27% 
Cthe0735   0.00% 25.37% 0.00% 25.37% 
Cthe0736   32.18% 23.07% 33.64% 55.25% 
Cthe0745 CelW 36.44% 31.64% 17.95% 68.08% 
Cthe0797 CelE 0.00% 5.65% 0.00% 5.65% 
Cthe0821   72.04% 13.80% 62.54% 85.84% 
Cthe0825 CelD 27.58% 19.11% 5.70% 46.69% 
Cthe0912 XynY 3.34% 11.51% 4.27% 14.86% 
Cthe1271   8.10% 15.76% 0.88% 23.86% 
Cthe1307 SdbA 27.42% 28.05% 28.68% 55.47% 
Cthe1398 XghA 33.73% 33.25% 23.75% 66.98% 
Cthe1400   14.22% 2.89% 0.00% 17.11% 
Cthe1472 CelH 7.89% 14.44% 0.11% 22.33% 
Cthe1806   0.00% 4.50% 0.00% 4.50% 
Cthe1838 XynC 60.42% 13.41% 52.99% 73.83% 
Cthe1963 XynZ 19.47% 15.65% 11.47% 35.13% 
Cthe2038   49.94% 4.09% 0.00% 4.09% 
Cthe2089 CelS 18.03% 16.19% 45.61% 70.58% 
Cthe2147 CelO 18.03% 19.24% 18.33% 37.27% 
Cthe2193   10.13% 21.20% 6.01% 31.33% 
Cthe2590 XynD 13.46% 15.18% 6.89% 28.64% 
Cthe2760 CelV 31.11% 29.45% 26.43% 60.56% 
Cthe2761   34.94% 29.84% 33.24% 64.78% 
Cthe2807 CelC 0.00% 20.41% 0.00% 20.41% 
Cthe2809 LicA 6.96% 19.91% 5.22% 26.87% 
Cthe2811 ManA 20.30% 29.44% 13.20% 49.75% 
Cthe2812 CelT 45.17% 10.80% 24.88% 55.97% 
Cthe2872 CelG 52.65% 15.72% 37.10% 68.37% 
Cthe2879   0.00% 6.26% 0.00% 6.26% 
Cthe2950   0.00% 6.32% 0.00% 6.32% 
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Cthe2972 XynA/U 14.79% 12.01% 12.15% 26.79% 
Cthe3012   0.00% 12.38% 0.95% 12.38% 
Cthe3077 CipA 31.79% 16.57% 23.75% 48.35% 
Cthe3078 OlpB 11.98% 7.70% 9.60% 19.67% 
Cthe3079 Orf2p 28.05% 13.95% 20.64% 42.01% 
Cthe3080 OlpA 38.48% 21.48% 27.29% 59.96% 
Cthe3132   0.00% 7.54% 0.00% 7.54% 
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Signal-to-noise ratios for quantitation experiments in Chapter 5 (Section 5.3).  Values are averaged for each sample in a particular 









VEIPITL(K) 40 144 19 73 
SFDTAIYPD(R) 31 7 5 11 
VTNTGSSAIDLS(K) 14 71 8 34 
NDWSNYTQSNDYSF(K) 43 26 21 27 








LWGSSGAINYGQEA(R) 244 25 25 69 
TAVDYSWFGDQ(R) 51 157 49 93 
GIVDGYTIQGS(K) 840 19 10 179 
DSEYYGYYGNSL(R) 23 156 20 75 








ATFINTFQ(R) 18 38 19 26 
AIQAVYWAN(K) 30 59 8 33 
DMAAELVN(R) 10 27 14 18 
SGISINTDNADLNEDG(R) 12 8 9 9 








VNQVGYLPFA(K) 25 69 51 53 
DGGMNIPE(R) 13 7 7 8 
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FEDPTITAAV(K) 62 23 28 33 
SGISINTDNADVNADG(R) 7 15 13 13 








VNQVGYLPEG(K) 15 15 7 12 
SNVVAYGNEFL(K) 50 11 6 17 








YGPTPVAGNDI(K) 21 77 9 39 
EGDVIIATI(R) 18 7 4 8 








INSTDLGMLN(R) 38 118 22 64 
LVILDDNL(K) 36 16 745 312 








SGTLAIIGF(K) 19 17 8 14 
YDPAVLQAVNPVTGEPMSD(K) 34 26 9 21 








GPETVELTTEEAYSG(R) 30 21 8 17 
SISDFPTPEG(K) 23 384 56 181 










SQIDYALGSNPDN(R) 86 287 7 135 








EGIVVGSGDIINP(R) 29 9 109 53 








ELFTFADTT(R) 44 21 5 19 








DIAEGVIYHSY(K) 2 3 3 3 








FENTPVMPGA(K) 87 14 19 31 
          







YLYEIA(R) 49 30 5 23 








All Peptides 64 60 41 53 
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Ratios of chromatographic peak areas for unlabeled:labeled peptides used in quantitation experiments in Chapter 5 (Section 5.3) 
for technical replicate 1 of extracellular fraction samples. 
 
Cthe_3077 CipA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
VEIPITL(K) 4.4018 2.8591 6.5400 10.2864 6.6881 7.8218 6.2780 2.8366 
SFDTAIYPD(R) 1.2332 0.5129 1.6916 1.9922 1.4090 3.2785 1.5503 0.7702 
VTNTGSSAIDLS(K) 5.2793 3.7264 9.2368 12.4275 8.8807 13.0387 17.2316 5.4231 
NDWSNYTQSNDYSF(K) 5.3358 3.0694 8.8722 11.3111 10.3079 8.5229 10.0496 3.2705 
                  
Cthe_0269 CelA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
LWGSSGAINYGQEA(R) 4.2007 2.5313 8.3205 12.3426 7.1283 7.8689 9.3893 0.9594 
TAVDYSWFGDQ(R) 4.1911 2.8374 8.4236 13.1154 6.5758 7.1225 9.2858 0.9700 
GIVDGYTIQGS(K) 3.3687 3.0692 10.7605 11.7689 6.2621 8.2241 10.1979 1.1675 
DSEYYGYYGNSL(R) 4.2411 2.6985 9.6175 11.8218 8.1520 8.7626 10.1911 1.0986 
                  
Cthe_2089 CelS F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
ATFINTFQ(R) 6.7430 3.5376 9.5389 11.1352 16.6095 21.8528 9.9455 2.8958 
AIQAVYWAN(K) 4.9700 2.2486 5.5159 14.1181 12.0705 14.3550 4.0916 1.4426 
DMAAELVN(R) 4.7837 3.1935 15.8324 18.8829 51.0492 33.3543 6.8795 2.0248 
SGISINTDNADLNEDG(R) 1.4719 1.1066 2.1593 3.0010 3.2976 3.7634 2.2518 1.3445 
                  
Cthe_0412 CelK F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
VNQVGYLPFA(K) 2.8283 1.9282 5.5775 7.2307 6.3062 7.3756 5.2226 2.4467 
DGGMNIPE(R) 4.5232 2.3564 4.2392 4.2829 16.4931 3.8898 9.7653 1.8598 
FEDPTITAAV(K) 3.5257 2.5445 7.4753 7.8536 9.8018 11.6368 6.7425 2.4505 
SGISINTDNADVNADG(R) 5.2315 4.4529 9.9483 12.8265 14.7409 18.7316 9.5635 4.6817 
                  
Cthe_0413 CbhA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
VNQVGYLPEG(K) 0.2985 0.1199 0.4197 0.8017 1.2218 1.6123 0.4460 0.2674 
SNVVAYGNEFL(K) 0.0244 0.0501 0.1581 0.4139 0.5076 0.7427 0.5923 0.1230 
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Cthe_3078 OlpB F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
YGPTPVAGNDI(K) 0.6335 0.2840 0.5583 0.8417 1.3272 1.4084 0.5636 0.2067 
EGDVIIATI(R) 0.0177 0.2360 0.2960 0.3878 0.7652 0.6653 0.3716 0.1020 
                  
Cthe_0821 F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
INSTDLGMLN(R) 1.3517 1.1668 5.2422 5.5808 3.7993 3.7718 6.9443 3.1289 
LVILDDNL(K) 1.8625 1.2365 4.8365 8.9164 3.5882 5.1520 4.2350 3.2160 
                  
Cthe_0736 F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
SGTLAIIGF(K) 0.6150 0.3883 2.0043 2.3627 0.9782 0.9623 1.9844 0.9801 
YDPAVLQAVNPVTGEPMSD(K) 0.4719 0.2738 1.4170 1.9922 0.5428 0.5972 1.5370 0.4334 
                  
Cthe_1838 XynC F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
GPETVELTTEEAYSG(R) 1.7546 1.4102 3.9036 4.5055 2.6230 3.1634 3.9145 1.9442 
SISDFPTPEG(K) 0.8180 0.4682 1.4809 1.7794 0.8902 1.0134 1.5612 1.0332 
                  
Cthe_0625 CelQ F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
SQIDYALGSNPDN(R) 0.6941 0.4832 1.2500 1.3177 0.9790 1.2287 1.0827 0.3972 
                  
Cthe_1307 SbdA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
EGIVVGSGDIINP(R) 0.1974 0.0784 0.1113 0.0735 0.1288 0.1789 0.0428 0.0001 
                  
Cthe_0543 CelF F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
ELFTFADTT(R) 0.3572 0.3823 1.6528 2.6861 1.3419 1.2395 2.0079 0.6009 
                  
Cthe_3080 OlpA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
DIAEGVIYHSY(K) 0.0010 0.0284 0.0849 0.0294 0.1110 0.0120 0.0123 0.0022 
                  
Cthe_3079 Orf2p F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
FENTPVMPGA(K) 0.0585 0.0377 0.0463 0.0654 0.1724 0.1917 0.0391 0.0006 
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Bovine Serum Albumin F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 




Ratios of chromatographic peak areas for unlabeled:labeled peptides used in quantitation experiments in Chapter 5 (Section 5.3) 
for technical replicate 2 of extracellular fraction samples. 
 
 
Cthe_3077 CipA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
VEIPITL(K) 3.9168 2.8648 6.5114 8.8163 6.4993 6.6371 7.0101 2.9707 
SFDTAIYPD(R) 0.9194 0.5769 1.9226 2.8422 3.7076 1.7919 1.7919 0.8580 
VTNTGSSAIDLS(K) 4.3488 3.8203 8.5190 12.3874 9.8679 14.7621 14.2316 4.8468 
NDWSNYTQSNDYSF(K) 4.2187 3.1145 9.1368 9.8749 12.3504 11.5996 11.5996 3.4946 
                  
Cthe_0269 CelA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
LWGSSGAINYGQEA(R) 4.3196 2.8148 8.0061 11.4533 6.5067 7.5173 9.9677 1.0817 
TAVDYSWFGDQ(R) 4.1965 2.7486 8.7813 11.9895 6.9829 8.0071 10.0067 1.1009 
GIVDGYTIQGS(K) 4.4261 3.0211 9.2477 15.4601 8.4614 9.8374 8.3923 1.2544 
DSEYYGYYGNSL(R) 4.8200 2.5100 9.1598 11.8066 7.6889 9.6538 9.4274 1.1519 
                  
Cthe_2089 CelS F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
ATFINTFQ(R) 6.1266 3.7352 8.8257 11.4407 17.1464 20.5475 9.6943 2.9568 
AIQAVYWAN(K) 5.2228 2.1610 5.5895 15.6148 16.9902 15.1944 5.9606 1.4347 
DMAAELVN(R) 5.4079 3.6899 9.9858 16.7696 59.2244 33.6768 8.0825 2.3225 
SGISINTDNADLNEDG(R) 1.0222 0.8682 1.8850 1.5911 4.4100 3.5015 2.0433 1.6951 
                  
Cthe_0412 CelK F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
VNQVGYLPFA(K) 3.0876 2.0738 5.5538 6.2627 6.1097 6.9830 5.0727 2.3873 
DGGMNIPE(R) 4.0999 2.1475 10.5536 5.2198 6.1411 7.9852 4.6739 1.6988 
FEDPTITAAV(K) 4.1056 2.3700 6.8390 9.3623 9.3224 10.6058 6.9865 2.3794 
SGISINTDNADVNADG(R) 4.9711 4.2038 11.9424 18.5545 12.6790 16.1715 12.8318 4.4878 
                  
Cthe_0413 CbhA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
VNQVGYLPEG(K) 0.2404 0.1331 0.4312 0.9364 1.0887 1.1675 0.5820 0.2441 
SNVVAYGNEFL(K) 0.0510 0.0595 0.2054 0.2151 0.4898 0.6468 0.3771 0.1122 
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Cthe_3078 OlpB F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
YGPTPVAGNDI(K) 0.3568 0.2882 0.5187 0.8388 0.9225 1.2730 0.5877 0.2147 
EGDVIIATI(R) 0.0599 0.1148 0.2013 0.4757 0.8349 1.2586 0.3466 0.0446 
                  
Cthe_0821 F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
INSTDLGMLN(R) 2.7007 1.3853 5.4651 5.5716 3.6451 6.0784 3.9565 2.4844 
LVILDDNL(K) 1.5515 1.4408 4.7277 7.2916 4.4401 3.9455 4.9086 2.9937 
                  
Cthe_0736 F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
SGTLAIIGF(K) 0.5968 0.4502 2.3275 2.5024 1.0581 1.1396 2.2066 0.8222 
YDPAVLQAVNPVTGEPMSD(K) 0.4767 0.1966 1.7129 1.9159 0.7463 0.8780 1.2757 0.6922 
                  
Cthe_1838 XynC F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
GPETVELTTEEAYSG(R) 2.1300 1.2790 4.1133 4.6057 2.4279 2.4228 3.6207 1.7028 
SISDFPTPEG(K) 0.7974 0.5687 1.8426 1.7803 0.9623 0.9796 1.5778 0.9243 
                  
Cthe_0625 CelQ F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
SQIDYALGSNPDN(R) 0.5755 0.3680 1.0407 1.3444 1.2431 1.2279 1.0075 0.3307 
                  
Cthe_1307 SbdA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
EGIVVGSGDIINP(R) 0.1418 0.0626 0.1000 0.0619 0.1180 0.1664 0.0345 0.0010 
                  
Cthe_0543 CelF F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
ELFTFADTT(R) 0.4634 0.2800 1.7957 2.9639 1.4488 1.4584 1.9777 0.7987 
                  
Cthe_3080 OlpA F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
DIAEGVIYHSY(K) 0.0926 0.0588 0.1124 0.0191 0.0404 0.0775 0.0247 0.0026 
                  
Cthe_3079 Orf2p F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
FENTPVMPGA(K) 0.0804 0.0388 0.0543 0.0721 0.1309 0.1665 0.0416 0.0129 
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Bovine Serum Albumin F85.P5.S F86.P5.S F87.P5.S F88.P5.S F85.P10.S F86.P10.S F87.P8.S F88.P8.S 
YLYEIA(R) 0.5184 0.5151 0.5671 0.4355 0.4512 0.5146 0.5447 0.4832 
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Ratios of chromatographic peak areas for unlabeled:labeled peptides used in quantitation experiments in Chapter 5 (Section 5.3) 
for technical replicate 1 of whole cell fraction samples. 
 
Cthe_3077 CipA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
VEIPITL(K) 2.4298 2.4133 0.7945 1.1042 1.4509 1.4536 0.6125 0.4584 
SFDTAIYPD(R) 1.0776 1.2840 0.3108 0.3393 0.1924 0.1422 0.3614 0.2043 
VTNTGSSAIDLS(K) 5.2758 4.5122 1.8918 3.8430 2.2835 3.1825 1.0478 0.7558 
NDWSNYTQSNDYSF(K) 3.8955 4.6782 0.7481 1.4451 2.5010 2.0405 0.7658 0.5689 
                  
Cthe_0269 CelA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
LWGSSGAINYGQEA(R) 3.0182 4.4788 1.2317 0.9609 0.9837 1.0914 0.8908 0.7842 
TAVDYSWFGDQ(R) 3.8509 4.9810 1.3050 2.2365 2.3977 1.8847 1.4453 0.8860 
GIVDGYTIQGS(K) 2.7465 4.0032 1.0385 1.9964 3.3595 2.2628 0.9082 0.8096 
DSEYYGYYGNSL(R) 3.6386 4.8243 1.3836 1.9658 1.4987 1.8407 1.4808 0.8999 
                  
Cthe_2089 CelS F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
ATFINTFQ(R) 6.4795 9.0935 1.5771 2.1634 7.7886 6.9455 1.3214 1.1812 
AIQAVYWAN(K) 6.2274 5.6260 1.2699 2.4982 4.3066 5.5011 2.3275 1.0718 
DMAAELVN(R) 4.7911 17.5912 2.4180 5.4221 7.2253 8.2957 4.8275 1.4978 
SGISINTDNADLNEDG(R) 1.4722 1.1471 0.3184 0.5293 1.9670 1.0839 0.3826 0.2405 
                  
Cthe_0412 CelK F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
VNQVGYLPFA(K) 2.5030 3.2987 0.7617 1.7502 2.6169 2.5395 0.8469 0.5184 
DGGMNIPE(R) 4.9422 3.3785 6.4788 8.0849 25.8207 1.2027 5.9840 0.2104 
FEDPTITAAV(K) 3.5158 4.6161 1.1359 1.6794 2.7325 2.9997 0.7613 0.5891 
SGISINTDNADVNADG(R) 3.9808 5.1818 2.3609 2.8124 6.3219 4.7322 1.8599 1.1134 
                  
Cthe_0413 CbhA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
VNQVGYLPEG(K) 0.1739 0.4319 0.0606 0.2726 0.2902 0.2621 0.0998 0.1229 
SNVVAYGNEFL(K) 0.1419 0.1840 0.0041 0.1355 0.0533 0.2030 0.0089 0.0200 
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Cthe_3078 OlpB F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
YGPTPVAGNDI(K) 0.4999 0.7511 0.2904 0.4160 0.2656 0.3350 0.3667 0.2571 
EGDVIIATI(R) 0.7396 0.3986 0.4070 0.5031 0.0458 0.4832 0.3261 0.2507 
                  
Cthe_0821 F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
INSTDLGMLN(R) 1.3074 1.3790 0.6723 1.7078 1.0960 1.3128 1.1423 0.5893 
LVILDDNL(K) 1.3011 1.5182 0.5058 1.3726 1.2503 0.9182 0.4132 0.4132 
                  
Cthe_0736 F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
SGTLAIIGF(K) 0.2322 0.2483 0.1088 0.1244 0.0655 0.1220 0.1085 0.0820 
YDPAVLQAVNPVTGEPMSD(K) 0.2032 0.1724 0.0603 0.1222 0.0847 0.0928 0.0885 0.0498 
                  
Cthe_1838 XynC F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
GPETVELTTEEAYSG(R) 1.0970 1.1289 0.6091 1.0633 0.5515 0.6982 0.5014 0.4992 
SISDFPTPEG(K) 0.5459 0.7131 0.4129 0.5472 0.1382 0.3894 0.1166 0.2499 
                  
Cthe_0625 CelQ F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
SQIDYALGSNPDN(R) 0.5080 0.4688 0.1272 0.4453 0.5277 0.2643 0.1396 0.1925 
                  
Cthe_1307 SbdA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
EGIVVGSGDIINP(R) 0.2195 0.2403 0.2127 0.4022 0.4240 0.4049 0.3080 0.2067 
                  
Cthe_0543 CelF F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
ELFTFADTT(R) 0.4060 1.1792 0.3597 0.5645 0.5595 0.4983 0.4057 0.3538 
                  
Cthe_3080 OlpA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
DIAEGVIYHSY(K) 1.0946 1.4519 0.4737 0.5077 1.1760 1.4679 0.8500 0.2168 
                  
Cthe_3079 Orf2p F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
FENTPVMPGA(K) 0.1507 0.2103 0.0678 0.1593 0.1876 0.1288 0.1015 0.0425 
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Ratios of chromatographic peak areas for unlabeled:labeled peptides used in quantitation experiments in Chapter 5 (Section 5.3) 
for technical replicate 2 of whole cell fraction samples. 
 
 
Cthe_3077 CipA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
VEIPITL(K) 2.3370 2.7205 0.8575 1.0197 1.2863 1.1493 0.6334 0.6440 
SFDTAIYPD(R) 1.2563 0.8477 0.4647 1.4727 0.2433 0.2190 0.3191 0.5095 
VTNTGSSAIDLS(K) 5.7878 7.1132 2.5345 2.1690 1.4559 1.7906 1.1540 0.6928 
NDWSNYTQSNDYSF(K) 3.7581 4.7504 1.1580 3.0179 3.0112 2.2471 1.2287 1.0760 
                  
Cthe_0269 CelA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
LWGSSGAINYGQEA(R) 3.5058 3.5799 1.2101 1.1990 1.1333 1.0675 0.9619 0.9670 
TAVDYSWFGDQ(R) 3.8190 4.4792 1.4417 2.3818 1.9842 1.7426 1.3385 0.8960 
GIVDGYTIQGS(K) 5.1454 4.3348 0.9725 1.0806 2.4525 2.0731 1.4160 0.7058 
DSEYYGYYGNSL(R) 3.1546 3.9490 1.4309 2.8224 1.8541 1.7881 1.3431 0.8468 
                  
Cthe_2089 CelS F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
ATFINTFQ(R) 8.2751 7.9101 1.5120 2.0862 5.9458 6.6857 1.5122 1.0338 
AIQAVYWAN(K) 4.1622 6.8177 1.1870 2.7971 10.7725 3.9383 1.5360 0.9272 
DMAAELVN(R) 4.5027 7.4016 2.3520 7.5464 3.0255 9.5921 2.9342 1.3797 
SGISINTDNADLNEDG(R) 1.5444 1.7713 0.4107 0.4725 1.7215 0.7804 0.5235 0.4854 
                  
Cthe_0412 CelK F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
VNQVGYLPFA(K) 2.5178 3.6277 0.8078 2.1249 2.5399 2.3499 0.6832 0.5028 
DGGMNIPE(R) 1.0126 4.8058 6.0806 4.4971 29.5630 0.8622 7.2343 0.4362 
FEDPTITAAV(K) 4.1297 4.4921 0.9422 1.7294 2.6626 2.6079 0.8102 0.5513 
SGISINTDNADVNADG(R) 3.9100 11.9462 1.1466 1.6824 4.6223 6.8418 1.4341 0.7983 
                  
Cthe_0413 CbhA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
VNQVGYLPEG(K) 0.3901 0.3518 0.1026 0.1116 0.1339 0.3141 0.1060 0.1550 
SNVVAYGNEFL(K) 0.1120 0.2492 0.0448 0.1464 0.1007 0.0768 0.0154 0.0226 
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Cthe_3078 OlpB F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
YGPTPVAGNDI(K) 1.1313 0.7201 0.3389 0.6393 0.4987 0.4633 0.4342 0.2195 
EGDVIIATI(R) 0.0861 0.5992 0.3381 0.0737 0.1415 0.1381 0.3870 0.2143 
                  
Cthe_0821 F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
INSTDLGMLN(R) 1.6559 1.3972 0.7354 1.0709 1.0357 0.8825 1.3445 0.3980 
LVILDDNL(K) 0.9776 1.4032 0.8406 0.8393 1.2500 1.1138 0.9214 0.4334 
                  
Cthe_0736 F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
SGTLAIIGF(K) 0.2970 0.3017 0.1009 0.0745 0.1457 0.1669 0.1206 0.0945 
YDPAVLQAVNPVTGEPMSD(K) 0.1112 0.2709 0.0321 0.0475 0.1462 0.0903 0.1103 0.0840 
                  
Cthe_1838 XynC F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
GPETVELTTEEAYSG(R) 0.5362 0.9485 0.6560 0.6487 0.6755 0.4756 0.5754 0.4053 
SISDFPTPEG(K) 0.4198 0.6560 0.3340 0.5491 0.3374 0.2765 0.1747 0.3255 
                  
Cthe_0625 CelQ F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
SQIDYALGSNPDN(R) 0.4703 0.3710 0.2168 0.5084 0.3478 0.3396 0.1654 0.0808 
                  
Cthe_1307 SbdA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
EGIVVGSGDIINP(R) 0.2066 0.2484 0.2641 0.3881 0.3667 0.3368 0.2613 0.2071 
                  
Cthe_0543 CelF F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
ELFTFADTT(R) 0.6549 0.6916 0.1344 0.2795 0.6565 0.4569 0.3104 0.1158 
                  
Cthe_3080 OlpA F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
DIAEGVIYHSY(K) 1.5075 2.0935 0.2899 1.3584 1.8681 3.8702 0.6105 0.3350 
                  
Cthe_3079 Orf2p F85.P5.P F86.P5.P F87.P5.P F88.P5.P F85.P10.P F86.P10.P F87.P8.P F88.P8.P 
FENTPVMPGA(K) 0.1280 0.2132 0.0836 0.1498 0.3145 0.1762 0.0734 0.0116 
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Ratios of chromatographic peak areas for unlabeled:labeled peptides used in quantitation experiments in Chapter 5 (Section 5.3) 
for technical replicate 1 of purified cellulosome samples. 
 
 
Cthe_3077 CipA F85.C F86.C F87.C F88.C 
VEIPITL(K) 7.3340 14.8658 33.2592 41.1250 
SFDTAIYPD(R) 2.5793 4.4812 8.6821 11.5528 
VTNTGSSAIDLS(K) 12.9216 23.8076 44.9727 51.7175 
NDWSNYTQSNDYSF(K) 14.5807 24.3044 56.6013 66.5233 
          
Cthe_0269 CelA F85.C F86.C F87.C F88.C 
LWGSSGAINYGQEA(R) 26.1532 28.8875 24.4332 23.8979 
TAVDYSWFGDQ(R) 35.4883 49.6344 108.2919 104.6885 
GIVDGYTIQGS(K) 33.1649 44.7681 106.3034 102.6103 
DSEYYGYYGNSL(R) 32.6449 41.6592 96.3918 92.6060 
          
Cthe_2089 CelS F85.C F86.C F87.C F88.C 
ATFINTFQ(R) 62.3183 83.6502 73.2416 61.0945 
AIQAVYWAN(K) 57.4398 79.0553 69.3646 57.5273 
DMAAELVN(R) 68.0302 78.6296 79.4466 72.7581 
SGISINTDNADLNEDG(R) 7.9449 9.8140 8.8380 10.5067 
          
Cthe_0412 CelK F85.C F86.C F87.C F88.C 
VNQVGYLPFA(K) 7.5878 12.4529 60.3355 49.4700 
DGGMNIPE(R) 16.2302 23.1488 60.2501 25.5383 
FEDPTITAAV(K) 17.0022 22.2024 54.9468 41.5605 
SGISINTDNADVNADG(R) 10.7020 15.2488 53.2216 33.6586 
          
Cthe_0413 CbhA F85.C F86.C F87.C F88.C 
VNQVGYLPEG(K) 1.4357 1.2479 3.3344 3.6902 
SNVVAYGNEFL(K) 0.8787 0.7655 2.1658 2.5767 
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Cthe_3078 OlpB F85.C F86.C F87.C F88.C 
YGPTPVAGNDI(K) 0.9441 1.2244 2.3248 5.3957 
EGDVIIATI(R) 0.6421 0.7089 0.8509 0.8394 
          
Cthe_0821 F85.C F86.C F87.C F88.C 
INSTDLGMLN(R) 4.3312 9.7313 27.8774 35.5198 
LVILDDNL(K) 3.7018 7.4949 20.0622 23.4315 
          
Cthe_0736 F85.C F86.C F87.C F88.C 
SGTLAIIGF(K) 1.0168 1.8470 7.4545 6.9750 
YDPAVLQAVNPVTGEPMSD(K) 0.8642 1.3296 6.2220 5.3624 
          
Cthe_1838 XynC F85.C F86.C F87.C F88.C 
GPETVELTTEEAYSG(R) 2.3383 6.1472 25.9581 25.1119 
SISDFPTPEG(K) 1.0049 1.6005 6.3031 5.9461 
          
Cthe_0625 CelQ F85.C F86.C F87.C F88.C 
SQIDYALGSNPDN(R) 2.8798 5.2279 12.1418 6.5242 
          
Cthe_1307 SbdA F85.C F86.C F87.C F88.C 
EGIVVGSGDIINP(R) 0.0185 0.0402 0.0504 0.0404 
          
Cthe_0543 CelF F85.C F86.C F87.C F88.C 
ELFTFADTT(R) 2.3170 4.5855 13.4784 11.2552 
          
Cthe_3080 OlpA F85.C F86.C F87.C F88.C 
DIAEGVIYHSY(K) 0.0068 0.0118 0.0077 0.0116 
          
Cthe_3079 Orf2p F85.C F86.C F87.C F88.C 
FENTPVMPGA(K) 0.0156 0.0666 0.1017 0.0772 
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Ratios of chromatographic peak areas for unlabeled:labeled peptides used in quantitation experiments in Chapter 5 (Section 5.3) 
for technical replicate 2 of purified cellulosome samples. 
 
 
Cthe_3077 CipA F85.C F86.C F87.C F88.C 
VEIPITL(K) 7.5799 14.2676 32.3130 42.8844 
SFDTAIYPD(R) 2.6711 4.5645 5.7406 7.5273 
VTNTGSSAIDLS(K) 9.9846 19.7669 59.1788 49.7194 
NDWSNYTQSNDYSF(K) 13.2669 24.0671 68.0824 84.2432 
          
Cthe_0269 CelA F85.C F86.C F87.C F88.C 
LWGSSGAINYGQEA(R) 26.1958 28.1770 25.2599 28.3635 
TAVDYSWFGDQ(R) 36.0618 47.4380 104.8701 101.1696 
GIVDGYTIQGS(K) 34.9948 44.7490 94.5778 79.3891 
DSEYYGYYGNSL(R) 29.6657 40.3096 86.1170 87.1572 
          
Cthe_2089 CelS F85.C F86.C F87.C F88.C 
ATFINTFQ(R) 57.8623 89.2210 66.2336 67.0854 
AIQAVYWAN(K) 59.5034 80.8443 78.9597 46.9871 
DMAAELVN(R) 75.3746 86.3377 102.0654 53.8379 
SGISINTDNADLNEDG(R) 7.3600 12.5100 9.4800 15.4600 
          
Cthe_0412 CelK F85.C F86.C F87.C F88.C 
VNQVGYLPFA(K) 7.3783 11.8324 67.0437 58.5124 
DGGMNIPE(R) 20.6930 22.3468 37.4592 51.3056 
FEDPTITAAV(K) 12.1047 21.8804 56.1055 40.8200 
SGISINTDNADVNADG(R) 13.9880 13.6269 37.0241 42.6223 
          
Cthe_0413 CbhA F85.C F86.C F87.C F88.C 
VNQVGYLPEG(K) 1.2687 1.3536 3.5232 5.0633 
SNVVAYGNEFL(K) 0.9128 0.7966 2.1299 2.4919 
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Cthe_3078 OlpB F85.C F86.C F87.C F88.C 
YGPTPVAGNDI(K) 0.8364 1.1871 2.4856 3.7800 
EGDVIIATI(R) 0.6255 0.5615 0.5617 0.9694 
          
Cthe_0821 F85.C F86.C F87.C F88.C 
INSTDLGMLN(R) 4.8363 9.3852 31.8731 36.0970 
LVILDDNL(K) 3.3775 7.2124 19.6991 25.6293 
          
Cthe_0736 F85.C F86.C F87.C F88.C 
SGTLAIIGF(K) 0.8186 1.9333 7.8007 5.7649 
YDPAVLQAVNPVTGEPMSD(K) 0.8296 1.4115 6.8988 5.2453 
          
Cthe_1838 XynC F85.C F86.C F87.C F88.C 
GPETVELTTEEAYSG(R) 2.3732 5.3844 21.1451 20.9459 
SISDFPTPEG(K) 1.0944 1.6442 5.3760 6.6336 
          
Cthe_0625 CelQ F85.C F86.C F87.C F88.C 
SQIDYALGSNPDN(R) 2.8606 5.2884 8.9216 8.5706 
          
Cthe_1307 SbdA F85.C F86.C F87.C F88.C 
EGIVVGSGDIINP(R) 0.0210 0.0408 0.0397 0.0573 
          
Cthe_0543 CelF F85.C F86.C F87.C F88.C 
ELFTFADTT(R) 2.1730 4.5205 14.8190 11.6517 
          
Cthe_3080 OlpA F85.C F86.C F87.C F88.C 
DIAEGVIYHSY(K) 0.0007 0.0049 0.0053 0.0064 
          
Cthe_3079 Orf2p F85.C F86.C F87.C F88.C 
FENTPVMPGA(K) 0.0166 0.0669 0.0542 0.0626 
 
 202 
          
Bovine Serum Albumin F85.C F86.C F87.C F88.C 






Andrew Dykstra was born in Oak Ridge, TN and was educated in the Jefferson 
County, TN public school system.  He graduated from Jefferson County High School in 
2000.  After spending brief periods of time in Charleston, SC and Pushkino, Russia, he 
enrolled at Boston University, where he double majored in biochemistry and philosophy.  
He was introduced to the field of mass spectrometry by participating in undergraduate 
research in Catherine Costello’s lab at the Boston University Mass Spectrometry 
Resource throughout his undergraduate career.  He received his B.S. in 2005.  After a 
year of professional pizza-making, he eventually enrolled in the graduate chemistry 
program at the University of Tennessee, where he studied analytical chemistry under 
Kelsey Cook and Robert Hettich.  He expects to receive his Ph.D. in chemistry in May 
2011. 
